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Toxoplasma gondii and Neospora caninum are intracellular protozoan parasites 
from the phylum Apicomplexa. Both parasites share many morphological and 
genetic features, but have diverse host preferences. While T. gondii can infect any 
warm-blooded animal including humans, N. caninum does not. The basis of host 
preference in these two parasites is unknown, but could be due to differences in 
tropism to specific host cells. The discovery of differences between host cell 
responses could lead to a better understanding to why T. gondii can lead to disease 
in humans and N. caninum cannot, specifically related to infection of the CNS. 
To investigate the differences in host cell response, the differential expression 
patterns of host-cell transcripts and proteins as well as protein secretions and 
dopamine level during the invasion of human astrocyte (HA) cells by both 
Toxoplasma and Neospora were investigated. Proteomic investigations were 
achieved by global proteomic profiling of human astrocytes during infection using 
two dimensional difference gel electrophoresis (2D-DIGE) and a quantitative label-
free approach. Transcriptomic investigation of infected human astrocytes was 
carried out using an RNA-Seq approach.  
A number of differences in host cell response genes/proteins were noted between 
Toxoplasma and Neospora infection. Transcriptome analysis revealed differential 
expression of host cells transcripts associated with cell adhesion and cytokine 
receptor interaction pathways. Differences were observed in cell adhesion 
molecules (such as VCAM1 and NCAM2) and chemokines (such as CCL2), which 
were up-regulated in T. gondii infected cells compared to N. caninum infection. 
Whereas up-regulation of neutrophil activation was identified in N. caninum 
infected cells compared to T. gondii infection. Host cell secretome analysis during 
infection identified significant changes in many secreted proteins such as cytokines 
chemokines and cell adhesion molecules (i.e. CXCL1, CXCL2, IL8 and ICAM1).  This 
data suggested that the two parasites stimulate different host cell responses. 
Dopamine acts as a neurotransmitter in the brain and the induction of dopamine 




gondii. Dopamine levels were measured in dopaminergic PC-12 cells during 
infection by T. gondii and N. caninum through tachyzoite conversion to the 
bradyzoite stage. Increased levels in dopamine production was observed in 
dopaminergic cells infected with T. gondii, compared to no changes in cells infected 
with N. caninum. This result suggested that T. gondii modifies the host’s behaviour 
(rodents), whereas the successful vertical transmission of N. caninum in cattle has 
led the parasite to not need to alter changes in the host’ brain. 
Overall, differences were mostly observed in molecules associated with cell 
adhesion and cytokine receptor signalling pathway, which may suggest why T. 
gondii is more successful in host cell infection of the CNS compared to N. caninum. 
Dopamine measurements of host cells during infection has also confirmed that T. 
gondii induces significant production of dopamine in infected host cells compared 
to N. caninum infection, suggesting different modulation of the host cell between 
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 Chapter one: Introduction 
 
 
 Toxoplasma gondii and Neospora caninum 
Toxoplasma gondii and Neospora caninum are intracellular protozoan parasites of 
wide clinical and veterinary importance. They are members of the phylum 
Apicomplexa, class Sporozoa and subclass Coccidia. Other members of the 
Apicomplexa include Plasmodium, Cryptosporidium, Theileria and Eimeria. It was 
only in 1984 that N. caninum was distinguished from T. gondii as a separate species 
(Bjerkas et al. 1984), and later described and characterised by Dubey et al. in 1988. 
The parasite was identified in Norwegian dogs causing severe encephalomyelitis 
and had no antibodies to T. gondii (Bjerkas et al. 1984). The two parasites were 
distinguished based on three main differences. First was the clinical outcome of the 
disease where N. caninum causes paralysis especially in the hind limbs in dogs was 
not detected in T. gondii infected species. Differences in the tissue cysts were also 
distinct between the two parasites and antibodies of T. gondii were absent in the 
infected dogs (Dubey et al. 2002). 
These two parasites are closely related and share many genetic, physiological and 
morphological similarities (Dubey 2009). Yet, there have been differences detected 
between T. gondii and N. caninum that resulted in their placement in separate 
genera (DeBarry & Kissinger 2011; Dubey et al. 1988a). The definitive host of T. 
gondii is the cat (felidae family) and in N. caninum is the dog (canidae family). While 
T. gondii can infect any warm blooded host including humans (Montoya & 
Liesenfeld 2004), N. caninum has not been found to be zoonotic and has a more 
restricted host range (Dubey et al. 2007), although it can infect human cells in vitro.  
Toxoplasmosis is a cosmopolitan disease of humans and animals (Dubey & Schares 
2011); it is estimated that nearly one third of the world’s population is infected with 
T. gondii (Montoya & Liesenfeld 2004). N. caninum is the causative agent of the 
Neosporosis; a disease mainly of cattle and dogs.  It infects a more restricted range 
of animals as intermediate hosts, but mostly has a major impact as a pathogen of 




gondii is the only known species in Toxoplasma; there are two known species in 
Neospora; N. caninum and N. hughesi (Hemphill & Gottstein 2000).  
 
 Life cycle of T. gondii and N. caninum 
Both T. gondii and N. caninum have similar life cycles (Figure 1.1) but they differ in 
the definitive and intermediate hosts they can infect. They have complex life cycles 
which include a sexual cycle occurring in the definitive host and an asexual cycle in 
the intermediate host (Lindsay, Dubey & Duncan 1999; McAllister et al. 1998). 
Vertical transmission is of high importance in N. caninum infection, in which the 
disease is transmitted to the foetus via the placenta that can result from a newly 
acquired exogenous infection or reactivation of an endogenous infection (Trees & 
Williams 2005). Whereas in T. gondii infections; transmission mainly occurs through 
the horizontal route. 
Three main parasitic stages are involved; tachyzoites, bradyzoites (tissue cysts) and 
the oocysts. The definitive host, which is the cat in T. gondii and dog in N. caninum, 
is infected through digestion of contaminated food or water, or from transplacental 
transmission of tachyzoites to developing foetuses (Barber & Trees 1998; Dubey et 
al. 1988b). The parasites are then liberated and the sexual stage occurs in the gut 
epithelium. When intermediate hosts ingest contaminated substances with oocysts, 
sporozoites are released from the oocysts and differentiate into tachyzoites, which 
spread through the circulatory system to different tissues and organs (Montoya & 
Liesenfeld 2004; Gibney et al. 2008; Williams et al. 2009). Tachyzoites multiply in 
parasitophorous vacuoles (PV) asexually in intermediate hosts through a process 
called endodyogeny, in which two progeny form within the parent parasite 
(Goldman, Carver & Sulzer 1958; Sheffield & Melton 1968). Unsporulated oocysts 
are excreted in the faeces of the definitive host and sporulate in the surrounding 
environment (Dubey et al. 2007). In the latent stage (chronic form) of infection, 
tachyzoites are converted into the cyst forming bradyzoite stages which are mostly 







Figure 1.1: Life cycles of a) T. gondii and b) N. caninum. An oocyst, after being shed by the definitive 
host, sporulates and is ingested by an intermediate host; where sporozoites then invade cells lining 
the gut and form tachyzoites which then migrate to tissues. Infection transmission can then occur 
horizontally by a definitive host ingesting infected tissue and the cycle proceeding through the sexual 
stages, or vertically through the placenta of intermediate hosts. Tachyzoites can convert to tissue 
cysts and encyst in tissue such as the brain and muscles in T. gondii and N. caninum infections. 







1.2.1 Tachyzoite stage of T. gondii and N. caninum 
The tachyzoite is a motile fast multiplying form of the parasite; involved in the 
establishment of the acute stage of infection. Tachyzoites replicate every 6 to 8 
hours within host cells in the parasitophorous vacuole (PV). Tachyzoites in T. gondii 
and N. caninum have similar structures; they are crescent shaped with a pointed 
anterior end and a rounded posterior end (Figure 1.2). Their sizes are usually 2 x 6 
μm in T. gondii and slightly larger in N. caninum at 7.5 x 2 μm and contain numerous 
organelles. They contain a unique cytoskeleton (subpellicular microtubules, conoid, 
inner membrane complex), secretory organelles (rhoptries, micronemes, dense 
granules), mitochondrion, apicoplast, eukaryotic, nucleus, endoplasmic reticulum, 
Golgi apparatus and ribosomes, all surrounded by a complex membrane structure 
called the pellicle (Gustafson, Agar & Cramer 1954; Ferguson & Dubremetz 2007). 
They are able to invade host cells by penetrating the host cell membrane using their 
secretory organelles.  
 
 
Figure 1.2: Diagram of a T. gondii tachyzoite, which also represents the same diagram in N. caninum 





1.2.2 Bradyzoite stage 
Bradyzoites are intracellular, slow replicating, quiescent form of the parasites and 
are an indication of the chronic stage of the disease. Morphological features of this 
stage include the presence of a thick wall surrounding the cyst (Figure 1.3) 
containing parasite glycoproteins that may be associated with protection of the 
parasite from the host’s immune defence (Zhang et al. 2001). When comparing 
bradyzoite with tachyzoite stage; bradyzoites are more slender, the nucleus is 
located more towards the posterior end of the parasite and bradyzoite replication 
does not cause the rupture of host cells (Dubey & Lindsay 2006; Zhang et al. 2001). 
In the CNS, in vivo studies demonstrated that T. gondii encysts in neurons and 
astrocytes (Ferguson & Hutchison 1987; Fischer et al. 1997). These cysts do not 
induce host inflammatory reactions and may persist throughout the host’s life span 
(Hill & Dubey 2002). Tissue cysts of T. gondii are usually spherical shaped 
surrounded by elastic walls (0.5 um), the size of bradyzoites can reach up to 100 μm 
containing hundreds of parasites. In N. caninum, tissue cysts are round or oval 
shaped and can reach up to 107 μm in size, cyst walls thickness can reach up to 4 




Figure 1.3: Bradyzoite cyst stage in host cells infected with T. gondii or N. caninum; a) T. gondii 
bradyzoite thin cyst wall stained with haematoxylin & eosin, b) T. gondii bradyzoite enclosing 
hundreds of bradyzoites (unstained), c) A thick walled (black arrow) N. caninum tissue cyst stained 
with haematoxylin & eosin, (taken from Dubey et al. 2007). 




 Secretory organelles of T. gondii and N. caninum 
All members of the Apicomplexa comprise an apical complex in one or more stages 
of the life cycle, a collection of organelles involved in host-cell invasion process 
(Dubremetz et al. 1998). The organelles of the apical complex in both T. gondii and 
N. caninum include rhoptries, micronemes and dense granules. Rhoptries are 
secretory organelles essential in host cell invasion in T. gondii and N. caninum and 
are associated with virulence in T. gondii tachyzoites (Bradley et al. 2005). They 
include rhoptry neck proteins (RONs) that form elongated necks which function as 
ducts to discharge their contents, and rhoptry proteins (ROPs) that form  large, club 
shaped secretory organelles (Bannister et al. 2003; Bradley et al. 2005). In T. gondii; 
ROP5, ROP16 and ROP18 have been associated with virulence (Reese et al. 2011; 
Saej et al. 2007; Peixoto et al. 2010). ROP18 destabilizes interferon gamma 
response of the host to prevent the rupture of the PV. Micronemes (MICs) are the 
smallest organelles that vary in their numbers in different Apicomplexa parasites 
and are involved in the early phase of the invasion process by attachment and 
penetration of the host’s cell (Dubey & Lindsay 1996). Microneme proteins such as 
MIC1 enables the attachment to host cells through their adhesive domains and 
MIC1 also can form a complex with MIC4 and MIC6 that is associated with invasion 
(Garnett et al. 2009; Reiss et al. 2001). Dense granules (GRA) are involved in the 
establishment and maintenance of the PV during and after host cell invasion 
(Bannister et al. 2003; Speer et al. 1999). The conoid is a fibrous spiral-shaped 
structure which plays a role in invasion (Del Carmen et al. 2009) and the apicoplast 
is a non-photosynthetic plastid found in most Apicomplexa (Zhu et al. 2000).  
 
 
 Host cell invasion by T. gondii and N. caninum   
The host cell invasion process takes place rapidly in a sequential series of events. 
Tachyzoites first move the host cell surface through an active actin-myosin driven 
motor called the gliding motility (Kappe et al. 2004). At first, the parasite must 




surface (Nichols, Chiappino & O'Connor 1983), followed by the formation of the 
‘moving junction’ with the host cell membrane, using surface antigen proteins and 
proteins secreted from the micronemes and rhoptries (Besteiro et al. 2009). The 
parasite forms a parasitophorous vacuole (PV), where the membrane consists of 
host cell plasmalemma with integrated parasite proteins (Beckers et al. 1994). The 
mitochondria and endoplasmic reticulum (ER) of the host accumulate around the 
PV (de Melo et al. 1992); host transmembrane proteins are left out so that the 
vacuole is incapable to fuse with lysosomes and is shielded from host immune 
defences (Mordue et al. 1999).   
 
 Differences between T. gondii and N. caninum  
There are ultrastructural differences between the two parasites (Speer & Dubey 
1989). The size of N. caninum tachyzoite is slightly larger than T. gondii. 
Micronemes are more numerous in N. caninum (Speer et al. 1999) and the number 
of rhoptries in N. caninum is six to sixteen compared to four to ten in T. gondii 
(Speer et al. 1999). Electron-dense rhoptries of N. caninum tachyzoites are similar 
to the mature bradyzoites of both species, whereas in T. gondii are spongy and 
electron-lucent (Speer et al. 1999). Cyst walls of the bradyzoite stage in T. gondii are 
smooth and less than 0.5 μm thick and may contain hundreds of bradyzoites, 
whereas in N. caninum they tend to have irregular thick cyst walls (≤ 4 μm) but are 
smaller in size and contain fewer bradyzoites when compared to T. gondii tissue 
cysts (Figure 1.2) (Speer et al. 1999). Also, the number of oocysts shed in cats faeces 
are high and can reach up to millions of oocysts in comparison the dog which sheds 
less amounts of oocysts and can only reach up to 500.000 oocysts (Gondim et al. 
2005). 
Differences have been also associated with variances in surface antigens and 
secreted virulence factors; the number of surface antigen proteins were found to be 
increased in N. caninum (227) compared to T. gondii (109) (Reid et al. 2012; 






 Pathogenesis and clinical outcome of T. gondii and N. 
caninum infection 
Human infection with T. gondii can occur as a result of food or water contamination 
and organ transplantation or blood transfusion from individuals infected with T. 
gondii (Siegel et al. 1971). During pregnancy, a mother infected with T. gondii can 
transmit the parasites to the foetus; as these parasites can cross the placenta 
(Dubey & Jones 2008). As a result, severe congenital toxoplasmosis, hydrocephalus, 
abortion or death of the foetus inside the uterus may occur (Desmonts & Couvreur 
1974; Holliman 1995). Other congenital clinical symptoms might include infection of 
the eyes (retinochoroiditis), which can lead to blindness and also mental 
abnormalities (Wilson et al. 1980; McAuley et al. 1994). Toxoplasma infection in 
immune supressed individuals, such as HIV/AIDS patients, may cause toxoplasmic 
encephalitis (TE) that can be fatal (Carruthers & Suzuki 2007).  
Neosporosis can cause disease in dogs and more significantly in cattle. N. caninum 
transmission from mother to foetus in cattle is a major cause of abortion, stillbirth 
and clinical disease in new-born calves (Williams et al. 2000). In pregnant cattle, 
multiplication of the parasite can occur in the placenta through its entry to the 
foetal bloodstream, along with activation of pro-inflammatory cytokine and 
chemokines in the placenta can lead to tissue damage (Buxton et al. 2002; Innes et 
al. 2007). The parasite can cross endothelial barriers and reach the CNS of the 
foetus, in which it is purposed to reach the CNS through infection of dendritic cells 
(Collantes-Fernandez et al. 2012). In dogs, the disease manifests as neuromuscular 
dysfunction (Dubey 2005; Dubey et al. 2009). In severe cases in young, congenitally 
infected pups, hind limb paresis occurs and may progresses to paralysis. Additional 
symptoms in dogs include difficulty in swallowing, paralysis of the jaw, muscle 





1.5.1 Economic impact of T. gondii and N. caninum 
T. gondii causes toxoplasmosis in humans and animals. It is estimated that 16-40% 
of the population in the United States of America and the United Kingdom are 
infected with T. gondii. In Central and South America the infection rate is higher 
where it can reach from 50- 80% (Dubey et al. 1988). The socio-economic impact of 
the disease causes increase costs in healthcare, such as children with blindness 
(Roberts et al. 1990). In the United states, Toxoplasmosis was identified as the 
second primary cause of foodborne illness and around 4800 ocular infections are 
detected annually (Scallan et al. 2011; Jones & Holland 2010). 
N. caninum has an economic impact especially in cattle and also causes pathology in 
dogs. Bovine neosporosis effects dairy and beef industries around the globe. In the 
United Kingdom, Neosporosis is the causative agent of abortion in cattle at an 
estimated number of 6000 abortions annually (Davison, Otter & Trees 1999b). A UK 
study into occurrence in cattle found that over 90 % of herds had at least one cow 
seropositive for N. caninum (Woodbine et al. 2008). Substantial economic losses 
result from abortion and stillbirths, reduced milk yield and reduced weight gain 
(Barling et al. 2000). 
 
 Host immune responses during T. gondii or N. caninum 
infection 
During parasitic infection with T .gondii or N. caninum the host generates an 
immune response to the invading tachyzoites in order to control their spread and 
limit cell damage. Immune responses in hosts during T. gondii infection differ 
according to the parasite burden, type of parasitic strain and the host immune 
status (Suzuki & Remington, 1993). As T. gondii and N. caninum are closely related, 
similarities in host immune response have been detected. The host produces a Th1 
immune response through up-regulation of interleukin-12 (IL12) by different cell 
types such as macrophages, neutrophils and dendritic cells leading to the induction 




Wilson & hunter 2004; Innes et al. 1995). IFN-γ is a cytokine that is important in 
control of infection in both acute and chronic stage of disease (Suzuki et al. 1988; 
Gazzinelli et al. 1993; Innes et al. 2002). Under the protective immune response of 
the host, parasites are compelled to convert from tachyzoite to bradyzoites. These 
cysts can be found in different sites and organs but are mainly detected in muscle 
tissue and the CNS, persisting throughout the host’s life (John, Weninger & Hunter 
2010; Dubey & Lindsay 1996). In immunosuppressed hosts such as individuals with 
AIDS; the production of IFN-γ decreases as a result of the low level secretion of 
CD+4 T helper cells, thus reactivation of the parasitic infection in the brain reoccurs, 
where tachyzoites are reactivated from bradyzoite cysts and cause Toxoplasma 
encephalitis or even cause death (Luft & Chua 2000). In N. caninum infection, if 
tachyzoites reach the CNS, they can cause clinical signs of abortion of the foetus in 
cattle or neurological outcomes (Dubey & Lindsay 1996; Hemphill 1999). During 
pregnancy in infected cattle with N. caninum, Th1 immune responses as a result of 
infection may harm the foetus and therefore is reduced (Innes et al. 2001). In 
return, the Th2 response is elevated through the production of immune regulatory 
cytokines such as interleukin-10 (IL10) by the placental tissue (Quinn, Ellis & Smith 
2004; Quinn, Miller & Ellis 2002; Innes et al. 2007).  
 
 The involvement of T. gondii in behavioural changes and 
neurological disorders 
In recent years, there has been more interest in the possible involvement of T. 
gondii infection with neurological disorders (Torrey & Yolken 2003; Zhu 2009).  It 
has been proposed that T. gondii infection in the CNS may cause behavioural 
changes in humans (Flegr 2007). Toxoplasma infection has been suggested to be 
connected to many neurological diseases; such Parkinson’s disease through clinical 
observations of patients seropositive with T. gondii (Miman et al. 2010). There is 
evidence to indicate the possible involvement of T. gondii in modifying and 
increasing the hosts’ dopaminergic signalling in the CNS (Gaskell et al. 2009; 




changes and increased levels of dopamine (Stibbs 1985; Flegr et al. 2003; Gaskell et 
al. 2009; Prandovszky et al. 2011). Elevated dopamine production was also found in 
patients with schizophrenia (Torrey & Yolken 2003; Carlsson 1988; Howes & Kapur 
2009). Dopamine is a monoamine neurotransmitter formed in the brain by the 
decarboxylation of dopa and is needed for normal performance of the central 
nervous system. It is involved in important roles related to behaviour, cognition, 
voluntary movement and attention. Dopamine secretion is known to be involved in 
the modulation of neuronal activities linked to learning and memory functions in 
the hippocampus region of the brain (Backman et al. 2010).  
Many factors play roles in the determination of neurological outcomes related to 
toxoplasmosis such as genetic and environmental factors, strain of T. gondii 
acquired, age of individual infected, severity of the acute stage of disease, the 
ability of the parasite to reach important parts of the body such as the CNS and the 
host’s immune response (Murakami et al. 2000; Wilson & Hunter 2004). The 
parasite’s localization to specific parts of the brain could play a role in the host’s 
behavioural changes, especially in relation to fear responses (McConkey et al. 
2013). There have also been reported cases linking disorders and diseases such as 
depression, anxiety and psychoses in patients with the chronic stage of disease 
(Arendt et al. 1999; Torrey & Yolken 2003).   
 
 Importance of astrocytes in the central nervous system   
In the central nervous system (CNS), cells consist of neurons and glia cells. There are 
many types of glia cells such as astrocytes, microglia, oligodendrocytes and others: 
one of the most important glia cells are astrocytes (Figure 1.4). Astrocytes form the 
majority of the cells in the mammalian brain and are involved in the blood brain 
barrier (BBB) formation (Fields & Stevens-Graham, 2002). Moreover, they are 
important in cell-cell communication of neurons, defence against infectious 
organisms or traumatic injuries and provide homeostasis in the brain through 
neurite outgrowth and synaptic plasticity (Norenberg 1994; Pekny & Nilsson 2005; 







Figure 1.4: Images of human astrocytes in vitro using light microscopy and x40 magnification a) 
uninfected human astrocyte cells, b) cells infected with T. gondii and c) cells infected with N. 
caninum (red arrow indicated tachyzoite in parasitophorous vacuoles. 
 
Any damage occurring to astrocytes can seriously effect neuron survival and have 
also been linked to pathological outcomes of many neurological diseases such as 
Alzheimer’s disease and toxoplasmic encephalitis (TE) (Nedergaard et al. 2010; 
Drogemuller et al. 2008). In addition, astrocytes infected with T. gondii can decrease 
gap junctions between cells which may result in reduced communication between 
cells (Fischer et al. 1997). Astrocytes have been found to be infected to a higher 
extent with T. gondii compared to neurons and microglia cells in studies done both 
in vivo and in vitro (Halonen et al. 1996; Fagard et al. 1999; Luder et al. 1999). 
IFN-γ induction of astrocytes can inhibit and limit immune pathological responses of 
parasitic infection in both T. gondii and N. caninum (Wilson & Hunter 2004; 
Halonen, Taylor & Weiss 2001). During inflammatory responses, these cells are 
capable of chemokine and cytokine production in addition to them acting as antigen 
processing cells (APC) to the T cells (Brenier-Pinchart et al. 2004; Strack et al. 2002; 
Wilson & Hunter 2004).   
Human astrocytes used in this thesis were ethically approved for research purposes 
only and are a primary cell line that can be used up to five passages. There are some 
limitations associated with the use of these cells; such as the limitation of the 
number of passages used (five passages). N. caninum are arguably unlikely to infect 





Most of the comprehensive understanding about astrocytes has been achieved 
through in vitro studies. Therefore, in vitro cultures are an effective systems model 
for the study of pathological occurrence in the CNS, allowing a better understanding 
of host-parasite interactions. T. gondii and N. caninum have been found to infect 
astrocytes successfully in vitro (Pinheiro et al. 2006; Jesus et al. 2013). They are also 





 Methodologies for investigating host cell responses using 
proteomic and transcriptomic approaches  
 
1.9.1 Quantitative proteomics in host cell investigations 
Proteomic research deals with large scale profiling of protein expression levels, 
post-translational modifications (PTMs) and protein-protein interactions in many 
complex biological systems (Pandey & Mann 2000). Advances in mass spectrometry 
(MS) have broadened proteomic studies and enabled systems biology investigations 
that helped to solve important biological questions which were once considered a 
challenge (Aebersold & Mann 2003; Cravatt, Simon & Yates 2007). Generally, the 
classical way for many proteomic investigations include a protein separation step 
via gel based approaches and identification using MS, or a non-gel based approach 
by direct tryptic digestion of whole protein lysates into peptides before MS analysis. 
Protein or peptide fractionation is routinely utilised to increase proteome coverage 
and depth. Peptides are identified by MS then allocated to proteins by 





1.9.2 Gel based separation investigation methods 
In order for complex protein samples to be separated, a classical approach is usually 
performed using a gel matrix along with the application of an electric field. One of 
the earliest separation methods to be established was Sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) (Shapiro, Vinuela & Maizel 1967). It 
enables the breakdown of interactions between proteins through solubilisation, 
denaturation and reduction steps followed by separation using a polyacrylamide gel 
along with a current, in which the proteins then migrate according to their 
molecular weight (Rabilloud 1996). Two dimensional electrophoresis (2-DE) 
separations consists of first separating the proteins according to their isoelectric 
point (pI) where the protein net charge is zero and in the second dimension 
according to its molecular weight (O’Farrell 1975). Then, gels are stained for protein 
visualization and proteins of interest are excised, digested into peptides using a 
proteolytic enzyme (usually trypsin) and finally proteins are identified using MS 
techniques. However, 2-DE methods are difficult to conduct on multiple 
comparative studies and are time-consuming and labour-intensive, in which the gels 
need to be run, analysed, and compared. They also suffer from poor reproducibility 
between gels which may cause variability (Zhou et al. 2002). Thus, two dimensional 
difference gel electrophoresis (2D-DIGE) was developed.  
 
1.9.3 Two dimensional difference gel electrophoresis (2D-DIGE) 
investigations  
Introduced in 1997, 2D-DIGE is a high performance proteomic tool used for 
separation of complex samples (Unlu et al. 1997). The development of 2D-DIGE 
enabled a more sensitive and reliable quantification method for the estimation of 
protein abundance compared to 2-DE, as samples are run altogether on the same 
gel, which minimizes potential gel-to-gel variation (Kondo 2008). Basically, steps 
involved in 2D-DIGE involve directly labelling proteins using the lysine groups on 
proteins with different fluorescent (cyanine) dyes (Cye™ dyes, GE healthcare) prior 




second dimension through the application of an electrical field across a solid-based 
gel. Protein spots are then either directly scanned in the Cydye gels or stained first 
with a fluorescent stain for visualization of the proteins in the pick gel. Proteins of 
differential expression are selected using an appropriate software program such as 
Decyder 2D™ (GE Healthcare). Finally deferentially modulated proteins of interest 
are excised from the pick gel, digested into peptides and placed on a MS for protein 
identification followed by bioinformatic analysis (Westermeier & Gorg 2011).  
 
1.9.4 Non-gel based proteomic investigations 
There are numerous studies that have used 2D-DIGE for global proteomic profiling. 
Yet, this technique has many limitations; it requires a substantial level of skill, is 
time consuming, laborious and has many technical restrictions related to resolving 
proteins with high or low masses and has limited sensitivity (Zhu, Smith & Huang 
2010; Old et al. 2005). Therefore; alternative proteomic approaches using non-gel 
based techniques have been developed for quantifying protein changes between 
samples of interest. This can be applied through two approaches; label-based and 
label-free proteomic analysis.  
 
 Label- based quantitative methods 
In label based methods, such as stable isotope labelling, quantification is achieved 
by incorporating isotope labelled molecules into MS analysis as internal standards 
or relative references (Zhu, Smith & Huang 2010). This method involves the 
application of chemical and physical properties similar to the natural compounds of 
the samples to be investigated that enables the mass spectrometer to differentiate 
between identical proteins in separate samples. The labelled protein samples are 
then pooled together, digested, mixed and relative protein abundance changes are 
determined from ratios of intensities between the differentially labelled peptides 
(Gygi et al. 1999). Labelling approaches in ‘shotgun’ type experiments include stable 




2004), tandem mass tags (TMT) (Thompson et al. 2003),  isotope-coded affinity tags 
(ICAT) (Gygi et al. 1999; Smolka et al. 2001) and isobaric tags for relative and 
absolute quantification (iTRAQ) (Ross et al. 2004). These methods have enabled the 
identification and quantification of complex biological samples in systems biology 
approaches and in the reduction of variability between samples. However, most 
label-based quantification approaches have many limitations, including complex 
sample preparation, incomplete labelling and increased costs of these methods 
(Patel et al. 2009). Moreover, in the labelling approach, a higher sample 
concentration is needed and so far only TMT and iTRAQ methods can allow up to 
eight samples to be compared in a single experiment. Thus, non-labelled 
quantification procedures have been an interest for many researchers in the field of 
quantitative expression profiling of proteins (Panchaud 2008).  
 
 Label-free quantitative based methods 
Label-free approaches use raw data directly from multiple mass spectrometry runs 
to enable the comparison of the relative protein abundances in different protein MS 
runs (Wastling et al. 2012). In contrast to label based approaches, each protein 
sample is separately prepared, then subjected to individual LC-MS/MS analysis. 
They have many advantages over labelling techniques including low cost, simplicity 
and a lower concentration of samples are required. Moreover, it has a higher 
proteome coverage and dynamic range and numerous protein samples can be 
compared in a single experiment. High resolution MS/MS instrumentation along 
with multiple sample preparations is recommended in label-free quantitative 
approaches. However, as every sample needs to be separately prepared and run on 
the LC–MS/MS, steps extending from sample preparation to MS analysis can 
introduce variations which may cause bias in the the quantitative analysis. Relative 
quantification offers calculation of abundance ratios between peptides and proteins 
by comparing their signals created from different samples. Usually this approach is 
used in non-targeted based experiments. It allows global quantitative profiling of 
tens of thousands of peptides from thousands of proteins within an experiment 




determine the amount (mass or copy number) of proteins in a mixture or complex 
and is generally performed at the peptide level. Currently, there are two different 
protein quantification schemes in label-free quantification: spectral counting (Liu, 
Sadygov & Yates 2004) and peak intensity measurements (Bondarenko, Chelius & 
Shaler 2002). 
 
1.9.4.2.1 Spectral counting measurements 
Spectral counting relies on the practical observation that more abundant peptides 
are more likely to be observed and detected in an MS experiment and involves the 
observation of possible linear correlation between MS/MS spectra of peptides 
acquired from a certain protein to the relative concentration of the protein 
(Zybailov et al. 2005). Calculation of relative quantification is done by comparing the 
number of spectra between the experiments. While spectral counting is a fairly 
simple technique and is easily applied, normalization and cautious statistical 
evaluation are still necessary for accurate quantification, which can decrease 
significantly for proteins with only a few recognisable peptides and when the 
quantitative changes between experiments are small (Mallick & Kuster 2010).This 
method is also controversial due to the fact that it does not take in account any 
measurement of direct physical property of a peptide, it relies on the quality of the 
spectra and low abundant peptides may not be detected and measured. It also does 
not measure any direct physical property of a peptide and assumes the same 
linearity response for every protein. 
 
1.9.4.2.2 Peptide peak intensity measurements 
Ion intensity based method is produced by obtaining an ion chromatogram for each 
peptide precursor from the MS data and also measuring the peak area over the 
chromatographic retention time. It aligns precursor ion spectra of the same peptide 
of a sample from parallel runs according to their retention times (RT) and protein 




three peptides that have been matched to peptides for a given protein. This is done 
by comparing intensity values for each peptide between one or more experiments 
for relative quantification purposes. This method allows peptide measurements 
with high accuracy and wide dynamic range, especially when high-resolution mass 
spectrometers are used and can differentiate distinct peptides sequences with 
interfering signals of similar masses (Nikolov, Schmidt & Urlaub 2012).  
 
1.9.5 Liquid chromatography mass spectrometry (LC-MS) 
Liquid chromatography–mass spectrometry (LC-MS) is a powerful analytical 
technique that enables the separation using liquid chromatography (LC) combined 
with the mass analysis of mass spectrometry (MS). LC-MS has very high sensitivity 
and selectivity used in the separation, detection and identification of molecules of 
particular masses found in complex mixtures.  
 
 Reverse-phase high performance liquid chromatography (RPLC) 
 During the investigation of complex biological systems, it is recommended to 
introduce additional steps of separation to allow better resolution of the peptides. 
High performance liquid chromatography (HPLC) is a procedure in which molecules 
contained within a liquid mobile phase are forced under pressure through a 
stationary phase within a closely-packed column. In the stationary phase, 
compounds bind to the column based upon their chemical properties. In reverse 
phase (RP) HPLC, non-polar molecules are recollected while polar molecules are first 
to elute. The mobile phase solvent is adjusted along a gradient by increasing the 
acetonitrile content gradually, to elute the more polar molecules by increasing 






 Tandem mass spectrometry (MS/MS) 
Mass spectrometry determines the mass to charge ratio (m/z) of gas phase ions. 
Peptides are converted into the gas phase through an ionization source such as 
electrospray ionization source (ESI). The peptide mass (m/z) is measured by the 
detector followed by peptide fragmentation through collision with an inert gas. The 
mass (m/z) of the fragmented ions are then measured and used to determine the 
sequence of the peptide. Tandem mass spectrometry (MS/MS) includes multiple 
steps of MS selection in which fragmentation steps take place between the stages. 
Peptides are converted into the gas phase through an ionization source such as 
electrospray ionization source (ESI) as seen in a linear trap quadropole (LTQ) mass 
spectrometer. The three most abundant peptides identified from the gas phase by 
an initial spectrum search are fragmented by collision-induced dissociation (CID), 
followed by a second scan that measures mass to charge ratio (m/z) of the 
consequential fragments (MS/MS). Orbitrap mass spectrometer is a recent more 
accurate developed mass spectrometer instrument that has many advantages 
including high resolution of peptides, greater sensitivity and data acquisition that 
enables better identification and quantification of thousands of proteins during 
proteomic investigations (Makareov 2000; Beck et al. 2011). Basically in an Orbitrap, 
ions are trapped in an outer barrel like electrode, due to their attraction to the 
inner electrode through centrifugal force, ions end up cycling around the inner 
electrode and move back and forth in the central electrode in space which 
resembles a spiral form of movement. 
 Protein identification and bioinformatics analysis  
Following mass spectrometry analysis, the tandem mass spectra data needs to be 
compared to an in silico database for protein identification. This is done to ensure 
that all possible peptides cleaved with the proteolytic enzyme are searched from 
predicted proteins of interest of the organism’s genome. One of the major 
challenges in global proteomic expression profiling is processing large amount of 
data attained. Many database search tools have been developed for 




1999), Sequest (Eng, McCormack & Yates 1994), X! Tandem (Craig & Beavis 2004) 
and PEAKs (Zhang et al. 2012). These search tools identify peptides using algorithms 
that match the precursor and MS/MS spectral data to those from an in silico 
digestion of a translated genome. As a result, a score unique to the spectra 
searched against theoretical spectra of the specific organism is given. Otherwise, de 
novo sequencing of individual MS/MS spectrum can be achieved using certain 
software such as PEAKS (Zhang et al. 2012). In order to guarantee that peptides 
identified do not contain any false positives, the false discovery rate (FDR) is 
needed. This is done by re-searching the data with a false database generated by 
reversing amino acid sequences of the actual database used for the protein search, 
usually around 1% or less is accepted. In addition, proteins identified from LC-
MS/MS data analysis with only one peptide hit is excluded from the data search 
result.   
 
 Transcriptomics  
Within a biological system, the analysis of messenger RNA (mRNA) provides 
information of the changes happening in the cell at the transcriptional level. The 
two methods commonly used to measure the expression profile of the 
transcriptome are hybridization and sequence based procedures. Hybridization 
approaches usually include incubating fluorescently labelled complementary DNA 
(cDNA) with custom-made or commercial oligonucleotide microarrays and 
measuring the intensity of the fluorescent dye used (Bammler et al. 2005). 
Sequence based approaches determine the cDNA sequence directly. These 
techniques include expressed sequence tag (EST) libraries that use relatively low 
throughput cDNA (Gerhard et al. 2004), tag-based methods such as serial analysis of 
gene expression (SAGE) (Velculescu et al. 1995); cap analysis of gene expression 
(CAGE) (Kodzius et al. 2006) and massively parallel signature sequencing (MPSS) 
(Brenner et al. 2000) and were produced to deliver quantitative expression profiles 
in a high throughput manner in a cell or tissue organism. Quantitative polymerase 




numbers of sequences; therefore the development of RNA-Seq nowadays is the 
preferred technique.          
 
1.11.1 RNA-Seq 
RNA-Seq involves the sequencing of cDNA libraries generated from reverse 
transcription of mRNA. Sequencing techniques such as Sanger capillary sequencing 
is done through in vivo cloning of DNA in E. coli before sequencing with dye-labelled 
terminator dNTPs (Sanger et al. 1977). The application of next generation 
sequencing (NGS) has eased transcriptional investigations and eliminated the need 
of in vivo cloning. NGS requires either DNA synthesis, as used by the Illumina and 
454 Life Sciences (Roche) sequencing platforms, or through ligation as in SOLiD 
(Applied Biosystems) sequencing. The 454 platform is also known as the de novo 
sequencing platform uses emulsion PCR for generating libraries to perform 
pyrosequensing; reads generated are around 500 base pairs and are similar in their 
lengths. This platform is widely used for DNA and RNA sequencing for organisms 
without any reference genome available (Margulies et al. 2005).  SOLiD sequencing 
is done through a series of ligation runs of dinucleotides to adapters and each base 
is read twice (Shendure et al. 2005). Short reads produced from this platform are 
considered to be an accurate method but have a complex sample preparation and 
data processing procedure compared to other platforms such as Illumina. A new 
sequencing method developed by Helicos Biosciences is called ‘single molecule 
sequencing’ has been established (Harris et al. 2008), which requires only a small 
amount of mRNA material; but it is not yet widely accessible. Compared to 
microarray or cDNA sequencing, RNA-Seq is cheaper, involves less mRNA 
concentrations and has a high dynamic range for quantitation of transcripts with 
minimum background noise (Wang, Gerstein & Snyder 2009).  
Illumina sequencing preparation involves the generation of a cDNA library from the 
sample mRNA. They are then amplified through PCR reaction and bridges are 
formed between oligonucleotide primer on a flow cell (Bennett et al. 2005; Bentley 




attached are added to the flow cell is imaged then the dye removed and the next 
base is added and so on, until the whole sample has been sequenced. (Holt & Jones 
2008). Illumina increases accuracy of sequencing, but read lengths are much shorter 
(50-100 base pairs) compared to other sequencing platforms, so a reference 
genome to align to is needed. 
 
 Systems biology in host-parasite interactions 
Owing to advances in different genomic, transcriptomic and proteomic techniques; 
biological investigations in an organism is changing from components being 
examined individually, to a ‘systems biology’ approach. These advances have 
enabled the movement of studies focusing on single genes to broader integrative 
comprehensive studies (Wastling et al. 2012). In the last decade; systems biology 
has been of interest to many researchers, in which it allows deeper insight into 
genes and proteins involved in a complex cellular system and easing the 
investigation of the biomolecules roles, interaction and functions. Moreover, 
systems biology studies assisted in the integration of genomic, transcriptomic and 
MS based proteomic investigations of biological interactions that aided in the 
discovery of signalling pathways and networks of different organisms.  
 
 
 Current research in astrocytes proteome 
Astrocytes play major roles in brain injury and pathogenesis, yet, only a few 
analyses of the whole-cell proteome and secretome in astrocytes have been 
performed (Mark et al. 1996). Proteome and secretome investigations on astrocytes 
were carried out to examine their roles in neurological diseases and disorders such 
as Alzheimer’s disease, Huntington disease, schizophrenia and Parkinson’s disease 
(Nedergaard, Rodriguez & Verkhratsky 2010; Sofroniew & Vinters 2010; Molofsky et 
al. 2012). An investigation was carried out on neurons, astrocytes, 




nuclei sorting (FANS), in which a monoclonal antibody against the neuron specific 
splicing factor was applied. This approach identified 1755 cell-type-specific nuclear 
proteins that were involved in histone modifications, and regulation networks 
altered with normal brain aging or neurodegenerative disease (Dammer et al. 
2013). In another study using a 2-DE based analysis of the proteome of mouse 
astrocytes, Yang et al. (2005) identified 191 individual proteins mostly involved in 
nucleic acid binding, cytoskeleton and signalling proteins and the proteasome. 
Using 2D-DIGE, investigation of specific protein modifications was carried out in the 
hippocampus region of rat brains following spatial learning. A total of 42 proteins 
were found significantly modulated after 24 hours associated with cellular structure 
and cellular metabolism compared to uninfected rat brains (controls) (Monopoli et 
al. 2011). In addition, Alzheimer’s disease examination for biomarker detection and 
discovery in individuals was performed using 2D-DIGE, a putative indicator of 
neuroinflammation called YKL-40, was highly increased in Alzheimer patients and 
could be used as a biomarker for preclinical Alzheimer’s (Craig-Schapiro et al. 2010). 
Yet, viral infection in astrocytes was explored by 2D-DIGE, polyriboinosinic-
polyribocytidilic acid (polyI:C) was used to simulate immune activation by viral 
infections on mouse astrocyte conditioned medium (ACM). In total, 13 proteins 
were differentially expressed compared to uninfected ACM, among these proteins 
with significant expressions was matrix metalloproteinase-3 (MMP3), in which it can 
be associated with neurodevelopmental impairment (Yamada et al. 2014).  
Malignant mouse astrocyte cells were explored using 2D-DIGE to investigate 
metabolic programming in cancerous cells. Several changes were detected in 
isoenzymes associated with metabolic reprograming, such as the up-regulation of 
glycolytic enzymes to increase the use in glycolysis (Bentaib et al. 2014). 
 
 Proteomic investigations in host cells and parasitic infections 
Several proteomic studies done on T. gondii have elucidated the specialized 
invasion organelles and their composition, as well as proteins associated with the 
cytoskeleton (Xia et al. 2008; Bradley et al. 2005; El Hajj et al. 2006). Shin et al. 




caninum (KBA-2 and VMDL1) using 2-DE and found significant homology in the 
proteome and antigenic proteome profiles between them, though isolated from 
distinct geographical locations. In T. gondii investigation, tachyzoites of three 
different strains were compared using 2D-DIGE. Similar proteomic profiles were 
detected between type I (GT1 train) and type II (PTG strain) compared to type III 
(CTG strain). A total of 84 differentially expressed proteins were identified (Zhou et 
al. 2013).   
In host cell response during T. gondii infection; Nelson et al. (2008) described the 
proteomic analysis (2D-DIGE) of human foreskin fibroblasts (HFFs) during infection 
in vitro, in which modulations of the host metabolic pathways, including glycolysis, 
lipid and sterol metabolism, mitosis, apoptosis and structural-protein expression 
were detected.  
However, to date there have been no reported comparative proteomic studies of 
host astrocyte responses during T. gondii and N. caninum infection or any other cell 
type. 
 
1.13.2 Current research in astrocytes and other host cells transcriptome 
In relation to the use of RNA-Seq in exploring human astrocytes during parasitic 
infection, to date there have not been any studies published. The investigation of 
increased expression of astrocyte cell markers in schizophrenia and its association 
with neuroinflammation was done using RNA-Seq and has showed that patients 
with schizophrenia had increased expression of glial fibrillary acidic protein (GFAP) 
and hypertrophic astrocyte morphology (Catts et al. 2014). A study that localised 
Alzheimer’s disease in the parietal cortex of the brain and its involvement in the 
early symptoms of the disease in humans was carried using RNA-Seq. The authors 
identified transcriptional profile changes related to lipid metabolism and concluded 
that astrocytes are associated with neurodegenerative disorders (Mills et al. 2013). 
Gail, Gross & Bohne (2001) explored transcriptional changes of human foreskin 
fibroblast (HFF) cells during T. gondii infection compared to Salmonella typhimurium 




Interluikin-6 (IL6) and tumour necrosis factor-inducible gene 6 (TNFAIP6)) up-
regulated exclusively in infected cells with Toxoplasma. Another study examining 
the functional changes in the central nervous system (CNS) in vivo in mice during 
chronic T. gondii infection found that genes involved in immune responses and cell 
activation were up-regulated in the mouse brain after infection (Tanaka et al. 2013). 
In addition, host transcripts whose expression was reduced by infection were 
involved in small-GTPase-mediated signal transduction and vesicle mediated 
transport (Tanaka et al. 2013). Jia et al. (2013) examined transcriptional changes of 
brain tissues and peripheral lymphocytes of BALB/C mice infected with T. gondii RH 
and ME 49 strain along with uninfected mice through microarray hybridization and 
qPCR. Genes associated with immunity were up-regulated higher in ME49 strain 
infection, whereas up-regulated pathways associated with pathogenesis of the CNS 
was up-regulated significantly compared to ME49 infection.  
 
 RNA-Seq in T. gondii and N. caninum parasite investigation 
In a comparative transcriptome study between T. gondii and N. caninum 
tachyzoites; an expansion in the number of surface antigens were identified in N. 
caninum compared to T. gondii tachyzoite stage using RNA-Seq. Furthermore, 
differences between the two parasites regarding secretory virulence factors found 
in T. gondii, specifically rhoptry kinase 18 (Rop18) which was found to be a 
pseudogene in N. caninum (Reid et al. 2012). 
 
 
 Secretome investigations in host cells  
The secretome consists of proteins secreted or shed from the cells surface of an 
organism. Many of these proteins play essential roles in many physiological 
processes in a cell; such as cell signalling, communication, migration and tumour 
differentiation and invasion (Weston & Hood 2004). The word ‘secretome’ was first 




subtilis bacteria. Protein secretion is believed to be a balanced procedure essential 
for the normal physiological functions in host cells. In mammalian cells, secreted 
proteins are complex and closely regulated and have vital roles in physiological and 
pathological processes (Hathout 2007). Tissues in mammalian host such as the brain 
and muscle secrete several biological molecules. Any excess or enduring changes in 
the secretion of these secretory proteins may indicate a sign of abnormalities or 
pathological condition (Hathout 2007). Secretome analysis has been widely used in 
the many research fields, such as host-tumour communication, host-pathogen 
interaction and drug/vaccine development (Ochsenbein 2002; Sibbald et al. 2009; 
Brey 2005). 
Challenges associated with secretome studies include; sample preparation, 
filtration, in which potential cytosolic protein contaminants in supernatant can be 
present and low protein concentrations of the secreted proteins.  
 
 Methods for secreted protein identification 
While computer based genome analysis is an indirect approach for secreted protein 
identification using amino acid sequence information, proteomic based methods 
enabled a direct investigation of the secreted proteins in a different range of 
biological systems (Thouvenot et al. 2006). Label free quantitative proteomics is 
used nowadays widely; especially in neuroproteomic and secretome studies, owing 
to the advances and improvements in MS instrumentation (Findeisen & Neumaier 
2009). An additional computational step can authenticate secreted proteins from 
other cytosolic proteins through peptide signal sequences database search tools 
such as SignalP and SecretomeP (Bendtsen et al. 2005; Petersen et al. 2011).   
 
 Astrocyte importance in secretome investigations 
Astrocytes secrete proteins that are important for neuronal growth, neurogenesis, 
development and survival and synaptic development. These are mediated by the 




factors and proteases (Bachoo et al. 2004). Also, astrocytes have been identified as 
a source for chemokine secretion and may participate in the infiltration process of 
leukocytes (Krumbholz et al. 2006)  
Through studying secreted proteins in vitro, this can assist in understanding the 
biological processes happening in cells in vivo. Though in vitro investigations cannot 
exactly comprehend all cellular interactions under in vivo conditions, it is a valuable 
method for mapping quantified secreted proteins and enables metabolic pathway 
analysis in a biological system.   
 
 
 Current research in astrocytes secretome 
While the first secretome studies were conducted on bacteria and fungi (Antelmann 
et al. 2001), there are now many investigations of the mammalian secretome. 
Major advances in the proteomic studies of the cells secretome have occurred 
during the past seven years, owing to the improvements in proteomic techniques 
and especially in MS (Brown et al. 2012). This has been applied in the systematic 
investigation of secreted proteins of astrocytes (Greenbaum et al. 2001; Dowell, 
Johnson & Li 2009), microglia (Liu et al. 2008) and other glial cells (Chen et al. 2012). 
Characterization of the whole cell proteome and secretome in astrocytes using 
label-free quantitative proteomics coupled with high resolution MS identified 6000 
proteins (Han et al. 2104). In supernatants of astrocytes infected with T. gondii, 
induction of matrix metalloproteinase-2 and -9 lead to fibronectin degradation, 
which is associated with extracellular matrix degradation and was detected by 
western blot (Lu & Lai 2013). Moore et al. (2009) identified 133 secreted proteins 
involved in neuronal development in primary rat astrocytes using a label-free 
quantitative method.  These included proteins of the extracellular matrix and 
protease systems that were induced by astrocyte cholinergic stimulation. 
Neuroinflammation of astrocyte-derived cytokines and chemokines play both 
neuroprotective and neurotoxic roles in brain lesions of human neurological 




profile of human astrocytes using a protein microarray approach. Results showed 
that astrocytes expressed a distinct set of NF-kB-target cytokines and chemokines, 
that may suggest that NF-kB signalling pathway, regulates gene expression of 
cytokines and chemokines in human astrocytes under physiological and 
inflammatory conditions.   
 
 Aims and objectives 
The main aim of this thesis was to explore differences in host response (in HA cells) 
and host-parasite interactions that reflect the divergent evolutionary biology and 
life cycles between the closely related parasites T. gondii and N. caninum. This will 
be achieved by the investigation of differential transcriptional/proteomic and 
protein secretion expression changes during host cell responses to T. gondii 
infection compared to N. caninum infection. Examining N. caninum bradyzoite cysts 
involvement in neurotransmission induction through dopamine stimulation in 
neural cells compared to T. gondii cysts infection in cells will be achieved through 
dopamine concentration measurements using HPLC.  
In order to compare differences of human astrocyte cell responses during infection 
with either T. gondii or N. caninum at the molecular level, both proteomic (2D-DIGE 
and label-free proteomic) and transcriptomic approaches were carried out. The 
analysis of host cell protein secretions during infection was also further investigated 
through global proteomic profile analysis using a label-free quantitative method. 
This was important as astrocytes are known to secrete signalling and inflammatory 
proteins during infection and injury and is associated with leukocyte trafficking. 
RNA-Seq provided a high-throughput platform from which to analyse and examine 
the differences in expression of key genes between host cell infections with T. 
gondii compared to N. caninum.  
Although both parasites; T. gondii and N. caninum can infect and reach the CNS of 
the host, T. gondii causes more pathology and behaviour changes in the brain of 




relation to the pathology caused by N. caninum in the CNS found mainly in dogs and 
cattle that may suggest it may not cause severe pathogenesis of the CNS.  
Therefore, investigation of cells related to the CNS such as the use of astrocytes 
during infection with T. gondii and N. caninum will elucidate our understanding of 
differences that may be present between them. Astrocytes have been 
demonstrated to be good models for system biology investigations as both T. gondii 
and N. caninum can successfully infect these cells in vitro (Halonen et al. 1998; 
Pinheiro et al. 2006).  
It has already been established that infection of T. gondii in the brain at the chronic 
stage increases dopamine secretion and was believed to be associated with 
behavioural changes in the intermediate host in mice to enable the transfer   of the 
parasite to the cat through the cat mouse cycle (Gaskell et al. 2009; Prandovszky et 
al. 2011). However, it is not known if N. caninum can alter behaviour or other 
changes in the CNS host cells.  
The current information on the cell biology and particularly the molecular aspects of 
host-parasite interactions, obtained from T. gondii were applied to N. caninum. Yet, 
in many cases this has been done without cautiously assessing potential differences 
between the two parasites. Therefore, it is important to elucidate what Neospora is 
doing differently compared to Toxoplasma in host cell of the CNS, and how we 
could exploit these differences to generate a better understanding of key 
differences between them that can result in the production of an efficient 
therapeutic or diagnostic tool of intervention in the future. 
Overall, this thesis aimed to increase the knowledge of host biological responses in 
astrocytes during parasitic infection between these closely related parasites that 
would enable a broader understanding of changes occurring in the CNS intending to 
identify key differences in responses that will help explain the difference in the 






 Chapter two: Global proteomic investigation of host 




T. gondii and N. caninum can both reach different sites in the host including the CNS 
and modulate changes in the host cells. These two parasites, although closely 
related, have distinct differences in their host range and definitive hosts. To 
understand the mechanisms of host cell modulation during parasitic infections, it is 
very important to consider the effects the parasite has upon the host cell machinery 
which often includes changes both at the gene and protein level. Technological 
advances in protein separation methods, mass spectrometry and bioinformatics 
analysis have facilitated the ability to study global proteomic profiles of cells and 
organisms (Aebersold & Mann 2003; Schrader & Klein 2004). These techniques are 
more useful to use for global proteomic profiling compared to traditional 
approaches such as western blot analysis or immuno-cytochemical methods, which 
only help to examine one or a few proteins at a time. Thousands of proteins can be 
examined in multiple samples in a quantitative manner through global proteome 
analysis which has become one of the preferred approaches (Tannu & Hemby 
2006). Quantitative proteomic techniques have facilitated examination of 
intracellular parasite invasion revealing novel protein modulation of host-pathogen 
interactions (Nelson et al. 2008). It has also assisted in important advances in the 
measurement of protein expression changes between normal and disease 
conditions and conveys corresponding analysis of proteins within samples 










One of the main advantages of 2D-DIGE over the conventional 2-D techniques is the 
ability to label two to three samples with different dyes and run them all on the 
same gel, thus reducing spot pattern variability, the number of gels used in an 
experiment and yielding accurate spot matching. As a result, the confidence that a 
difference between two samples in fluorescence intensity is due to biological rather 
than experimental variation is increased (Van den Bergh et al. 2003). This technique 
has demonstrated that it can generate statistically significant data using fewer 2D 
gels (Alban et al. 2003; Friedman, Hoving & Westermeier 2009). At the time of 
preparing this experiment; the combination of 2D-DIGE, mass spectrometry and 
bioinformatics approach was deemed to be a powerful tool for comparative 
proteomic investigations, but now has been superseded by the technological 
advances in the field. Mass spectrometry is needed for the identification of the 
proteins corresponding to any spots observed by 2D-DIGE; the data is then searched 
against the gene and literature database to interpret the proteomic data. 
Bioinformatics helps in determining the proteomic signatures responsible for the 
main pathological features and identifying key proteins, which could be candidates 
for disease markers and therapeutic targets (Hopf et al. 2011). The use of 
bioinformatics, together with the information of the individual proteins identified 
by 2D-DIGE, gives a clearer view host parasite interactions (Xi et al. 2011). 
Using 2D-DIGE involves prelabelling two protein samples, using two fluorescent 
cyanine dyes (Cy3™ and Cy5™), in addition to a pooled sample of both proteins 
labelled with a third dye (Cy2™). Labelled samples can then be mixed and run on 
the same 2D gel where proteins are detected and visualised using fluorescence 
imaging. This enables the detection of differences between protein abundance and 
any post translational modifications taking place in the two samples. An overview of 
the 2D-DIGE workflow is outlined in Figure 2.1. Scanned gels are analysed using 2D 
DeCyder™ software containing ANOVA test and t-test to detect the fold change of 
the protein expression levels. The proteins of interest can then be excised from the 




mass spectrometry (LC-MS/MS). Protein identification was performed using 
database search engines such as MASCOT along with bioinformatic analysis.  
 
 
Figure2.1: Schematic of a typical 2D-DIGE experiment. Proteins from samples are first extracted, 
labelled with different fluorophores (Cy2, Cy3, and Cy5) and are resolved on the same 2D gel. 
Proteins spots are detected by scanning the gel with the appropriate wavelength for the Cy dyes; 
merging all of them yields an overlay image consisting of all three Cy dyes. The images are analysed 
using 2D DeCyder™ software and proteins of interest are identified, excised, digested and analysed 
on the MS followed by bioinformatic analysis (taken from Paul et al. 2013). 
 
 2D-DIGE studies in Neospora, Toxoplasma and host cells 
Astrocytes are glia cells in the CNS that form the majority of the cells in the 
mammalian brain and are linked with all parts of neurons (Hatton 2002). Any 
damage to astrocytes can critically effect neuron survival and have been involved in 
the pathological processes of many neurological diseases such as Alzheimer’s 
disease (Nedergaard, Rodriguez & Verkhratsky 2010). The understanding of 
astrocytes importance in nervous system functioning is increasing, especially in the 
modulation of neural activity (Nedergaard, Rodriguez & Verkhratsky 2010). Most of 




astrocyte cultures are continuing to provide a useful tool in exploring the diverse 
property of these cells (Halonen, Weiss & Chiu 1998; Pinheiro et al. 2006).  
 
 
 Parasite proteome investigations using 2-DE and 2D-DIGE  
Several proteomic studies on T. gondii have elucidated the specialized invasion 
organelles and their composition, as well as proteins associated with the 
cytoskeleton (Bradley et al. 2005; El Hajj et al. 2006; Xia et al. 2008).  For example; 
rhoptry proteomic investigation in T. gondii (RH strain) was carried out by Bradley et 
al. (2005) through the application of SDS-PAGE coupled with MS analysis. A total of 
38 novel rhoptry proteins were discovered and the first T. gondii genes encoding 
rhoptry neck proteins were identified, along with novel proteases, phosphatase 
proteins that may be associated with the parasites invasion, survival and growth 
processes (Bradley et al. 2005). Xia et al. (2008) used 2-DE in combination with 
tandem mass spectrometry, and multidimensional protein identification technology 
(Mud-PIT) for characterizing the proteome of three different strains of T. gondii 
(GT1, ME49 and VEG), and 2252 proteins were identified.  
Hill et al. (2011), characterised sporozoite specific antigen from T. gondii through 
the use of 2-DIGE in combination with tandem MS. Zhou et al. (2013), explored the 
proteomic profiles of three lineages in T. gondii (Type I, II and III) by 2D-DIGE along 
with MS. The total numbers of differentially expressed proteins were 84, in which 
similar protein profiles were detected between type I and II lineages of T. gondii, 
while type III was found with different protein profiles. Two different strains of T. 
gondii tachyzoites proteomic profile changes were also compared using 2D-DIGE. A 
total of 56 proteins matching to T. gondii were identified which included surface 
antigen (SAG1), heat shock protein 70 (HSP70), disulfide isomerase, coronin, heat 
shock protein 60 (HSP60), pyruvate kinase, receptor for activated C kinase 1, and 
peroxiredoxin. Most of the differentially expressed proteins were related to 
biological regulation, metabolic process, response to stress, binding, antioxidant 




In N. caninum proteomic investigations; Shin et al. (2005) investigated the possible 
relationship between two distinct isolates of N. caninum (KBA-2 and VMDL1) using 
2-DE and identified many proteins such as heat shock protein 70, subtilisin-like 
serine protease, nucleoside triphosphatase in the two isolates. Significant homology 
in the proteome and antigenic proteome profiles between the two N. caninum 
isolates were observed, though isolated from distinct geographical locations (Shin 
et al. 2005). Comparative investigation of two isolates of N. caninum (KBA-2 and 
JPA1) and RH strain of T. gondii were investigated through 2-DE by Lee et al. (2005). 
The study displayed increased similarities between N. caninum isolates (KBA-2 and 
JPA1), whereas differences in protein expressions between N. caninum and T. gondii 
were observed, as proteins NcSUB1, NcGRA2 and NcGRA7 are thought be species-
specific proteins for N. caninum tachyzoites (Lee et al. 2005). However, there were 
no reported studies of the application of 2D-DIGE in the investigation of N. caninum 
parasites.  
In other host cells investigation; Nelson et al. (2008) described the proteomic 
analysis of T. gondii infected human foreskin fibroblasts (HFFs) in vitro using 2D-
DIGE which revealed that the proteome of host cell responded in a dramatic way to 
T. gondii invasion associated with modulations of the host metabolic pathways, 
including glycolysis, lipid and sterol metabolism, mitosis, apoptosis, and structural-
protein expression.    
 
 
2.1.2 Aims and objectives 
In this chapter, the main aim was to investigate differential protein modulation of 
the host cell response to T. gondii and N. caninum infection. The hypothesis is that 
host responses during infection will reflect differences in the proteins being 
translated during infection between the two parasites. The investigation of global 
proteome profile changes during host infection will be carried out using 2D-DIGE, 
mass spectrometry (LC-MS/MS) and bioinformatic analysis. Human astrocytes are a 




cells in the brain and can be successfully cultured in vitro compared to other cells of 
the CNS such as neurons. In addition, both parasites have been found to infect 
astrocytes at a higher rate compared to neurons and microglia cells (Pinheiro et al. 
2006; Jesus et al. 2013; Halonen et al. 1996). In order to understand biological 
changes occurring in the hosts CNS during infection with tachyzoites of T. gondii 
compared to N. caninum; proteomic investigation of these cells will help to identify 
key differences between parasite infections in cells of the CNS. As T. gondii is found 
more frequently in intermediate host brain cells compared to N. caninum which was 















 Materials and methods 
  
2.2.1 Cell culture 
 Human Astrocytes (HA) 
Human astrocyte (HA) cells (ScienCell Research Laboratories, USA) are primary cell 
lines isolated from human brain cerebral cortex that have a limited lifespan and can 
only be maintained up to five passages. Prior to seeding HA cells, the flasks need to 
be coated with poly-L-lysine hydrobromide (mol. wt. 70,000-150,000, Sigma Aldrich) 
in order for the cells to attach on the surface. Poly L-lysine was (0.1 mg/ml) coated 
on surfaces of T75 cm2 flasks for 5 minutes with 1 ml of the suspension, then flasks 
washed twice with ddH2O and left to incubate for a minimum of 2 hours in the 
incubator. A total of 15 ml of Dulbecco’s Modified Eagle’s Medium/Ham’s Nutrient 
Mixture F12 (DMEM-F12) (Sigma Aldrich, UK) was inserted in each flask prepared 
with 10 % (v/v) foetal bovine serum (FBS) (Sigma Aldrich), 100 U/ml penicillin and 
100 μg/ml streptomycin sulphate (Sigma-Aldrich) and filtered prior to use. Flasks 
were seeded with HA cells incubated at 37°C and 5 % CO2, and medium was 
changed every three days for cell maintenance, where they were left until they 
reached 80-90% confluence and were passaged into new coated flasks. 
 
 Human astrocyte cell passage 
A total of 15 ml of fresh DMEM-F12 medium was added to the poly-L-lysine coated 
T75 flask. Confluent HA cells were first washed with 10 ml of Dulbecco’s Phosphate 
Buffered Saline (DPBS), without calcium chloride and magnesium chloride (Sigma 
Aldrich), followed by incubation for 2-3 minutes in 2 ml Trypsin-Versene (EDTA) 
mixture (Lonza) in addition to 8 ml of DPBS, at 37°C and 5 % CO2 until cells round up 
and detached. Detached cells were transferred to 5 ml filtered FBS in 50 ml 
centrifuge tubes. If some cells were still attached, flasks were gently tapped to 
dislodge cells and added to the tubes. Tubes containing the cells were centrifuged 




resuspended in 5 ml DMEM-F12 medium. The numbers of cells were calculated 
using a haemocytometer; coated T75 cm2 were seeded with 4 x 105 cells/flask and 
incubated at 37°C and 5 % CO2. The medium was changed every three days until 
cells reached 80-90% confluency, then either passaged for maintenance or directly 
used for the experiment.    
 
 
 Vero cell passage 
Vero cells are monolayer cells of African green monkey kidney fibroblasts. They 
were used to culture and grow the parasites. Confluent vero cells in 25 cm2 tissue 
culture flasks were washed with 5 ml 1M HEPES Balanced Salt Solution (Sigma-
Aldrich) before incubating the cells for 5 minutes in 5 ml Trypsin-Versene (EDTA) 
mixture, at 37°C and 5 % CO2. The cell suspension was centrifuged for 5 minutes at 
1500 x g, and then resuspended in 5 ml IMDM (Iscove’s Modified Dulbecco’s 
Medium, Lonza). The medium was supplemented with 10 % (v/v) foetal calf serum 
(Sigma Aldrich), 100 U/ ml penicillin and 100 μg/ml streptomycin sulphate (Sigma-
Aldrich) and filtered prior to use. A haemocytometer was used for calculating the 
number of cells, before they were seeded at a ratio of 1 x 105 per 5 ml IMDM/ 25 
cm2 flask. 
 
 Parasite passage 
Two different lineages of T. gondii parasites were used in this experiment; the 
virulent type I (RH strain) and a less virulent type III (VEG strain) and one strain of N. 
caninum (Liverpool isolate). At 24 hours post seeding, when vero cells reached 10-
20 % confluency, they were infected with 4 x 105 tachyzoites through counting the 
parasites using a haemocytometer. T. gondii (type I strain (TgRH) and type III strain 
(TgVEG)) and N. caninum Liverpool isolate (NcLIV) tachyzoite stages were passaged 
twice weekly onto a layer of vero cells and parasites were maintained at 37°C and 5 




sterile cell scraper. Parasites were then either passaged into new cells, or isolated 
for use in experiments. 
 
 Parasite isolation 
Tachyzoites of TgVEG, TgRH and NcLIV were isolated from host cells by filtration 
through 47 mm diameter 3 μm pore-sized Nucleopore™ polycarbonate membranes 
(Whatman). Then, they were washed twice in phosphate-buffered saline (PBS) pH 
7.4 by centrifugation at 1500 x g for 10 minutes. The supernatant was discarded, 
and parasites were resuspended in DMEM-F12 and were used to infect either HA 
cells for the experiment or vero cells for parasite maintenance. 
 
 Human astrocyte cell infection 
Purified tachyzoites were applied to confluent HA cells at an infection ratio of 10 
parasites per cell through counting the cells and parasites using a haemocytometer. 
As a control (mock infection); uninfected HA cells were harvested and mixed with 
the same amount of parasites as added to the infected cells (Neospora and 
Toxoplasma RH), parasites were inserted directly prior to centrifugation to keep the 
proportion of host and parasite material the same for each sample. Two replicates 
of each flask (i.e. infected and uninfected) were collected at 24 hours post infection. 
Cells were harvested then washed twice with Dulbecco's Phosphate-Buffered Saline 
(DPBS) through centrifugation at 188 x g for 5 minutes. Afterwards, the numbers of 
cells were calculated and a final wash and centrifugation at 13000 x g was applied 










 Human astrocyte cell lysis 
The cell pellets were lysed in 500 μl of lysis buffer (30mM Tris, 2M Thiourea, 7M 
Urea, 4% CHAPS) along with 10 μl DNases/RNases (100 mg) and 5 μl of protease 
inhibitors. The samples then were subjected to five cycles of freeze-thaw 
procedures (freezing in liquid nitrogen, thawing at 29°C and briefly vortexing) 
before centrifuging at 13000 x g for 10 minutes to remove any remaining cell debris.  
 
 2D Clean up 
In order to remove any salts, detergents, lipids, nucleic acids and percipitate 
present in the samples a 2D-clean up kit (GE Healthcare) was used. All steps were 
carried out on ice unless stated otherwise according to the manufacturer’s protocol. 
Briefly, 300 μl of precipitant was added to each sample and mixed by vortexing 
before being incubated on ice for 15 minutes. Then, 300 μl of co-precipitant was 
added to each sample and vortexed briefly before centrifugation at 13 000 x g for 5 
minutes. 
The supernatant was discarded and the tubes centrifuged once more to guarantee 
that any remaining supernatant was removed. Then, 40 μl of co-precipitant was 
carefully layered on top of the pellet, to avoid pellet disturbance and were 
incubated on ice for 5 minutes. Samples were centrifuged again and the 
supernatant was discarded. Next, 25 μl of ddH2O was added to each pellet and 
vortexed until the pellet was dispersed but not completely dissolved in the solution. 
A total of 1 ml of chilled wash buffer was added together with 5 μl of wash additive 
and the tubes were incubated at -20°C for at least 30 minutes, making sure that the 
samples were vortexed for 20-30s every 10 minutes. Then, samples were 
centrifuged at 13 000 x g for 5 minutes and the supernatant was decanted before 




resuspended in 40 μl of 2x sample buffer (2M Thiourea, 7M Urea, 2% CHAPS), 
followed by determining the protein concentration in each sample. 
 
 Bradford assay 
In order to determine protein concentrations, a Pierce Coomassie plus (Bradford) 
protein assay (Thermo Scientific) was used for protein concentration measurements 
of the samples. Two replicates of protein standards ranging from 2.5-25 µg/ml BSA 
were prepared. A serial dilution of each sample was applied (1:100, 1:200 and 
1:400) and two replicates per sample were used. Then, 150 µl of each standard and 
also samples were inserted on a 96 well plate; 150 µl of Coomassie plus reagent was 
added to all standards and afterwards left to incubate 10 minutes at room 
temperature. A multiskan Ascent microplate photometer was used at 595 nm to 
read the absorbance. A standard curve was formed from the absorbance of the 
standards and the sample concentrations were calculated and verified. 
 
 2D-DIGE labelling 
Before starting the CyDye labelling, it is essential to optimize the concentrations 
and pH of the samples for efficient labelling with CyDyes. Samples were adjusted to 
5 µg/µl and pH 8-9. The CyDyes were reconstituted with anhydrous 
dimethylformamide (DMF) and a working solution of 400 pmol/μl was prepared 
through mixing and vortexing, followed by centrifugation at 12 000 x g for 30 
seconds. For each protein sample, a total of 50 μg was labelled with 1 μl of the 
appropriate CyDye and combined according to the gel they would be loaded onto 
(as stated in the experimental design (Table 2.1)) as well as 50 μg of the internal 
standard for each gel. The pick gel (gel 6); in which the proteins of interest will be 
excised from includes a gel containing an equal amount of pooled protein samples 
without labelling the proteins with CyDye’s labelling (Table 2.1). All samples were 
mixed thoroughly and centrifuged briefly before incubating them for 30 minutes on 




to each reaction before being further incubated on ice for 10 minutes in the dark. 
The internal standard, labelled with Cy2, was prepared by pooling 25 µg of each 
sample in each gel and was included on every gel. Therefore, a standard was 
available for every spot on the gel, and all gels could be quantitatively linked within 
the same experiment. The internal standard minimizes gel-to-gel variation, thus 
technical replicates were not essential for this experiment. In the experimental 
design (Table 2.1); dye-swapping approach was applied to control any dye-specific 
effects that may result from preferential labelling or different fluorescence 
characteristics of acrylamide at the different wavelengths of excitation for Cy2, 3 
and 5, particularly at low protein spot volumes. 
 
Table 2.1: 2D-DIGE experimental design performed on 24 hour p.i. HA cells infected with Toxoplasma 
RH, Toxoplasma VEG or N. caninum LIV along with controls (mock infections) were used in this 
experiment. For the internal standard; a total of 50 µg was needed/gel. 




(TgRH 1 + mock NcLIV 1) 
HA infected with 
 TgRH 1 





(NcLIV 1 + TgVEG 2) 
HA Infected with 
 NcLIV 1 
HA infected with 
TgVEG 2 
3 
Internal standard  
HA infected 
(mock TgRH 2 + TgRH 2) 
mock infected HA 
 with TgRH 2 
HA infected with  
TgRH 2 
4 
Internal standard  
HA infected  
(TgRH 2 + NcLIV 2) 
HA infected with  
TgRH 2 
HA infected with 
 NcLIV 2 
5 
Internal standard HA 
infected  
(mock NcLIV 2 + mock 
TgRH 2) 
mock infected HA 
 with NcLIV 2 




All 10 samples combined together (unlabelled) 
(TgRH 1, mock NcLIV 1, NcLIV 1, TgVEG 2, mock TgRH 2, TgRH 2, mock NcLIV 2, 






  IPG strip rehydration 
Each sample mixture was combined with 450 μl rehydration buffer (8M urea, 2% 
CHAPS, 0.002% bromophenol blue) including 40 mM Dithiothreitol (DTT) and 0.5% 
IPG buffer pH3-10 (GE Healthcare). The solution was then loaded to one reservoir 
slot of the immobiline DryStrip reswelling tray (GE Healthcare). A 24 cm pH 3-10 
nonlinear NL IPG strip (GE Healthcare) was placed in the reservoir slot for each 
sample with the gel side down, was covered with cover fluid (GE Healthcare) and 
left to rehydrate in the dark overnight at room temperature. For the pick gel a total 
of 300 μg of protein (made from a combination of 30 ug of each sample, Table 2.1) 
was loaded onto the strip. 
 
 Isoelectric focussing (IEF) 
First-dimension separations were carried by focussing the rehydrated strips using 
the Ettan IPGphor II (GE Healthcare) at 30V for 5hours, 500V for 1 hour, 100V for 
1hour, 8000V for 2 hours and 8000V for 9 hours with current restricted to 50 
μA/strip. The strips were either directly used or carefully stored at -20°C. 
 
 Second dimension SDS-Page 
In the second dimension, proteins were separated using 12.5% precast acrylamide 
gels (size 255 x 196 x 1 mm) (GE Healthcare). For the pick gel, the IPG strip was 
applied on a 12.5% precast gel. The pick gel was prepared using low fluorescence 
glass plates (size 255 x 196 x 1 mm) treated with bind saline solution (80% (v/v) 
ethanol, 18% (v/v) ddH2O, 2% (v/v) acetic acid, 0.1% (v/v) γ-
methacryloxypropyltrimethoxysilane) and left to dry completely (minimum of 2 
hours) before casting.  Reference markers were inserted to each treated glass plate 




gel was prepared (40% (v/v) bis-acrylamide, 25% (v/v) Tris-HCl, pH 8.8, 30% (v/v) 
ddH2O and 10% SDS, 0.01% (w/v) ammonium persulphate APS and 0.001% (v/v) 
TEMED) and poured straight away into the casting unit before placing on top  a 
0.1% solution of SDS and leaving them to polymerise overnight at room 
temperature.  
 
2.2.2.7.1  Strip equilibration 
For strip equilibration; two steps were carried out. Firstly, IPG strips were incubated 
in equilibration buffer (2% (w/v) SDS, 50 mM Tris-HCl pH 8.8, 6M urea, 30% (v/v) 
glycerol and 0.002% (w/v) bromophenol blue) containing 100 µg of (10 mg/ml) DTT 
for 15 minutes at room temperature with shaking. The IPG strips were then 
transferred to equilibration buffer containing 250 µg (25 mg/ml) iodacetamide (IAA) 
and incubated for further 15 minutes to alkylate the cysteine residues. 
 
2.2.2.7.2 2D gel electrophoresis 
The equilibrated strips were assembled onto a DALT precast gel carefully and sealed 
in with an agarose sealing solution (25 mM Tris, 192 mM glycine, 0.1% (w/v) SDS, 
0.5% (w/v) agarose, trace bromophenol blue). The gels were assembled in an Ettan 
Dalt six electrophoresis system (GE Healthcare) and the tank was filled with 
electrophoresis buffer (2.5 mM Tris-base, 19.2 mM glycine, 0.02% (w/v) SDS). The 
gels were run at 5W per gel for 30 minutes and afterwards adjusted to 17W per gel 
for 4 hours until the tracking dye reached the bottom of the plate. The same 
previous steps were also carried out on the precast gel for the pick gel.  
 
 Staining of pick gel with SYPRO™ Ruby  
To visualize the proteins present on the pick gel, SYPRO™ Ruby protein gel stain 
(Sigma-Aldrich) was used. The gel was fixed in 40% (v/v) MeOH, 10% (v/v) acetic 




then washed in 10% (v/v) MeOH, 7% (v/v) acetic acid for one hour followed by two 
5 minutes washes in ddH2O prior to gel imaging. 
 
 Scanning the gels 
The gels were scanned immediately after the electrophoresis step using an Ettan 
DIGE imager (GE Healthcare) that was set at 100 pixels and 0.800 exposures on all 
three CyDye channels (Cy2, Cy3 and Cy5) (Table 2.2). For the pick gel, SYPRO Ruby 
conditions were used at the settings as described in Table 2.2.  
 
 
Table 2.2: Filter parameters for each Cydye as recommended by Ettan DIGE System (GE Healthcare) 
for scanning the gels. 
Dye Excitation filter (nm) Emission filter (nm) 
Cy2 480/30 530/40 
Cy3 540/25 595/25 
Cy5 635/30 680/30 
SYPRO Ruby 540/25 595/25 
 
 
 Decyder-2D image analysis 
The DeCyder-2D image analysis software (version 7.0) (GE Healthcare) was used for 
the analysis of DIGE images. A total of fifteen gel images produced from three 
channels of the five 2D-DIGE gels were loaded onto the DeCyder software and the 
differential in gel analysis (DIA) module was used to detect the number of spots on 
one gel (Figure 2.2). All spots in each gel were then identified using the batch 
processor and the output files were then opened in the Biological Variation Analysis 
section (BVA) module. Gel to gel matching of spots was carried out in the BVA 
module using the match detection algorithm allowing quantitative comparisons of 
protein expression across multiple gels (Figure 2.2). One of the Cy2 internal 
standard images was allocated as a master gel status and all other images were 




common protein spots across the gels. The student’s T-test was used to determine 
whether changes in volume of specific spots were significant between samples from 
different experimental groups. Protein spots which displayed a greater than 1.5 fold 
change (p<0.05) between the samples were reported. The pick gel was loaded onto 
the DeCyder-2D software and assigned as the pick gel in the BVA module. The 
protein spots of interest were matched onto the pick gel and a pick list was 








Figure 2.2: An example of DIA analysis in DeCyder showing total number of proteins increased, 
decreased or similar on the top right. On the top left corner; images of the gels that are being 
compared and on the bottom left corner an example of a protein spot decreased. BVA analysis in 
DeCyder showing on the top the internal standard image where the protein of interest were 








 Spot picking  
The protein spots of interest were excised from the pick gel using an Ettan™ spot 
picker (GE Healthcare) that automatically calculates the locations of the selected 




2.2.3 Protein Identification 
 
 Trypsin digestion 
The gel spots were digested using trypsin in order to generate peptides appropriate 
for analysis by mass spectrometry. To guarantee the removal of any stain from the 
plugs, each plug was incubated at 37°C for 10 minutes in 10 μl of 50 mM 
ammonium bicarbonate/50% acetonitrile (in HPLC grade water); the liquid was 
discarded and the step repeated. A dehydration step was then followed by adding 
10 μl of 100% acetonitrile to each gel spot and incubated at 37°C for 15 minutes. 
After removing the solvent from the dehydrated gel plug, the tubes were left to 
incubate at 37°C until all traces of the solvent had evaporated for 10 minutes. 
Trypsin stock solution (0.1 µg/μl) was diluted 1 in 10 with 25 mM ammonium 
bicarbonate and 10 μl of this was inserted on each plug and incubated at 37°C for 1 
hour. A further 10 μl of 25 mM ammonium bicarbonate was added and samples 
incubated overnight at 37°C. The reaction was stopped by storing the samples at -
20°C. 
 
 Tandem mass spectrometry LC-MS/MS  
Tandem mass spectrometry was performed by Dr. Stuart Armstrong and Dr. Dong 
Xia (Liverpool) as follows: peptide mixtures (1 μg) were analyzed by on-line 




coupled to an LTQ-Orbitrap Velos (ThermoFisher Scientific) mass spectrometer 
equipped with the manufacturer’s nanospray ion source. The analytical column 
(nanoACQUITY UPLCTM BEH130 C18 15 cm x 75 μm, 1.7 μm capillary columns) was 
maintained at 35 oC and a flow-rate of 300 nl/minute. The gradient consisted of 3-
40 % acetonitrile in 0.1 % formic acid for 90 minutes then a ramp of 40-85 % 
acetonitrile in 0.1 % formic acid for 3 minutes. Full scan MS spectra (m/z range 300-
2000) were acquired by the Orbitrap at a resolution of 30,000. Analysis was 
performed in data dependant mode. The top 20 most intense ions from MS1 scan 
(full MS) were selected for tandem MS by collision induced dissociation (CID) and all 
product spectra were acquired in the LTQ ion trap. Ion trap and orbitrap maximal 
injection times were set to 50 ms and 500 ms, respectively. 
 
 Protein identification using Mascot 
The generated raw files were converted to mgf files (mascot generated files) in 
order to search for the proteins in MASCOT Daemon™ search engine Version 2.3.2 
(Matrix Science). From the ESI-LTQ Orbitrap Velos, the monoisotopic peaks were 
extracted from the raw data, and searched against the relevant database (Homo 
sapiens in Uniprot database). The enzyme trypsin, fixed modification of 
Carbamidomethyl (C) and variable modification of oxidation (M), 1 missed cleavage 
site and charge states +1, +2, and +3 were all specified. Only identifications with 
scores of p<0.05 were accepted. The data was searched against a decoy database of 
reversed peptide sequences to attain a false discovery rate (FDR). 
 
 Bioinformatics analysis 
Proteins that were identified were searched in Uniprot Protein knowledgebase 
(http://www.uniprot.org/) for their functions; gene ontology, cellular content and 
molecular functions. No further functional annotations or pathway analysis were 
carried out due to the low number of proteins identified and variations between the 




protein of interest and this has led to the low number of proteins identified. 
Functional analysis of HA cell proteins that were statistically significant (p- 
value<0.05 and ≥2 hits) were also investigated using the functional analysis and 
clustering tool from the Database for Annotation, Visualisation, and Integrated 
Discovery (DAVID) (DAVID bioinformatics resources 6.7) (Huang et al. 2009). 
Proteins were searched in DAVID for metabolic pathway analysis (KEGG pathway) 
and functional annotations; for their GO biological processes, molecular function 





















2.3.1 Identification of host cell proteins modulated at 24 hours post 
infection 
2D-DIGE was used to compare proteomic differences in the host cell response to 
infection with N. caninum and T. gondii. After IEF and 2-DE, the analysis of the six 
gel scanned images were aligned and statistical analysis performed to differentially 
modulated protein detection using Decyder-2D. In order for a spot to be 
determined statistically significantly different, a t-test p-value of ≤ 0.05 and ≥1.5 
fold change from the BVA analysis (In total, 55 spots were detected before assigning 
them on the pick gel) . The use of the mixed internal standard allowed the detection 
of significant abundance changes, based on the variance of the mean change within 
the cohort. Overall, a total of 26 spots were found statistically different of Neospora 
infected cells with Toxoplasma infected cells (VEG, RH), and infected cells (N. 
caninum or T. gondii) compared to uninfected HA cells (mock infected) (Appendix I). 
The spots were excised, digested and run on the LC-MS/MS. Raw data from the 
mass spectrometer was searched in MASCOT using human database search 
parameter, only proteins with a score> 40 and ≥2 peptide hits were selected. Due to 
technical difficulties the pick gel had to be re-run at a later date, therefore 
variations between the gels were likely to occur. Moreover, there was an amount of 
contaminants seen on the gel which makes it difficult to distinguish individual spots.  
The spots identified and quantified in HA cells were as follow: nine spots identified 
as differentially modulated comparing TgRH2 with NcLIV2, four spots differentially 
modulated between NcLIV1 and TgVEG2, five spots identified between NcLIV and 
NcLIV control (mock infected), four spots between TgRH and TgVEG and four spots 
between TgRH and TgRH control (mock infected). Since the main aim was to 
investigate differences in host cells (HA) that occur between T. gondii and N. 
caninum, thus, only TgRH with NcLIV (nine spots) (Figure 2.3) and NcLIV with TgVEG 







Figure 2.3: 2D-DIGE pick gel showing spots that were differentially modulated between TgRH and 












Figure 2.4: 2D-DIGE pick gel showing spots that were differentially modulated between TgVEG and 
NcLIV either increased or decreased and assigned spot number (red arrows). 
 
Several protein identifications resulted from each digested spot (Appendix I) 









selected and others were excluded, in which each spot gave one ID as seen in Table 
2.3. Most of the modulated proteins were identified at several different places on a 
single gel, indicating that multiple isoforms and/or post-translationally modified 
forms might be present for that protein. In these instances, it was not always 
possible to assign a simple increased or decreased modulation to the protein.  
Proteins showing decreased modulation in HA cells infected with NcLIV when 
compared to TgRH infected cells were; ankyrin-3 (ANK3), L-lactate dehydrogenase A 
chain (LDHA), ribosome-releasing factor 2, mitochondrial (RRF2M), ATP synthase 
subunit alpha, mitochondrial (ATPA) and transgelin (TAGL) (Table 2.3). The four 
proteins that were increased in NcLIV compared to TgRH were: nesprin-2 (SYNE2), 
sodium/potassium-transporting ATPase subunit alpha-1 (AT1A1), creatine kinase B-
type (KRCB) and heat shock protein 60 kDa (CH60) (Table 2.3).   
In the comparison of modulated proteins between HA cells infected with NcLIV and 
cells infected with TgVEG; two proteins were decreased in cells infected with NcLIV 
compared to TgVEG (78 kDa glucose-regulated protein (GRP78) and actin, 
cytoplasmic 1 (ACTB); whereas vimentin (VIME) was increased in two different 







Table 2.3: Host cell proteins differentially modulated in response to infection with T. gondii and N. caninum (HA cells infected with NcLIV compared to TgRH). Proteins were 
identified by mass spectrometry analysis and searched against the human database using MASCOT. Up-regulated proteins (fold changes) are highlighted in red, down-
regulated proteins are highlighted in green. Spot numbers are as labelled on the pick gel (as seen in Figure 2.3 and 2.4) 
Spot number Accession 
number 






t-test fold change 
(NcLIV/TgRH) 
2418 Q12955 ANK3 Ankyrin-3 67 482394 19 0.045 -4.57 
4436 P00338 LDHA L-lactate 
dehydrogenase A 
chain 
225 37061 6 0.026 -2.39 
2638 Q969S9 RRF2M Ribosome-releasing 
factor 2, 
mitochondrial 
58 87512 4 0.004 -1.77 
3534 P25705 ATPA ATP synthase 
subunit alpha, 
mitochondrial 
658 59939 16 0.036 -1.51 
2293 Q01995 TAGL Transgelin 348 22764 14 0.026 -1.51 
2227 Q8WXH0 SYNE2 Nesprin-2 72 801817 18 0.013 2.67 











3070 P12277 KCRB Creatine kinase B-
type 
319 43013 8 0.021 2.03 
2125 P10809 CH60 60 kDa heat shock 
protein, 
mitochondrial 




Table 2.4: Host cell proteins differentially modulated in response to infection with T. gondii and N. caninum (HA cells infected with NcLIV compared to TgVEG). Proteins 
were identified by mass spectrometry analysis and searched against the human database using MASCOT. Up-regulated proteins (fold changes) are highlighted in red, down-
regulated proteins are highlighted in green. Spot numbers are as labelled on the pick gel (as seen in Figure 2.3 and 2.4) 
 
Spot number Accession 
number 








fold change  
(NcLIV/ TgVEG) 
2023 P11021 GRP78 78 kDa glucose-
regulated protein 
90 72513 3 0.0006 -2.07 
2307 P60709 ACTB Actin, cytoplasmic 1 221 42163 6 0.028 -1.89 
2782 P08670 VIME Vimentin 639 53787 16 0.02 1.68 







2.3.2 Functional annotation of host cells proteins 
In order to allocate functional information to the 12 proteins that were identified, 
Uniprot Protein knowledgebase (http://www.uniprot.org/) was used.  Each protein 
was searched individually for their biological process, cellular content and molecular 
function as described in Table 2.4. Proteins that were found increased in cells 
infected with TgRH compared to NcLIV were involved in different biological 
processes such as axon guidance, glycolysis, cell adhesion and protein biosynthesis; 
whereas the proteins that were decreased were involved in cell migration, ATP 
biosynthetic process (Table 2.5). 
Proteins that were increased in HA cells infected with TgVEG compared to cells 
infected with NcLIV were associated with astrocyte development and protein 
transport and translation; while the decreased infected cells were involved in 
metabolic processes and signalling pathways (Table 2.5). 
Functional analysis of the modulated host proteins were also investigated using 
DAVID. Unfortunately, no metabolic pathways were identified and functional 
annotations; for their GO biological process were not significant and the number of 
proteins associated with each biological process were low (2 proteins). Cellular 







Table 2.5: Proteins identified differentially modulated between cells infected with T. gondii compared to N. caninum, proteins were searched in Uniprot Protein 
knowledgebase.  Cellular components, biological process and molecular functions were identified. 
Protein Accession 
number 
Protein description Cellular 
component 
Biological process Molecular function 
ANK3 Q12955 Ankyrin-3 Cytoplasm 
Golgi apparatus 
Axon guidance Cadherin binding & 
protein binding 








RRF2M Q969S9 Ribosome-releasing 
factor 2, mitochondrial 
Mitochondrion Protein biosynthesis 
GTP catabolic process 
GTP binding 
DPP4 P25705 Dipeptidyl peptidase 4  Cell membrane Cell adhesion 
T cell activation 
Aminopeptidase 
TAGL Q01995 Transgelin Cytoplasm epithelial cell 
differentiation 
Muscle protein 
SYNE2 Q8WXH0 Nesprin-2 Cytoplasm 
Mitochondrion 





















CH60 P10809 60 kDa heat shock 
protein, mitochondrial 
Mitochondrion Host-virus interaction 
T and B cell  activation 
Chaperone 
GRP78 































Table 2.6: DAVID analysis of differentially modulated proteins of astrocytes infected with TgVEG, TgrRH and NcLIV. Biological process, cellular components and molecular 







Biological process  
axonogenesis 2 1.3 5.60E-02 
cell morphogenesis involved in neuron 
differentiation 2 1.3 6.00E-02 
neuron projection morphogenesis 2 1.3 6.20E-02 
cell morphogenesis involved in differentiation 2 1.3 7.00E-02 
cell projection morphogenesis 2 1.3 7.10E-02 
cell part morphogenesis 2 1.3 7.40E-02 
neuron projection development 2 1.3 7.40E-02 







cell projection 3 2 2.70E-02 
endoplasmic reticulum 3 2 4.80E-02 
intracellular non-membrane-bounded organelle 4 2.6 6.00E-02 
non-membrane-bounded organelle 4 2.6 6.00E-02 
cell fraction 3 2 6.00E-02 
axon 2 1.3 6.10E-02 







This chapter investigated proteomic profile changes in cells related to the CNS 
(human astrocytes) during infection with T. gondii compared to N. caninum infected 
cells. While T. gondii can infect a wide range of hosts including humans; N. caninum 
does not. Moreover, T. gondii is known to cause severe neurological pathogenesis in 
humans; especially in immune-deficient individuals, such as Toxoplasmic 
encephalitis whereas N. caninum can cause neuromuscular disease in dogs. 
Astrocytes are known to be involved in cell-cell communication of neurons, defence 
against infectious organisms and provide homeostasis in the brain (Norenberg 
1994; Pekny & Nilsson 2005). Moreover, they enable the propagation of T. gondii 
and N. caninum (Halonen, Lyman & Chiu 1996; Fagard et al. 1999).  
With conventional techniques, studies on proteins can only be conducted on a 
limited number of proteins. Advances in proteomic analysis nowadays help monitor 
global changes in protein expression and post-translational modifications. 2D-DIGE 
exploits mass and charge-matched spectrally resolvable fluorescent dyes (Cy3 and 
Cy5) to label two different protein samples before 2-DE.  
The use of 2D-DIGE as a means to compare proteomes from different infection 
states gives an outcome of the differences in protein expression between the 
cellular proteomes; however, it is not a faultless technique. There are many 
concerns associated with 2D-DIGE analysis, it can be bias towards the most 
abundant proteins and cannot distinguish the precise protein in each differentially 
modified spot. Moreover, proteins with large masses along with insoluble proteins 






2.4.1 Increased protein expression of human astrocyte cells infected 
with T. gondii 
Two different lineages of T. gondii parasites were used in this experiment; the 
virulent type I (RH strain) and a less virulent type III (VEG strain) and one strain of N. 
caninum (Liverpool isolate). It is known that different strains of T. gondii cause 
different host cell response and, as a consequence, pathogenesis of the infected 
host.  
 
 Host response to TgRH infection compared to NcLIV 
Proteins showing increased modulation in HA cells infected with TgRH compared to 
NcLIV infected cells were; ANK3, LDHA, RRF2M, ATPA and TAGL (Table 2.3).  
Ankyrin-3 (ANK-3), also known as ankyrin-G, is a protein from the ankyrin family 
that, in humans, is encoded by the ANK3 gene (Kapfhamer et al. 1995). It was up-
modulted with more than four fold in cells infected with TgRH compared to cells 
infected with NcLIV. This protein was initially found at the axonal initial segment 
and nodes of Ranvier of neurons in the central and peripheral nervous systems 
participate in the maintenance/targeting of ion channels and cell adhesion 
molecules. The protein links the integral membrane proteins to the primary 
spectrin-actin cytoskeleton. The ankyrin protein family play major roles in activities 
such as cell motility, activation, proliferation and the maintenance of specialized 
membrane domains. This protein has an important function in axon guidance. This 
may indicate that TgRH parasites modify ANK3 to enable host invasion and 
establishment of infection, as ANK3 is associated with cytoskeletal anchoring at 
plasma membrane and protein targeting.  
LDHA was up-modulated more than two fold in TgRH infected HA cells compared to 
cells infected with NcLIV. Lactate dehydrogenase (LDH) is a glycolytic enzyme that 
catalyses the conversion of pyruvate to lactate, and plays a crucial role in the 
glycolysis pathway; that is essential to provide energy to T. gondii parasites under 





two genes for lactate dehydrogenase; TgLDH1 and TgLDH2. A study done on 
knockout mice with LDH1 and LDH2 showed that LDH is essential for parasite 
differentiation, showed these parasites were unable to exhibit brain cysts in LDH1 & 
LDH2 knockout mice in the chronic stage of infection (Al-Anouti et al. 2004). Lee et 
al. (2003), identified lactate dehydrogenase as proteins conserved between T. 
gondii and N. caninum tachyzoites using 2-DE analysis. This protein is also 
associated with the glycolysis pathway (Denton et al. 1996), which may possibly be 
increased in TgRH infection due to the higher need for energy uptake by the fast 
replicating Toxoplasma strain (TgRH) compared to N. caninum. 
RRF2M is a mitochondrial ribosome protein that mediates the disassembly of 
ribosomes from messenger RNA at the termination of mitochondrial protein 
biosynthesis. It is associated with GTP catabolic process in the cell. This protein was 
up-modulated (1.7 fold) in cells infected with TgRH compared to NcLIV infected 
cells. It has a role in the regulation of normal mitochondrial function which may 
indicate TgRH modification of RRF2M to enable nutritional uptake from the host cell 
mitochondria.  
ATPA was only found increased (1.5 fold) in cells infected with TgRH. Mitochondrial 
membrane ATP synthase produces ATP from ADP in the presence of a proton 
gradient through the membrane which is produced by electron transport complexes 
of the respiratory chain. It is linked to cellular metabolic processes that may enable 
the establishment of TgRH parasitic infection in host cells.  
TAGL was also up-modulated (1.5 fold) in cells infected with TgRH. Transgelin a 
protein found in humans is encoded by the TAGLN gene (Kobayashi, Kubota & 
Hidaka 1994). The protein encoded by this gene is a transformation and shape-
change sensitive actin cross-linking/gelling protein found in fibroblasts and smooth 
muscles (Camoretti-Mercado et al. 1998). Proteomic analysis of host cells (HFF cells) 
infected with T. gondii by Nelson et al. (2008) found that TAGL was down-regulated 
during infection using a 2D-DIGE method, which contradicts the proteins found in 





properties of the cell and epithelial cell differentiation, which may also be 
associated with TgRH parasite establishment in host cells. 
 
 Host response to TgVEG infection compared to NcLIV 
Proteins that showed increased expression in cells infected with TgVEG compared 
to NcLIV infected cells were GRP78 and ACTB (Table 2.4).  
GRP78, also called heat shock 70 kDa protein 5, was increased two fold; it is 
involved in facilitating the assembly of protein complexes inside the endoplasmic 
reticulum and in the correct folding of proteins and degradation of misfolded 
proteins through its interaction with DNAJC10. This protein inhibits key effectors of 
the apoptotic pathway and plays a role in the proteasome-mediated degradation of 
apoptosis-regulatory proteins (Garrido et al. 2003). Moreover, HSP70 protects cells 
from stress-induced caspase-dependent apoptosis, both upstream and downstream 
of the death-associated mitochondrial events (Garrido et al. 2003). Notably, host 
HSPs have been implicated in immunity to T. gondii; through host defence against 
infection (Hisaeda & Himeno 1997). Another regulatory cascade known to be 
comprised of HSPs is the stress hypoxia pathway induced in parasite-infected cells 
(Spear et al. 2006). This may propose that infected cells with TgVEG induce GRP78 
to delay or inhibit apoptosis process in the cell compared to infected cells with 
NcLIV.  
Microfilaments are generally made up of actins, microtubules consist of tubulins 
and intermediate fibres include vimentin and keratin (Sodeik 2000). ACTB was 
increased 1.89 fold in TgVEG infected cells compared to cells infected with NcLIV. 
Actins are essential cellular components involved in cellular motility, movement of 
vesicles and organelles around the cell, cellular division and maintenance of cellular 
shape. It is known that infection with Toxoplasma causes broad remodelling of the 
host cell at the level of the cytoskeleton (Nelson et al. 2008). Actin and actin-related 
(ACTB) proteins representing key components of microfilaments were increased in 





during the process of attachment and invasion, through the moving junction 
interaction of T. gondii parasite with the host cytoskeleton (Blader & Saeij 2009).  
 
 
2.4.2 Increased protein expression of host cells infected with N. caninum 
 Host response to NcLIV infection compared to TgRH 
Four proteins were up-modulated in NcLIV infected cells compared to cells infected 
with TgRH: nesprin-2 (SYNE2), sodium/potassium-transporting ATPase subunit 
alpha-1 (AT1A1), creatine kinase B-type (KRCB)  and heat shock protein 60 kDa 
(CH60) (Table 2.3).  
SYNE2 was up-modulated more than 2.5 fold in cells infected with NcLIV. Nesprin-2 
is a protein which forms a linking network between organelles and the actin 
cytoskeleton to maintain the subcellular spatial organization. It is associated with 
the maintenance of nuclear organization and structural integrity. To our knowledge; 
there is no known function for this protein in relation to T. gondii or N. caninum 
invasion/infection process, but may be associated with establishment of N. caninum 
and parasite-host interaction.  
AT1A1 was up-modulated more than 2.5 fold in cells infected with NcLIV compared 
to infected cells with TgRH. This protein is the catalytic component of the active 
enzyme, which catalyses the hydrolysis of ATP coupled with the exchange of sodium 
and potassium ions across the plasma membrane and provides energy for active 
transport. This may suggest that N. caninum increases energy production and ion 
transport to enable its nutrient uptake and enable growth in host cells as AT1A1 
provides energy for active transport of various nutrients. 
KRCB was increased two fold.  It is important in energy transduction in tissues with 
large, unstable energy needs, such as skeletal muscle, heart and brain, which may 





Another heat shock protein found in this experiment was CH60. It was up-
modulated in cells infected with NcLIV (1.5 fold) in comparison to TgRH infected 
cells (Table 2.3). Human astrocyte heat shock proteins (HSPs) were modulated 
during parasitic infection in this experiment, which may be linked to an increase in 
transcription and translation, since HSPs are important in protein processing 
(Garrido et al. 2003). They are commonly responsible for preventing damage to 
proteins in response to high levels of heat and are classified into six major families 
based on their molecular mass: small HSPs, HSP40, HSP60, HSP70, HSP90, and 
HSP110 (Wu 1995). Additional studies have associated HSP60 to diabetes, stress 
response, cancer and certain types of immunological disorders. They are present in 
all cells under normal conditions and during stress (e.g., heat/cold/oxygen 
deprivation) and can make up to 15% of the total cellular protein content (Pockley 
2001). HSPs ensure the correct conformation of proteins and facilitate the 
degradation of selected proteins by the ubiquitin/proteasome system, as well as 
their own inherent activities (Garrido et al. 2003).  
CH60 is associated with mitochondrial protein import and macromolecular 
assembly, facilitate the correct folding of imported proteins and prevent misfolding 
of proteins. This may suggest that the N. caninum increases this protein due to its 
involvement in mitochondrial protein import and macromolecular assembly which 
may facilitate host-parasite interaction.  
 
 Host response to NcLIV infection compared to TgVEG 
In comparison of modulated proteins between HA cells infected with NcLIV and 
TgVEG infected cells; only one protein was increased in two different protein spots; 
vimentin (Table 2.4).  
A class of cytoskeletal structures is the intermediate filaments, characterized by the 
protein vimentin (Wang & Stamenovic 2002). Vimentin has been associated with 
various functions, from structural roles, cell cycle and mitosis (Wang & Stamenovic 
2002), as well as lipid metabolism (Schweitzer & Evans 1998), whose roles in lipid 





function (Annunen-Rasila et al. 2007). More important, vimentin is known to be 
reorganized around the parasitophorous vacuole (PV) in T. gondii-infected cells 
(Coppens et al. 2006; Halonen & Weidner 1994). The slight increase in cells infected 
with N. caninum may not indicate notable differences in vimentin modulation by N. 
caninum compared to T. gondii. Nelson et al. (2008) found vimentin to be increased 
in T. gondii infected HFF cells, which contradicts the findings related to this protein. 
Another suggestion would be that vimentin is increased in N. caninum infected cells 
for its growth due to its involvement in energy, metabolism processes and 
mitochondrial function.   
Host mitochondria and the endoplasmic reticulum (ER) have a close relationship 
with Toxoplasma and Neospora due to their recruitment to, and association with, 
the parasitophorous vacuole membrane (Sinai, Webster & Joiner 1997). The 
fundamental roles of both these organelle systems in nearly every aspect of cellular 
physiology points of remodelling established in the infected cell. From this data, 
most of the proteins identified were primarily found in these two organelles. 
 
2.4.3 Limitations of 2D-DIGE in host proteome investigations 
One of the main concerns with the proteins identified was whether their abundance 
was due to a contamination occurring on the 2D gels caused by a partial insolubility, 
or whether it is a true modification of cells responds to infection in protein 
expression. Each modulated protein spot contained multiple protein identifications, 
which made determining the exact protein causing differential changes challenging. 
Though calculating Mascot scores and peptide counts may help in estimating which 
protein is more dominant within a spot. In the analysis, differentially modulated 
protein spots that had high score and peptide number were selected from the total 
number of protein identifications. However, the results and analysis must be 
viewed with a degree of caution, due to incomplete protein resolution. Also, the 
numbers of identified protein spots modulated were very low and the dataset is 
small, both of which need to be taken in consideration when analysing the results. 





profiles of host cell response is needed. Recurrently, the same proteins appeared in 
many spots across the gel, which complicates the analysis of the data.  
In a gel spot from which numerous proteins can be identified it is difficult to define 
which protein has dominated the changes detected at the gel spot level. Also, a 
genuine protein change of a low abundance could be masked by a high abundance 
protein co-migrating that did not have any substantial changes.  
A paper published in the Journal of Proteomics investigated the occurrence of 
individual differentially expressed human, mouse and rat proteins reported in 169 
articles in 2-DE experiments between 2004 and 2006 (Petrak et al. 2008). This meta-
analysis study has shown that among the most frequently identified differentially 
expressed proteins were heat shock proteins (HSP60, HSP70), Vimentin, ATP 
synthase and actins (Petrak et al. 2008) which have also been identified in this 
chapter. The fact that the most commonly identified proteins are highly abundant 
soluble proteins raised concerns as to whether their repeated identification 
represents a technical artefact (Petrak et al. 2008).  
 
2.4.4 Conclusions and future directions 
In this chapter, the application of the quantitative proteomic approach 2D-DIGE in 
understanding protein expression changes of human astrocytes during Neospora 
and Toxoplasma tachyzoites invasion was investigated and discussed. 2D-DIGE 
analysis can provide a large scale quantitative screening of protein expression 
changes. Proteins have been identified, such as enzyme L-lactate dehydrogenase A 
chain, that is involved in the glycolysis, as well as Ankyrin3 were found differentially 
modulated between the infected cells, in which were up-modulated in T. gondii 
infected cells. That may suggest T. gondii modulation of proteins for nutritional 
uptake and regulation of ion transport for the parasites propagation and 
establishment in cells. While proteins such as Vimentin and Syne2 were up-
modulated in N. caninum infected cells compared to T. gondii, suggesting that N. 
caninum may modify the cytoskeleton of host cells for parasite invasion and entry.  





related to the separation limitations inherited from 2-DE, as well as the commonly 
observed occurrences of multiple proteins found at the same gel spot need to be 
taken in mind. There have been some suggestions that using 2D gels to separate 
proteins for identification of differentially expressed proteins can lead to similar 
proteins being found as modulated (Petrak et al. 2008). It is therefore important to 
ensure that the proteins identified as differentially expressed within a 2D-DIGE 
experiment are confirmed using alternative methods. Alternative methods for 
quantitating protein expression without using gels for separation are available such 
as label-free quantitative mass spectrometry. The whole cell lysate of samples are 
directly digested and run on a high resolution LC-MS/MS followed by bioinformatics 
analysis. This technique enables multiple samples to be compared and less 
concentrations of sample is needed. This kind of comparison should allow whole 
cell proteomes to be interrogated. While 2D-DIGE is a useful technique for exploring 
global proteomic changes and PTMs; it is time consuming, laborious and has 
numerous limitations. At the time this work was performed, this technique was a 
good approach for proteomic profiling analysis, but, with advances in MS, we are 
now able to use more sophisticated approaches.  This will provide valuable insights 
into the dynamic changes of human astrocytes during infection with these two close 
relatives (Toxoplasma and Neospora). Thus, in chapter four quantitative proteomic 
in solution investigation was carried out using Label-free proteomic with the 
addition of three different time points to capture the changes occurring at the 










 Chapter three: Transcriptomic analysis of host cells 





In the previous chapter, changes in the cellular proteome of human astrocytes in 
response to infection with T. gondii compared to N. caninum infection were 
investigated using 2D-DIGE. This chapter will focus on the changes of human 
astrocytes at the gene transcriptional level in response to infection with the two 
parasites. The transcriptome is the complete set of RNA molecules in a cell including 
coding and non-coding transcripts (Wang et al. 2009). In contrast to the genome 
which is stable for any given cell line, the external environment, physiological 
conditions and developmental stage can all cause variations to the transcriptome. 
Exploring the transcriptional changes enables us to explore the functional 
components of a genome and help to reveal changes in the molecular elements in 
cells and for understanding development and disease envolvement (Wang et al. 
2009).  
While both T. gondii and N. caninum parasites can reach the CNS and encyst in the 
brain, T. gondii is the parasite mostly known to cause tropism in neural cells. In 
order to understand molecular differences in astrocytes infected with T. gondii and 
N. caninum, it is vital to study these changes at the transcriptional level. This can be 





While mass spectrometry enables the identification and quantification of proteins, 
next generation sequencing (NGS) investigates the gene expression level profiles 





sequencing which makes it easier to analyse whole transcriptomes in a very short 
period of time (Liu et al. 2014). It also has many advantages over other 
transcriptional approaches as discussed previously in chapter one (1.10.1).  
The first publications on transcriptomic studies done using RNA-Seq were in 2008 
(Nagalakshmi et al. 2008; Lister et al. 2008; Sultan et al. 2008). It was applied to 
analyse and explore human, yeast and Arabidopsis mRNA and has extended further 
to investigate other organisms, including apicomplexan species such as T. gondii 
and Plasmodium spp. (Sorber et al. 2011; Hassan et al. 2012).  
 
3.1.1.1 Steps involved in RNA-Seq  
RNA-Seq involves multiple stages that including sample preparation, amplification, 
fragmentation, purification and sequencing of the samples of interest (Mortazavi et 
al. 2008). Briefly, this technique begins with the conversion of RNA to a constructed 
library of cDNA fragments with adaptors attached to one end (single-end 
sequencing) or both ends (paired-end sequencing), which is then sequenced with a 
high-throughput sequencing platform to attain short sequences from one end or 
both ends (Wang et al., 2009); reads generated from the sequencing platforms are 
typically 30–400 bp in length (Figure 3.1). The resulting sequences can then be 
aligned to the organism’s reference genome or transcriptome, or assembled de 
novo if no reference genome is available (Wang et al. 2009). In this chapter, Illumina 
platform was used for mRNA sequencing; details related to this platform including 











Figure 3.1: Illustrative scheme of RNA-Seq steps. RNA is first extracted, DNase treated, then 
fragmented into smaller pieces. Libraries are created from the fragments and sequenced at a high 
coverage. The sequenced reads are afterwards aligned to a reference genome and the results are 
analysed statistically and interpreted through bioinformatic approaches. (Image adapted from 








3.1.2 RNA-Seq in systems biology investigations 
RNA-Seq enables the deep sequencing of the transcriptome with high resolution 
and without the need of a known reference genome to be included. It is known that 
mammalian cells are highly complex, RNA-Seq is a tool that aids in understanding 
different biological processes occurring in the cell at the transcriptional level 
(Westermann et al. 2012). The transcriptomes from different mouse tissues in vivo 
was first mapped and analysed using RNA-Seq, and novel transcripts were detected 
in the liver, skeletal muscle and brain tissue analysed from mice (Mortazavi et al. 
2008). Human cell transcript analysis of an embryonic kidney cell line (Ramos B) was 
investigated in vitro through RNA-Sequencing; novel transcripts were identified and 
25% more genes were detected when compared to a microarray-based approach  
(Sultan et al. 2008).  
 
3.1.1.2 Transcriptomic studies in host cells and pathogens 
There have been many studies that investigated the biological changes that occur to 
a cell or tissue during infection with different organisms in the same experiment. 
For example, a study done by Gail, Gross & Bohne (2001) explored transcriptional 
changes of the human foreskin fibroblast (HFF) cells during T. gondii infection 
compared to Salmonella typhimurium and Chlamydia trachomatis using 
microarrays. They identified 13 genes (such as IL6 and TNFAIP6) up-regulated 
exclusively in cells infected with Toxoplasma ( Gail, Gross & Bohne 2001). Functional 
changes in the central nervous system (CNS) were examined during the chronic 
stage of T. gondii infection in mice, in which genes involved in immune responses 
and cell activation were up-regulated in mice brains after infection (Tanaka et al. 
2013). In addition, host transcripts whose expressions were reduced by infection 
were involved in small-GTPase-mediated signal transduction and vesicle mediated 
transport (Tanaka et al. 2013).  
Comparative genomic and transcriptomic analysis of N. caninum and T. gondii have 





secreted kinases. An expansion in the number of surface antigens were identified in 
N. caninum compared to T. gondii tachyzoite stage (Reid et al. 2012).  
An investigation of host responses to infection in HFF cells between these two 
parasites through comparative microarray profiling demonstrated that N. caninum 
is a strong inducer of innate IFN-α/β responses, whereas T. gondii has developed 
the capability to suppress this response (Beiting et al. 2014). It was concluded that 
N. caninum parasites are potent activators of type a/β interferon pathways in mice 
macrophages in vivo and were dependent on the toll-like receptor TLR3 and the 
adapter protein Trif (Beiting et al. 2014). 
 
3.1.1.3 RNA-Seq in human astrocyte investigations 
The investigation of increased expression of astrocytes markers in schizophrenia 
and its association with neuroinflammation was done using RNA-Seq and showed 
that patients with schizophrenia had increased expression of glial fibrillary acidic 
protein (GFAP) and hypertrophic astrocyte morphology (Catts et al. 2014). Another 
study explored the localization of Alzheimer’s disease in the parietal cortex of the 
brain and its involvement of the early symptoms of the disease in humans through a 
using Illumina RNA-Seq platform (Mills et al. 2013). This study identified 
transcriptional profile changes related to lipid metabolism and concluded that 
astrocytes were associated with neurodegenerative disorders (Mills et al. 2013). In a 
study of neuropathogenesis in HIV-1 subtype C (clade C), synaptic plasticity 
associated genes were examined in primary human astrocytes (Atluri et al. 2013). 
The findings suggest that severe neuropathogenesis as an outcome of infection may 
be related to the down-regulation of synaptic plasticity genes, decreased dendritic 
spine density and induction of apoptosis in astrocytes. To date, there have been no 
studies examining human astrocytes response during T. gondii and N. caninum 






3.1.3 Aims and RNA-Seq experimental design 
In this chapter, the aim was to investigate transcriptional expression changes of 
host cells (human astrocytes) during infection with T. gondii in comparison with N. 
caninum infection. Toxoplasma successfully invades the CNS and establishes its 
chronic stage of infection through cyst formation in any warm blooded animal 
including humans, while Neospora has a more restricted host range and seems to 
infect mostly the CNS of its definitive host. The main hypothesis is that differences 
in human astrocytes response during infection will reflect on the genes being 
transcribed during infection.  
In this study, high throughput sequencing (RNA-Seq) was used to compare the 
responses of human astrocytes to infection with T. gondii and N. caninum. Previous 
work by Dr. Dong Xia on T. gondii infected human foreskin fibroblast (HFF) cells 
showed that the majority of transcriptional changes occurred within the first 16 
hours post infection. Thus, in this study, three different time points were chosen to 
examine the transcriptional change in human astrocytes during early stages of 















 Materials and methods 
3.2.1 Human astrocyte cell sample preparation and collection 
HA cells, T. gondii (TgVEG strain) and N. caninum (NcLIV) were grown and 
maintained as previously described at chapter two (chapter 2.2.1). TgVEG was used 
throughout the thesis chapters, it is the less virulent strain and the cyst forming 
strain in the brain and other organs in the host compared to TgRH strain which is 
the virulent strain and was only used in chapter two (2D-DIGE) and does not form 
cysts compared to TgVEG. Due to time and cost limitation’s in the experiments as 
the costs (RNA-Seq and LC-MS/MS). In addition, the aim of the experiments was to 
compare the biological changes occurring in the host cells during infection with T. 
gondii compared to N. caninum.Parasites were resuspended in DMEM-F12 and 
confluent HA cells were infected at a M.O.I. of 8 parasites per cell. Duplicate 
confluent flasks (2 x T75 cm2 with 1 x 106 cells/flask) for both T. gondii and N. 
caninum HA infection were scraped and collected at (0, 4 and 16 hours p.i.) and 
were subjected to two washes with DPBS through centrifugation at 188 x g for 10 
minutes and a final wash in a 1.5 ml tube at 13 000 x g for five minutes. Finally 
supernatants were carefully discarded and the samples were stored at -80°C.  
In order to increase Total RNA yield in samples; the two flasks from each sample 
were pooled together at all three different time points for the cells infected with 
Neospora and T. gondii. 
 
3.2.2 Total RNA extraction  
Prior to isolation of total RNA(TRNA) , the samples were first resupended in 350 µl 
RLT buffer (Qiagen) to disrupt the cell, and processed with Qiashredder columns 
(Qiagen) to homogenize the cells and reduce viscosity caused by high-molecular-
weight cellular components and cell debris. Total RNA was extracted using RNeasy 
mini kit (Qiagen) according to the manufacturer’s protocol. Briefly, samples were 





flow-through was discarded, and the column was washed in buffers RW1 (700 μl, 30 
second centrifugation at 8000 x g) and RPE (500μl, 30 second centrifugation at 8000 
x g) before a  2 minute centrifugation step at   8,000 x g using a new collection tube 
to remove any remaining buffer. After that, the column was inserted to another 
collection tube and the total RNA eluted in 30 μl RNase-free water, through 
incubation at room temperature for 1 minute followed by centrifugation at 8,000 x 
g for 1 minute. Finally, samples were stored at -80°C for subsequent isolation of 
Poly(A) RNA. 
 
 Quantification of RNA 
The concentrations of the TRNA samples were verified using a Qubit assay (Life 
Technologies). The RNA buffer supplied in the kit was mixed with the RNA reagent 
at a dilution of 1:200 µl. The buffer was then added to 0.5 ml tubes and two RNA 
calibration standards were prepared. A total of 10 l of each standard was added to 
each tube containing 190 l of reagent. The tubes were then left for two minutes, 
and placed on the Qubit fluorometer 2.0 (Life Technologies) machine to determine 
the RNA concentration of each sample. 
 
 Quality Control 
Samples were submitted to the Centre for Genomic Research (CGR), University of 
Liverpool for quality and quantity evaluation on a Bioanalyzer chip (Agilent). Total 
RNA traces were checked for the intactness of RNA and Poly(A) RNA was assessed 
to ensure that appropriate depletion of ribosomal RNA had occurred so it does not 
interfere with the analysis of mRNA. An illustration of a total RNA and mRNA sample 







Figure 3.2: Bioanalyzer analysis (quality) of the samples which passed quality control. A displays total 
RNA, with two ribosomal peaks as shown (between 1500 and 4000 nt). B shows Poly(A) selection of 
RNA, ribosomal peaks can still be observed but they have been sufficiently depleted so as not to 
mask mRNA. The x axis shows the nucleotides and the fluorescence units are displayed on the y axis. 
Assessment of quality control was based on the appearance of the curve, and RNA quantitation was 
measured separately by Qubit Assay (Invitrogen). 
3.2.3 Poly(A) selection 
Isolation of messenger RNA (mRNA) from the samples was performed by the CGR. 
Poly‐adenylated RNA was selected from total RNA samples using two rounds of 
selection with the Micropoly(A) purist kit (Ambion). 
Briefly, mRNA enrichment of TRNA samples was performed as follows: samples 
were diluted to 250 μl with RNase-free water for mRNA selection using 
Micropoly(A) purist kit. All subsequent steps were performed according to the kit’s 
protocol: samples were mixed with an equal volume of 2x binding solution, bound 
to oligo(dT) cellulose, heated to 70°C and then incubated with rocking for 1 hour at 
room temperature. The oligo(dT) cellulose was afterwards pelleted at 4 000 x g for 
3 minutes at room temperature, washed twice with each of wash solutions 1 and 2, 
then eluted in 200 μl RNA storage solution preheated to 70°C, by centrifugation at  
5000 x g for 2 minutes. The eluted Poly(A) RNA was left to precipitate overnight at 
20oC through the addition of 20 μl 5 M ammonium acetate, 1 μl glycogen and 550 μl 
100 % (v/v) EtOH. It was recovered by 30 minutes of centrifugation at 12 000 x g at 
4°C and resuspended in RNA storage solution, and quality and quantity evaluation 
of the samples were also checked using a Bioanalyzer chip (Agilent) and Qubit 






3.2.4 Sequencing  
Library preparation, amplification and sequencing for six samples were done at the 
CGR. RNA Seq libraries were prepared from six HA cells infected with TgVEG/NcLIV 
enriched Poly(A)-RNA samples, and were subsequently sequenced on the Illumina 
HiSeq2000 platform in one lane to produce millions of paired-end reads per sample. 
Mapping to the human genome (GRCh37/Hg19) and also to the parasites (T. gondii 
and N. caninum genome (EuPathDB release 10.0)) was performed using TopHat 
version 2.0.10 (Trapnell et al. 2009; Kim et al. 2013) and generated FPKM 
(fragments per kilobase of exon per million fragments mapped) values which is a 
normalization step using Cufflinks.  
 
3.2.5  Differential gene expression analysis  
The experimental design contained no biological replicates due to the pooling of the 
samples together at the three different time points and the high cost of running an 
additional batch of samples. Therefore, the power to detect significantly 
differentially expressed genes was assumed to be low. However, it is still possible to 
estimate gene expression levels measured as fragments per kilobase per million 
mapped fragments (FPKM; a ‘fragment’ being a pair of reads, per kilobase being the 
gene length, so FPKM normalises for different gene lengths and total library size). 
The Cufflinks software package was used for normalization of the data (Trapnell et 
al. 2010). FPKM values were estimated across all six samples. At each time point 
post infection (0 hour, 4 hours and 16 hours); FPKM values from T. gondii infected 
human astrocytes were compared to those for N. caninum infected HA cells, using 
the Cufflinks package performed by the CGR.  
 
3.2.6 Data analyses and functional annotation  
A 20 percentile cut-off to the FPKM values was applied, together with ≥ 2 fold cut-
off for the FPKM values for all datasets to define the most different expression 





The software package GProX (Rigbolt, Vanselow & Blagoev 2011) was used to 
perform cluster analyses, using a fuzzification value of 2 for 100 iterations. 
Additional functional annotations investigating their metabolic pathways including 
the cellular contents and molecular functions were analysed using the functional 
analysis and clustering tool from the Database for Annotation, Visualisation, and 
Integrated Discovery (DAVID) (DAVID bioinformatics resources 6.7) (Huang da et al. 
2009). 
Additional networks, functional analyses, and canonical pathways were produced 
through the use of Ingenuity Pathway Analysis (IPA) (Ingenuity Systems, 
www.ingenuity.com) to the list modulated transcripts with FPKM values ≥2 fold 
change. The functional analysis identified the biological functions and diseases 
along with canonical pathways that were most relevant and statistically significant 

















This project aimed to analyse the expression of transcripts of human astrocytes 
infected with T. gondii compared to N. caninum over three different  time periods 
(0, 4 and 16 hours p.i.). In both infected cells (T. gondii and N. caninum infected 
cells) expression changes were compared between uninfected cells (0 hours) to 
infected cells (4 and 16 hours p.i.). This analysis was carried out as follows: 
sequence reads were aligned to reference sequence genomes of H. sapiens and T. 
gondii or H. sapiens and N. caninum. All samples submitted to the CGR for 
sequencing passed the quality control checks and gave the read counts shown in 
Table 3.1.   
Table 3.1: Summary of reads and mapping to the human genome. Human astrocytes cells infected 
with N. caninum tachyzoites (Nc) and T. gondii VEG (Tg) tachyzoites were collected and sequenced at 
0,4 and 16 hours post infection at the CGR.   
Sample Reads to align 1 Aligned reads (%) 2 Properly paired reads  
(%)3  
Nc 0h 76,987,466 65,624,990 (85.24%) 40,330,564 (52.39%) 
Tg 0h 64,597,110 49,443,284 (76.54%) 28,802,196 (44.59%) 
Nc 4h 54,650,324 45,948,538 (84.08%) 28,672,092 (52.46%) 
Tg 4h 75,787,490 64,778,431 (85.47%) 42,791,886 (56.46%) 
Nc 16h 48,529,504 41,124,481 (84.74%) 22,730,728 (46.84% 
Tg 16h 69,741,226 59,015,612 (84.62%) 37,426,250 (53.66%) 
1 Sum of reads used in the alignment. 
2 Reads that align to the reference genome (% of reads used in alignment). 
3 Properly paired reads (reads in correct relative orientation and within accepted distance from each 
other) (% of reads used in alignment). 
 
Read pairs were aligned to the human cDNA reference. In general, more than 76% 
of reads were mapped, but for 5/6 samples >84% of reads were mapped to the 
reference sequence (Table 3.1). 
The total human astrocyte FPKM value transcripts infected with either T. gondii or 
N. caninum were further filtered through a > 20 percentile cut-off and FPKM values 
that were ≥2 fold change. The total FPKM values identified in HA cells infected with 
T. gondii after the selection criteria were 1672 transcripts and in N. caninum 






3.3.1 Cluster analysis and data visualization of host cell mRNA 
Cluster analyses were carried out on FPKM values using GProX (Rigbolt, Vanselow & 
Blagoev 2011). These transcripts were clustered according to their transcriptional 
pattern changes in GProX (version 1.1.12) into five clusters which can be used to 
view the general trends in the data for FPKM values of TgVEG and NcLIV infected 
cells (Figure 3.3). Cluster analysis in T. gondii infected cells show transcripts 
identified to have a downward trend in expression over the time course (clusters 2 
and 3) and cluster 4 has an upward trend in expression. N. caninum infected cells 
analysis show that the majority of genes identified have an upward trend in 
expression over the time course (clusters 1 and 5), whereas cluster 2 has a 
downward trend in expression (Figure 3.3). Visualization of the transcripts using the 
dendrogram heat map of infected HA cells showed clear differences in the 
hierarchical clustering. In T. gondii infected cells, the transcript expression is closely 
related at 0 and 4 hours compared to 16 hours p.i. (Figure 3.4 a). On the other hand, 
in N. caninum infected cells (Figure 3.4 b), 4 hours and 16 hours were closely 
correlated compared to 0 hours which may suggest a delay in the expression 









                        
Figure 3.3: Cluster analyses of human astrocyte cells infected with T. gondii (VEG) and N. caninum. Transcripts were analysed in GProX using their FPKM values; 5 clusters 
were generated according to their transcript pattern expression across the time course for both T. gondii (A) and N. caninum (B). A total of 1672 transcripts were analysed 
for T. gondii and 1029 for N. caninum at all three time points.  The x axis shows parasite post infection of cells at time points (0, 4 and 16 hours post infection) and the y axis 
the expression changes of host cells. Cluster analysis (A) show transcripts identified to have a downward trend in expression over the time course (clusters 2 and 3) and 
cluster 4 has an upward trend in expression. Cluster analysis (B) show that the majority of genes identified have an upward trend in expression over the time course 
(clusters 1 and 5), whereas cluster 2 has a downward trend in expression. Transcripts that didn’t fall into any of the clusters were grouped in cluster 0.  







                 
                                                                                                                                
Figure 3.4: Dendrogram and heat map visualizing of human astrocyte cells infected with T. gondii 
and N. caninum using Gene-E software. In T. gondii infected cells (a); 0 and 4 hours p.i. were closely 
correlated compared to 16 hours p.i. On the other hand, N. caninum infected cells (b) showed that 4 




T. gondii infected cells 
N= 1672 







3.3.2 Functional annotation of human astrocyte infected cells 
For functional annotation and metabolic investigations of host transcriptional 
changes DAVID was used. A list of pathways for each cluster in both HA cells 
infected with T. gondii and cells infected with N. caninum were inserted into the 
search engine. Results involving metabolic pathways, gene ontology for biological 
process, cellular contents and molecular functions were delivered.   
When generally comparing metabolic pathways between the two infections, it was 
necessary to look at differences and similarities between the cells infected. From 
the metabolic pathway analysis; a significant pathway showing differences in their 
trend of transcript patterns between T. gondii infected cells compared to N. 
caninum infected cells was the mitogen activated protein kinase pathway (MAPK 
pathway), in which showed opposite trends in expression changes throughout the 
three time points (Table 3.2). MAPK pathways are highly conserved cascades 
important in different aspects of the immune response (Dong, Davis & Flavell 2002). 
In T. gondii infected cells, eight genes were involved in the MAPK pathway and the 
pattern of their expression showed an increase at 4 hours followed by decreased 
expression at 16 hours post infection. On the other hand, in N. caninum infected 
cells, seven transcripts were involved in the MAPK pathway with a trend of 
decreased expression at 4 hours followed by an increased expression at 16 hours 






Table 3.2: Metabolic pathways identified within human astrocytes infected with T. gondii and N. 
caninum. Transcripts from T. gondii cluster 1 and N. caninum cluster 3 (see figure 3.3) were searched 
using DAVID. The MAPK pathway found in both infected cells with different transcriptional 
expression are highlighted in green.  
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 Metabolic pathways of infected host cells                                                                                                  
During the functional analysis of global expression profiles of host cells during 
infection; some notable pathways were detected. These pathways were the 
cytokine-cytokine receptor interaction and cell adhesion molecule pathways that 
are important in leukocyte migration and cell signalling processes in the cell.  
The cytokine-cytokine receptor interaction pathway is associated with innate as 
well as adaptive inflammatory host defences, cell growth, differentiation, cell death, 
angiogenesis and development and repair processes directed at the re-
establishment of homeostasis in the cell. Differences in host cell mRNA expressions 
were detected (Figure 3.5). Interleukin-8 (IL8), growth-regulated alpha protein 
(CXCL1) and C-X-C motif chemokine 3 (CXCL3) are chemotactic factors that attract 
mainly neutrophils and play roles in cellular inflammation. They were up-regulated 
in cells infected with N. caninum compared to cells infected with T. gondii at 16 
hours p.i. (Table 3.3). Moreover, the chemokine CXCL2, also involved in neutrophil 
recruitment at sites of inflammation, was found up-regulated in N. caninum 
infected cells whereas, in T. gondii infected cells, it was decreased (Table 3.3). The 
chemokine CX3CL1, known as fractalkine, is a chemotactic for T-cells and 
monocytes, but not for neutrophils and is associated with regulating leukocyte 
adhesion and migration processes at the endothelium. It was found up-regulated in 
both infections with a higher fold change seen in T. gondii infected cells compared 
to N. caninum infected cells (Table 3.3). CXCL6, a chemotactic for neutrophil 
granulocytes that has strong antibacterial activity, was found up-regulated with an 
8.3 fold change detected in N. caninum infected cells; whereas it in T. gondii 
infected cells it was below the cut-off value which was excluded during the 20 
percentile cut off (Table 3.3). An illustration of the cytokine pathway and a 
descriptive table of the molecules associated with this pathway along with the 










                                                                                                   
               
Figure 3.5: Host transcripts involved in the cytokine-cytokine receptor interaction pathway in human astrocytes infected with T. gondii compared to N. caninum infected 
cells. CXCL1 shows an increased expression in cells infected with N. caninum compared to T. gondii infection and CXCL2 was also increased in N. caninum infection while 
showing the opposite trend of decreased expression in T. gondii infected cells. CX3CL1 was increased higher in T. gondii infected cells compared to cells infected with N. 
caninum. 







Table 3.3: Differentially expressed host cell transcripts involved in cytokine-cytokine receptor interaction pathway in cells infected with T. gondii compared to cells infected 
with N. caninum. Log2 fold change in HA cells infected with N. caninum (Nc) and T. gondii (Tg) at 0, 4 and 16 hours p.i. are shown. Fold changes highlighted in red show up-
regulated expression changes and fold changes highlighted in green show down-regulated transcript expressions.  
Accession number Gene name Gene description 
Log2 fold change 
 
 
Nc 0h Nc 4h Nc 16 h Tg 0h Tg 4h Tg 16h 
ENSG00000163739 CXCL1 growth-regulated alpha protein 0 2.28 4.82 0 0.576 0.620 
ENSG00000081041 CXCL2 C-X-C motif chemokine 2 0 2.27 3.561 0 -1.85 -2.086 
ENSG00000163734 CXCL3 C-X-C motif chemokine 3 0 -0.87 3.018 0 -0.617 0.201 
 ENSG00000006210 CX3CL1 Fractalkine 0 1.342 2.37 0 2.92 4.05 
ENSG00000019991 HGF Hepatocyte growth factor 0 -1.46 2.43 0 0.95 2.89 
ENSG00000139269 INHBE Inhibin beta E chain 0 0.610 2.28 0 -0.63 1.089 
ENSG00000169429 IL8 Interleukin-8 0 1.267 3.46 0 -0.22 1.064 
ENSG00000136244 IL6 Interleukin-6 0 0.137 0.37 0 -0.10 -0.862 
ENSG00000124875 CXCL6 C-X-C motif chemokine 6 0 -0.10 3.056  -  -  - 
ENSG00000150782 IL18 Interleukin-18 0 0.602 1.814  -  -  - 






The second pathway explored was the cell adhesion molecule pathway (CAM) 
(Figure 3.6). Cell adhesion molecules (CAMs) are glycoproteins found on the cell 
surface that are crucial to many biological processes in the cell that include immune 
responses, inflammation, haemostasis, embryogenesis, and development of 
neuronal tissue. Differences in their expression was detected between the two 
infections (Figure 3.6). Neural cell adhesion molecule 2 (NCAM 2) was significantly 
up-regulated in T. gondii infected cells whereas no change was detected in N. 
caninum infected cells (Table 3.4). An important molecule involved in blood brain 
barrier (BBB) permeability, vascular cell adhesion molecule 1 (VCAM1). It was up-
regulated in cells infected with T. gondii compared to N. caninum (Figure 3.6 and 
Table 3.4). Claudin-22 (CLDN 22) had a significantly down-regulated fold change in 
T. gondii infected cells compared to N. caninum. HLA class I histocompatibility 
antigen, alpha chain F (HLA-F) was down-regulated in T. gondii infected cells and up-
regulated in N. caninum infected cells (Figure 3.6 and Table 3.4). Cadherin-15 (CDH 
15) was detected up-regulated in cells infected with N. caninum, while down-
regulated in T. gondii infected cells (Figure 3.6 and Table 3.4). Intracellular cell 
adhesion molecule 1 (ICAM 1) was found with similar up-regulated expressions in 












                                                                                                                                                                                                                                                               
 
Figure 3.6: Host transcripts involved in the cell adhesion molecule pathway in human astrocytes infected with T. gondii compared to N. caninum infected cells. ICAM1 was 
up-regulated in a similar way andCLDN4 was down-regulated in both infected cells. On the other hand; NCAM2 was up-regulated in T. gondii infected cells compared to N. 
caninum infected cells. 
 







Table 3.4: Differentially expressed host cell transcripts involved in cell adhesion pathway in cells infected with T. gondii compared to cells infected with N. caninum. Log2 
fold change in HA cells infected with N. caninum (Nc) and T. gondii (Tg) at 0, 4 and 16 hours p.i. are shown. Fold changes highlighted in red show up-regulated expression 
changes and fold changes highlighted in green show down-regulated transcript expressions.  
 
Accession number Gene name Gene description 
Log2 fold change 
Nc 0h Nc 4h Nc 16h Tg 0h Tg 4h Tg 16h 
ENSG00000026508 CD44 CD44 antigen 0 -0.043 -0.20 0 -0.23 -0.473 
ENSG00000129910 CDH15 Cadherin-15 0 0.615 1.8336 0 -1.51 -1.184 
ENSG00000177300 CLDN22 Claudin-22 0 0.802 -0.415 0 -3.18 -4.35 
ENSG00000189143 CLDN4 Claudin-4 0 -1.39 -3.75 0 -1.68 -3.71 
ENSG00000204642 HLA-F 
HLA class I histocompatibility 
antigen, alpha chain F 0 -0.340 1.743 0 -1.25 -1.88 
ENSG00000090339 ICAM1 Intercellular adhesion molecule 1 0 0.209 1.349 0 -0.10 1.254 
ENSG00000169896 ITGAM Integrin alpha-M 0 -0.39 -0.184 0 -2.73 -1.35 
ENSG00000149294 NCAM1 Neural cell adhesion molecule 1 0 0.295 1.135 0 -0.21 0.992 
ENSG00000154654 NCAM2 Neural cell adhesion molecule 2 0 -0.81 -0.152 0 3.207 3.648 
ENSG00000110876 SELPLG P-selectin glycoprotein ligand 1 0 -0.494 -1.64 0 -1.152 -1.59 






The data was also searched for molecules of interest in the CNS. One of the 
important cytokine molecule was C-C motif chemokine 2 (CCL2) that is associated 
with brain pathogenesis and toxoplasma encephalitis. It was down-regulated in N. 
caninum infected cells at 3.33 fold compared to an up-regulated expression (3.5 
fold) in T. gondii infected cells at 16 hours post infection (Appendix II).  
In both T. gondii infected cells and N. caninum infected cells, one of the most 
abundant transcripts (as shown by the FPKM values) with a down-regulation 
expression (3.33 fold) was plasminogen activator inhibitor 1 RNA-binding protein 
(SERPINE1) (Appendix II). SERPINE1 plays a role in the regulation of mRNA stability 
in the cell.  
Matrix metalloproteases 1 (MMP1), a protease enzyme involved in proteolysis and 
extracellular matrix organization, was also one of the most abundant transcripts in 
both infected cells. It was found significantly down-regulated in cells infected with 
T. gondii at 16 hours p.i. (3.44 fold) compared to infected cells with N. caninum (1.6 
fold) (Appendix II). 
Neuronal pentraxin-1 (NPTX1) was up-regulated 3.8 fold in N. caninum infected cells 
higher, whereas in T. gondii infected cells was only up-regulated 1.4 fold. It is 
associated with the CNS development and synaptic transmission (Appendix II). 
Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and 2 (IFIT2) 
were only found in N. caninum infected cells with 25 fold in IFIT1 and 3.4 fold  were 
up-regulated at 16 hours p.i., these molecules are involved in innate immunity, 






The molecular functions, cellular contents and biological process of individual host 
transcripts within the clusters of interest were determined in HA infected cells. 
Clusters that showed differential expression changes and contained a significant 
number of transcripts were chosen for functional annotations (Figures 3.3). Of these 
clusters, cluster 4 in cells infected with T. gondii contained the highest number of 
transcripts (527 transcripts) and showed an upward trend in expression (Figure 
3.3a). Molecules associated within this cluster were involved in biological processes, 
including gland development, behaviour, chemokine activity, cell adhesion, 
forebrain development and leukocyte migration (Table 3.5). Cellular content was 
mainly found integral to membrane and the molecular functions were associated 
with chemokine activity (Table 3.5). 
In cells infected with N. caninum, cluster 1 had the most abundant number of 
transcripts (282 transcripts) and showed an upward trend in expression (Figure 
3.3b). The biological processes associated with these molecules were ion transport, 
chemotaxis and lipid transport (Table 3.6). The cellular content was related to the 
extracellular region part and the molecular function was involved in ion channel and 





Table 3.5: Functional annotation of a subset of the transcripts identified in the analysis of human 
astrocyte infected with T. gondii using DAVID. A total of 527 transcripts (from cluster 4, Figure 3.3a) 
that showed an upward trend in expression were searched for their biological processes, cellular 













gland development 11 2.2 1.40E-03 
behaviour 23 4.7 2.00E-03 
mammary gland development 7 1.4 3.80E-03 
telencephalon development 7 1.4 4.40E-03 
taxis 11 2.2 5.00E-03 
chemotaxis 11 2.2 5.00E-03 
cell-substrate adhesion 8 1.6 8.80E-03 
cell-cell signalling 25 5.1 9.20E-03 
biological adhesion 28 5.7 9.40E-03 
forebrain development 10 2 1.10E-02 
leukocyte migration 6 1.2 1.10E-02 
Cellular content 
integral to membrane 163 33.3 2.30E-04 
intrinsic to membrane 167 34.2 3.10E-04 
Molecular function 
chemokine activity 6 1.2 4.50E-03 
chemokine receptor binding 6 1.2 5.90E-03 




Table 3.6: Functional annotation of a subset of the transcripts identified in the analysis of human 
astrocyte infected with N. caninum using DAVID. A total of 282 transcripts (from cluster 1, Figure 
3.3b) that showed an upward trend in expression (Figure 3.3) were searched for their biological 
processes, cellular contents and molecular functions.   






ion transport 21 8.3 0.0011 
chemotaxis 8 3.2 0.0035 
taxis 8 3.2 0.0035 
cation transport 15 5.9 0.0078 
lipid transport 7 2.8 0.0087 
Cellular content 
extracellular region part 24 9.5 1.50E-03 
extracellular space 18 7.1 4.50E-03 
Molecular function 
ion channel activity 16 6.3 1.40E-04 
substrate specific channel activity 16 6.3 1.90E-04 
channel activity 16 6.3 2.80E-04 
passive transmembrane transporter 
activity 
16 6.3 2.90E-04 






 Ingenuity Pathway analysis (IPA) 
Previous analysis provided useful functional information for individual transcripts 
and pathways, but IPA can be used for a broader view of the transcripts especially in 
association with enriched pathways analysis. All the differentially expressed 
transcripts in T. gondii (n=1672) and N. caninum (n=1029) infected cells were 
searched using IPA pathway analysis. The top canonical pathway returned with the 
lowest p-values was mainly associated with the leukocyte extravasation signalling 
pathway. Astrocytes are known to cause migration of leukocytes during injury or 
infection. Therefore, the main pathway investigated was the leukocyte 
extravasation signalling pathway with a p-value of 1.89 x 10-4 and a total of 30 
molecules involved in the pathway of T. gondii infected cells (Figure 3.7). In N. 
caninum infected cells a total of 20 molecules were involved in this pathway with a 
p-value of 9.7 x 10-4 (Figure 3.8).  
The top enriched diseases in the T. gondii infected cells were associated with cancer 
(p-value of 1.32 x 10-6) and neurological diseases (p-value of 1.44 x 10-5). In N. 
caninum infected cells, they were associated with injury and abnormalities (p-value 
of 1.08 x 10-7) and inflammatory diseases (p-value of 1.56 x 10-6).  
The main aim of this analysis was to look at the differences occurring in the host 
cells in response to different parasite infection at a molecular level. The leukocyte 
extravasation signalling pathway is the process by which leukocytes migrate from 
blood to tissues during inflammation (Figure 3.7 and 3.8). Some molecules were 
found to be specific to infection with a particular parasite. For example, matrix 
metalloproteases 1 (MMP1) was down-regulated (3.44 fold) in T. gondii infected 
cells at 16 hours. Also Integrin beta-3 (ITGB3) was down-regulated at 16 hours (2.77 
fold) in T. gondii infected cells. In N. caninum infected cells, metalloproteinase 
inhibitor 4 (TIMP4) was up-regulated (3.2 fold) at 16 hours.  
There were also differences between the two infections in the regulation of 
phosphoinositide phospholipase C-gamma-2 which was down-regulated in T. gondii 





protein kinase (TEC) was found down-regulated (6.25 fold) in T. gondii infected cells, 
while up-regulated (4 fold) in N. caninum infection. Both of these molecules are 
involved in innate immune response. Another molecule also showing differences 
between the two infections was Ras-related C3 botulinum toxin substrate 2 (RAC2) 
which is associated with axon guidance and platelet activation. It was down-
regulated (1.8 fold) in cells infected with T. gondii and up-regulated (3.5 fold) in N. 
caninum infected cells. Claudin 14 (CLDN14) was up-regulated (2.9 fold) in T. gondii 
infected cells and down-regulated (3.7 fold) in N. caninum infected cells. This 








Figure 3.7: Leukocyte extravasation signalling pathway of human astrocyte cells infected with T. gondii. Expression data from the 1672 T. gondii transcripts were mapped 
onto pathways using Ingenuity pathway analysis. The molecules with up-regulated expression values were highlighted in red and the molecules with down-regulated 
expression values were highlighted in green. The molecules in grey shading indicate molecules associated with the pathway but were not found in the expressed transcripts 
inserted. Oolecules highlighted with purple lines without internal coloured shading are molecules detected in the pathway but show no significant (up-regulation or down-








Figure 3.8: Leukocyte extravasation signalling pathway analysis of human astrocyte cells infected with N. caninum; it was generated using Ingenuity pathway analysis, the 
1029 transcripts were all inserted to the IPA pathway. The molecules with increased expression values were highlighted in red and the molecules with decreased expression 
values were highlighted in green. The molecules in grey shading indicate molecules associated with the pathway but were not found in the expressed transcripts inserted. 





  Discussion 
Understanding interactions of the intracellular apicomplexan pathogens with their 
host cells will help in identifying key differences between T. gondii and N. caninum. 
This can be achieved through information obtained of alterations occurring within 
the transcriptome and proteome of the host’s responses during invasion. There are 
many factors that may affect the expression patterns of these transcripts such as 
the host cell type and biological status of the cell (Gail, Gross & Bohne 2001; 
McNicoll 2006).  
The main aim of this experiment was to compare changes in the transcript profile 
expressions of human astrocytes during infection with T. gondii compared to N. 
caninum.  
Initially, the experimental design was intended to include two biological replicates 
for the three time points in both infected cells. However, to ensure enough material 
was available for the experiment the two replicates were pooled together. 
Nevertheless, when looking into the literature; around 70% of the total published 
data was in fact using no replicates, through the application of RNA-Seq deep 
sequencing (e.g. Brawand et al. 2011; Graveley et al. 2011; Hah et al. 2011). 
Overall, the main findings show differential expression of host cells in response to T. 
gondii infection compared to N. caninum infection. In order for the parasite to 
maintain its survival and proliferate in host cells, it must moderate the host’s cell 
signalling pathways and scavenge nutrients needed from host cell organelles such 
as the mitochondria and ER. The RNA-Seq analysis presented here has identified key 
molecules associated with signalling pathways. For example, differences in the CAM 
receptor interaction pathway and cytokine-cytokine receptor interactions along 
with MAPK pathway were identified between T. gondii and N. caninum infected 
cells. Through IPA analysis, the leukocyte extravasation signalling pathway was 
identified as the top enriched pathway in both infected cells. This is in agreement 
with previous findings of the roles of astrocytes in leukocyte migration during 






 The cytokine-cytokine receptor interaction pathway 
During infection with T. gondii or N. caninum, activation of innate and adaptive 
immune responses are induced through induction and migration of chemokines and 
cytokines. Chemokines are small secreted molecules that are divided into four 
subfamilies according to the position of the conserved cysteine residues (C, CC, CXC 
and CX3C), in which are associated with leukocyte migration of immune cells to 
sites of infection, immune homeostasis and angiogenesis (Zlotnik & Yoshie 2000; 
Adams & Lloyds 1997). There were reports demonstrating the roles of chemokines 
in the control of toxoplasamic encephalitis (TE), such as CCL2 (Amichay et al. 1996; 
Wen et al. 2010).  It has been proven that chemokines can be secreted during T. 
gondii infection both in vitro and in vivo studies done on mice; for example CXCL1, 
CCL2 and IL8 (Brenier-Pinchart et al. 2000; Brenier-Pinchart et al. 2002).  
In the cytokine-cytokine receptor interaction pathway (Figure 3.5) the general 
overall transcript expressions of cytokines and chemokines were up-regulated in 
cells infected with N. caninum compared to T. gondii. Of these molecules were: IL8, 
CXCL1, CXCL2, CXCL3 and CXCL6. While CX3CL1 was up-regulated in cells infected 
with T. gondii compared to N. caninum infected cells (Figure 3.5 and Table 3.4). 
Interluikin8 (IL8) is a chemo attractant, mainly for neutrophils but also T cells, 
basophils and NK cells is stimulated during inflammatory responses (Burke et al. 
2008). IL8 also induces phagocytosis and is known to be a potent promoter of 
angiogenesis. IL8 was significantly up-regulated in cells infected with N. caninum 
compared to a slight up-regulation in cells infected with T. gondii. In a comparative 
microarray study done by Beiting et al. (2014), fold changes of IL8 were higher in N. 
caninum infection in mice macrophages in vivo compared to the T. gondii VEG 
strain. Another study has also shown up-regulation of IL8 in T. gondii infected HFF 
and HeLa cells which were correlated with the findings in this chapter (Denney, 
Eckmann & Reed 1999).  
During Toxoplasma infection, the innate immune response, in which neutrophils are 





CXCL1 and CXCL2, helps in the control of T. gondii infection (Viola & Luster 2008; 
Denkers et al. 2004). CXCL1, CXCL2, CXCL3 and CXCL6 all belong to the same family 
of chemokines were highly increased in N. caninum infected cells compared to T. 
gondii infected astrocytes. Microarray investigations of T. gondii tachyzoite (RH 
strain) infection in HFF, dendritic cells, macrophage and retinal vascular endothelial 
cells was carried out in previous studies, and have detected an up-regulation of 
CXCL1, CXCL2, CCL2, MHC-I and IL8 through the analysis of immune cell responses 
to the infection (Blader, Manger & Boothroyd 2001; Chaussabel et al. 2003; Gail, 
Gross & Bohne 2001; Knight et al. 2005). 
CXCL1, also known as growth-regulated alpha protein, is important in the processes 
of angiogenesis, inflammation, wound healing, and tumour genesis (Tsai et al. 
2002). In a comparative microarray study done by Beiting et al. (2014), CXCL1 had 
an increased expression in N. caninum compared to TgVEG infected cells, which was 
in agreement with the RNA-Seq data analysis in this chapter. Furthermore, it was 
up-regulated in microglial cells after 24 hour p.i. with T. gondii in vitro and in brains 
and retina of infected mice in acute stage of infection independent from IFN-ϒ 
(Brenier-Pinchart et al. 2004 Kikumura et al. 2012). C-X-C motif chemokine 2 
(CXCL2), also known as macrophage inflammatory protein 2-alpha, had up-
regulated mRNA expression in cells infected with N. caninum, whereas it was down-
regulated in T. gondii infection. It is involved in the activation of monocytes and 
neutrophils and is expressed at sites of inflammation. This contradicts findings that 
showed up-regulation of the CXCL2 in other studies; such as a study done by 
Kikumura et al. (2012), on the leukocyte migration during ocular toxoplasmosis in 
murine models and found up-regulated expression of CXCL2 and CCL2. However, 
there were no studies looking into the secretion of CXCL2 in N. caninum infected 
cells. Also, investigation of immune response at the transcriptional level were 
explored using human Muller cells in the retina. There findings also showed 
increase expression of CXCL2 in infected cells with two strains of T. gondii (Knight et 
al. 2006). This may suggest that T. gondii infection delays neutrophil recruitment 
more efficiently compared to N. caninum infection and as a result delays innate 





regulated expression in astrocytes infected with N. caninum as mentioned earlier. 
Chemokine (C-X-C motif) ligand 6 (CXCL6) functions as a chemo-attractant for 
neutrophilic granulocytes and has strong antibacterial activity against gram-positive 
and gram-negative bacteria (Proost et al. 1993; Van Damme et al. 1997). Both 
CXCL6 and IL8 activate their immune responses through CXCR1 and CXCR2 
receptors (Wuyts et al. 1998; Wolf et al. 1998). Investigation in gastrointestinal 
nematode infected cattle showed no differences between susceptible and 
resistance cattle in their secretion of CXCL6 (Li et al. 2007). CXCL6 has been linked to 
many inflammatory and pathological disorders such as inflammatory bowel disease 
and cancer (Zhu, Bagstaff & Woll 2006).  
CX3CL1, also known as fractalkine, has three amino acids between the two 
cysteines and acts as a chemo-attractant and an adhesion molecule that enables 
the adhesion of cells to the endothelium (Goda et al. 2000). The CX3CL1 chemokine 
was up-regulated in T. gondii infected astrocytes compared to N. caninum. This was 
in agreement with other studies looking at the effect of T. gondii infection on host 
cells, in which they have found the up-regulation of chemokines including CCL2, 
CXCL1, CXCL2 and CX3CL1  (Lachenmaier et al. 2011; Stein & Nombela-Arrieta 
2005). 
CCL2 was up-regulated during astrocyte infection with T. gondii compared to a 
down-regulated expression in N. caninum infected cells. CCL2, also known as 
monocyte chemotactic protein-1 (MCP-1), is a member of the β-chemokine family. 
It functions as an attractant for monocyte/macrophages, CD4 and CD8 memory T 
lymphocytes (Adams & Lloyds 1997). This chemokine plays important roles in the 
CNS as neuroinflammatory mediators of leukocyte migration and has been 
associated with many neurological disorders (Bajetto et al. 2001; Zlotnik & Yoshie 
2000). CCL2 has also been demonstrated to restrict T. gondii dissemination in 
human astrocytes and human fibroblastic cells (MRC5) and facilitate the 
recruitment of monocyte and lymphocytes to sites of inflammation (Brenier-
Pinchart et al. 2002; Brenier-Pinchart et al. 2004). In addition, in vivo investigation 
on murine models with TE infections demonstrated that astrocytes were the main 





correlated with the findings presented here in human astrocytes infected with T. 
gondii. This may suggest that up-regulation of CCL2 by T. gondii can result in the 
migration of macrophages and activated T cells, NK and immature dendritic cells 
into the sites of infection in the brain and initiate adaptive immune responses 
through the migration across the blood brain barrier to enable the parasite to 
establish the chronic stage of infection in the brain and persist in the hosts brain.  
A previous report has shown that neutrophils in peripheral blood increased in mice 
after T. gondii infection (Norose et al. 2008). Absence of IFN-γ function may cause 
neutrophil activation, as it is involved in the down regulation of IL8 production. 
Another cause of IL8 induction is the elevation of IL12 and TNFα found in human 
and mouse neutrophils in vitro (Denkers et al. 2003). From the mRNA data analysis; 
elevation of molecules related to TNFα have been detected suggesting that N. 
caninum may supress these genes which result in elevated production of neutrophil 
recruitment to sites of inflammation in cells infected with N. caninum compared to 
T. gondii infection. Most of the chemokines related to the induction of neutrophils 
were increased in N. caninum infected cells which may suggest that T. gondii 
attempts to supresses them in order to establish the chronic infection in the CNS 
and minimize inflammatory damage to the infected cells.  
 
 Cell adhesion molecule pathway 
Many processes and interactions are important in the development and 
maintenance of the CNS; this includes formation of neuronal connections, synapse 
plasticity and guidance and the differentiation and migration of neural cells and 
other cells of the CNS (Basch, Garcia-Castro & Bronner-Fraser 2004; Tessier-Lavigne 
& Goodman 1996). Cell adhesion molecules (CAM) have been associated with the 
connection between cells through homophilic or heterophilic interactions 
(extracellular matrix (ECM)). These adhesion molecules are involved in many cellular 
processes such as homeostasis, inflammatory, immune responses and wound 
healing (Koukoulis, Patriarca & Gould 1998). They include four main families of 





are also associated with cytoskeleton organization and the alteration of signal 
transduction processes and are expressed in neurodegenerative disorders such as 
Alzheimer’s disease (Bartsch 2003; Welzl & Stork 2003). Transcriptional changes in 
the peripheral lymphocytes of infected mice with type I and type II T. gondii were 
investigated by Jia et al. (2013), it was observed that in type I infected mice showed 
up-regulation of genes related to CAM, olfactory transduction and ribosome 
pathways, whereas in type II infected mice cytokine-cytokine pathway receptor 
interaction, chemokine signalling pathway, and toll-like receptor pathway were up-
regulated (Jia et al. 2013). Cell adhesion molecules play vital roles in brain 
morphology and functions including learning and memory through neuron synapse 
formation of cell-cell adhesion with neighbouring cells. 
Up-regulation of VCAM1 mRNA expression was found in HA cells infected with T. 
gondii compared to N. caninum and similar up-regulated expression was observed 
in ICAM1 (in both T. gondii and N. caninum infected cells). These are important 
adhesion molecules linked to parasitic infections of the CNS, such as cerebral 
malaria and TE. When inflammatory reactions take place in the CNS; cell adhesion 
molecules such as ICAM1, VCAM1 and selectins are induced through microvascular 
endothelial cells in addition to the secretion of many types of cytokine and 
chemokines (Kadl & Leitinger 2005; Coisne et al. 2006). Previous studies have 
demonstrated that both ICAM1 and VCAM1 are expressed on inflamed BBB 
endothelial cells and are critical for the transmigration of lymphocytes and 
monocytes (Carman & Springer 2004; Ifergan et al. 2006). ICAM1 is an endothelial 
and leukocyte-associated transmembrane protein related to the immunoglobulin 
family that is known for its importance in stabilizing cell-cell interactions and 
facilitating leukocyte endothelial transmigration. Increased expression of ICAM1 
was reported to decrease the function of the BBB and permit transendothelial 
migration of infected immune cells through the parasites MIC2 adhesion in T. gondii 
infection (Rahman & Fazal 2008; Barragan, Brossier & Sibley 2005). Usually these 
proteins are secreted in low concentration; upon cytokine stimulus their 
concentrations increase (Dustin et al. 1986). VCAM1 is expressed on both large and 





the adhesion of lymphocytes, monocytes, eosinophils and basophils to vascular 
endothelium and is involved in leukocyte-endothelial cell signal transduction. 
Transcriptional microarray profiles of infected retina cells (Muller cells) with two 
different strains of T. gondii (type I and II) demonstrated up-regulation of VCAM1, 
MHC-I (Knight et al. 2006). Siva et al. (2010), suggested that up-regulation of ICAM1, 
VCAM1 and increased BBB permeability participated in inflammatory cell infiltration 
into the CNS during T. gondii infection (Silva et al. 2010). This also correlates with 
the findings in this transcriptional analysis of human astrocytes.   
Another cell adhesion molecule significantly up-regulated in cells infected with T. 
gondii, while no significant changes were observed in N. caninum infected cells was 
neural cell adhesion molecule-2 (NCAM2), which belongs to the immunoglobulin 
(Ig) superfamily. Both NCAM1 and NCAM2 are widely expressed in the CNS and may 
have similar functions. There have been no studies looking in the role of NCAM1 or 
NCAM2 during infection with protozoan parasites. NCAM2 may be a marker of 
certain types of neurological diseases and cancer such as breast cancer (Massaro, 
2002). The sequence of NCAM1 has a high identity to NCAM2 and both are found 
abundant in the CNS suggesting that these two molecules share similarities 
(Paoloni-Giacobino, Chen & Antonarakis 1997). There has been limited research 
investigating the roles and functions of NCAM2 in the brain. Nevertheless, NCAM2 
has been suggested to contribute to the establishment and maintenance of 
dendritic bundle in the region associated with learning and memory in the brain 
(the granular retrosplenial cortex) (Sutherland, Whishaw & Kolb 1988). NCAM’s 
have also been associated with cell-cell adhesion (Zhang et al. 2003), which may 
indicate its role in increased permeability of the infected cells through the BBB.  
 Toxoplasma encephalitis (TE) involves strong activation of major histocompatibility 
complex (MHC) class I and II antigens as well as of the ICAM1 on cerebral 
endothelia, microglia and choroid plexus epithelium and VCAM1 on endothelial cells 
(Deckert-Schlüter et al. 1994). The major histocompatibility complex (MHC) consists 
of three subgroups: class I, class II and class III. HLA class I histocompatibility 
antigen, alpha chain F, is involved in the presentation of foreign antigens to the 





cells of the CNS do not express MHC-I, but astrocytes can up-regulate MHC-I 
expression through IFN-γ stimulation that is vital for controlling TE (Jarosinski & 
Massa 2002; Schluter et al. 1991). There is limited information of HLA-F function 
available, making it difficult to hypothesise possible roles in parasitic infections. One 
study examined the effect of Leishmania major infection on human monocyte cells 
and found no gene expressional changes in HLA-F secretion after 24 hours p.i. 
(Guerfali et al. 2008). HLA-F was down-regulated in astrocytes infected with T. 
gondii, whereas up-regulated in N. caninum infected cells. This could indicate that T. 
gondii down-regulates MHC-I expression at early stages of infection to invade and 
establish parasite infection in cells of the CNS. 
Tight junction molecules are known for their importance in the BBB permeability 
through enabling the closure of spaces between adjacent endothelial cells and 
thereby only permitting the entry of small molecules to the brain (Zlokovic 2008). 
The down-regulation of claudins and cadherin in this data, such as CLDN-22, CLDN4 
and CDH15 mainly in cells infected with T. gondii may be a result of a parasite-
induced mechanism to support immune cell entry. Claudins play a role in sealing the 
tight junction (Ohtsuki et al. 2008; Krause et al. 2008). Most of the claudins and 
CDH15 were down-regulated in cells infected with T. gondii, with the exception of 
CLDN14 which was up-regulated in cells infected with T. gondii and down-regulated 
in N. caninum infected cells. Cadherins are involved in intracellular communication 
and homeostasis (Vleminckx & Kemler 1999). CDH15 is a calcium-dependent cell 
adhesion protein associated with cell junction assembly that was also found 
reduced in primary culture of mice skeletal muscle cells infected with T. gondii after 
24 hours p.i. by Gomes et al. (2011). This may suggest that T. gondii down-regulates 
these molecules to loosen the tight junction and enhance its entry to the CNS.  
Overall increased expression of cell adhesion molecules mostly in T. gondii infected 
cells may imply the ability of the parasite to increase its permeability through the 
BBB and loosen the tight junction through down-regulation of claudins and cadherin 
molecules in the CNS more efficiently compared to N. caninum infection in the brain 






 MAPK pathway in host cells 
The MAPK pathway consists of proteins that transfer a signal from a receptor on the 
cell surface to the nucleus DNA.  The end product causes changes in the cell such as 
cell division. It has been suggested that the MAPK pathway is important during T. 
gondii infection, in which the parasite increases the regulation of this pathway 
(Brumlik et al. 2013). The MAPK pathway also functions in neutrophil activation 
during T. gondii infection (Sukhumavasi, Egan & Denkers 2007) and in controlling 
proinflammatory response during infection with T. gondii (Dong, Davis & Flavell 
2002). 
Differences in transcriptional expression patterns of molecules associated with the 
MAPK pathway was detected between astrocytes infected with T. gondii and N. 
caninum infected cells (Tables 3.2). While a total of eight transcripts associated with 
the pathway in T. gondii infected cells that were up-regulated at 4 hours and then 
down-regulated at 16 hours p.i., the opposite was detected in the seven transcripts 
in cells infected with N. caninum. However, the transcripts involved in each 
pathway in both infected cells differ and the only molecule found in both infected 
cells was the fibroblast growth factor receptor 2 (FGF2). Also, MAPK pathway was 
identified as statically significant in cells infected with N. caninum, whereas it was 
not significant in cells infected with T. gondii (Table 3.2). Therefore it is difficult to 
reach a definite conclusion related to the modifications found between the infected 
cells for this pathway.  
 
 Other functional annotations of host cell molecules 
Analysis of individual significant transcripts included SERPINE1, MMP1 and NPTX1 
(Appendix II). Plasminogen activator inhibitor 1 (SERPINE1) is a serine protease 
inhibitor involved in physiological and pathological processes in an organism such as 
angiogenesis, complement activation, coagulation and inflammatory responses. In 





with both parasites. In contrast, a previous study found SERPINE1 be up-regulated 
in T. gondii infected human neuron and microglial cells in vitro (Mammari et al. 
2014). SERPINs have been proposed to reduce the parasite’s duplication by 
obstructing the apoptosis process of the host cell. This has been associated to the 
increased production of SERPIN in microglial and neuron infected cells which may 
lead to the control of T. gondii replication and the inhibition of apoptosis of the 
nervous cells (Mammari et al. 2014).  
MMP1 was only detected in T. gondii infected cells and was down-regulated. Matrix 
metalloproteases (MMPs) are major enzymes that are associated with the 
extracellular matrix (ECM) degradation, and may also be associated with cell 
migration, differentiation, growth and inflammatory processes in the cell. The 
parasites are able to control human monocytic cells through the degradation 
process using MMPs (Buache et al. 2007). A study done on astrocytes infected with 
T. gondii showed down-regulation of MMP2 and MMP9 during infection (Lu & Lai 
2013). This correlates with the finding of MMP1. Thus, may suggest that the 
parasite may control inflammatory development in the host cells. 
In T. gondii infection, the parasite alters leukocyte interactions, evade the hosts 
immune system and spread to important sites such as the CNS using different cells  
such as macrophages, monocytes, and dendritic cells (Da Gama et al. 2004; Lambert 
et al. 2006; Courret et al. 2006). Pentraxin-related proteins regulate innate 
resistance to pathogen and inflammatory reactions and the control of 
autoimmunity (Rovere et al. 2000). Pentraxins are highly abundant in many cell 
types, including mononuclear and phagocytic cells (Breviario et al. 1992). Neuronal 
pentraxin-1 (NPTX1) is mainly found in the CNS and is involved in the development 
and synaptic transmission and is found increased in glia cells and less in neurons 
that function in limiting brain tissue damage (Blasi et al. 1995; Mazzolla et al. 1996). 
It was found up-regulated in cells infected with N. caninum compared to cells 
infected with T. gondii. This may suggest that N. caninum parasites up-regulate 
NPTX1 to increase synaptic transmission between cells. Although this can also be 
assumed in cells infected with T. gondii as these parasites are able to delay 





Other molecules that were found up-regulated in one infection compared to the 
other and are related to cell signalling and immune responses were Interferon-
induced protein with tetratricopeptide repeats 1 and 2 (IFIT1) and (IFIT2). Up-
regulated mRNA expression of these two molecules was detected in cells infected 
with N. caninum. IFIT1 and IFIT2 are associated with innate immune responses, 
antiviral defence and type I interferon signalling pathway. This correlated with the 
microarray analysis performed by Beiting et al. (2014). This may suggest that N. 
caninum may act more as a virus during infection as type I interferon responses are 
highly associated with viral responses. Also, this may indicate that T. gondii 
supresses early innate immune responses in infected host cells. 
 
3.4.2 Functional annotations of host cell transcripts 
The biological processes and molecular functions of a subset of transcripts that 
showed up-regulation in host cells during infection across the three time points of 
infection were investigated. In both host cell infections (cluster 1 in T. gondii 
infected cells and cluster 4 in N. caninum infected cells, Table 3.6 and 3.7); the 
biological processes and molecular functions were mostly associated with 
chemotaxis and chemokine activity. In addition, cells infected with T. gondii showed 
biological processes related to behaviour and cell adhesion functions. This may 
suggest that T. gondii up-regulates host genes associated with behaviour and brain 
development, in which T. gondii manipulates its behaviour for its persistence as 
detected by previous studies (Gaskell et al. 2009; McConkey et al. 2013) compared 
to N. caninum, where no biological processes related to behaviour alteration was 
detected. 
      
 Leukocyte extravasation signalling pathway 
The leukocyte extravasation signalling pathway was identified as the top enriched 
pathway in both infected cells through IPA analysis. This is in agreement with 





(Jones, Bienz & Erb 1986; Fischer et al. 1997). The transmigration of T. gondii 
through endothelial barriers differs according to strain type; type I strains have the 
highest ability to increase migration and dendritic cell activity (Lambert et al. 2009). 
With advances in culture techniques available, in vitro models have been 
established for deeper investigation of certain interactions between host-pathogen; 
such as the formation of 3D well models and transwell co-cultures. The 
investigation of CNS invasion by T. gondii and the involvement of leukocytes in this 
process were done using an in vitro model of the BBB of rat glia and endothelial 
cells (Veszelka et al. 2007). They have demonstrated the up-regulation of cytokines 
and chemokines, such as IL6, involved in the acute phase immune response and 
increased the transfer of T. gondii when compared to lymphocytes. This may 
suggest that APC are more likely to be involved in the parasites ability to cross the 
BBB (Veszelka et al. 2007). One of these molecules associated with this pathway 
was the tyrosine protein kinase (TEC). TEC was significantly down-regulated in cells 
infected with T. gondii while up-regulated in cells infected with N. caninum. The 
data related to this pathway proposes the role of these parasites in the migration of 
cytokines chemokines and other molecules during host astrocyte infection and 
especially in T. gondii infection. 
 
3.4.3 Conclusions and future direction 
In summary, transcriptional expression changes were observed between host cells 
infected with T. gondii compared to cells infected with N. caninum. These were 
mainly related to leukocyte migration through the BBB, which showed increased 
permeability of T. gondii infected cells compared to N. caninum infected cells. 
Neutrophil activation was found associated with N. caninum infection of cells 
compared to T. gondii infected cells. Functional annotations have also identified the 
up-regulation of biological processes such as behaviour changes in host cells 
infected with T. gondii, whereas both infected cells functional annotations were 
also associated with chemotaxis activities. In conclusion, T. gondii activates host 
cells to increase its establishment of the chronic stage in the host cell brain more 





N. caninum infected cells suggesting that N. caninum initiates an earlier innate 
immune response and may lead to induction of apoptotic processes in infected 
cells.  
It is known that not all identified transcripts are translated into proteins; therefore 
investigation of the host’s global expression protein profiles during infection 
through a label-free quantitative method enables a comparison of the 
transcriptome and proteome. This would enhance our knowledge and 
understanding of similarities/ differences of the transcriptome and proteome 
expression analysis in host responses during T. gondii and N. caninum infection as 






 Chapter four: Comparative proteomic profiles of 
host cells response during T. gondii and N. caninum 




There are many apicomplexan parasites associated with CNS diseases that 
collectively have a huge impact on both human and animal health outcomes 
(Carruthers 2006). For example, one of the most successful parasites is Plasmodium 
falciparum that causes cerebral malaria due to the microvascular sequestration of 
the parasite and can lead to death in severe cases (Mackintosh, Beeson & Marsh 
2004). N. caninum infection results in abortion in infected cattle and may cause 
neurological effects in congenitally infected calves. It can also result in limb 
paralysis in infected dogs (Dubey 2005). T. gondii infection in HIV/AIDS patients may 
lead to toxoplasmic encephalitis and may elicit severe cerebral damage in 
congenitally infected new-borns (Montoya & Liesenfeld 2004; Jones et al. 2001). 
The biological properties of both T. gondii and N. caninum along with limitations in 
N. caninum investigations in the CNS has enhanced the need for investigating  host-
parasite interactions that may elucidate improvements in management of the 
diseases. In order for the parasite to successfully invade cells; modulation and 
alteration of host responses are required.  
The availability of the genomic sequences of many organisms has facilitated the 
investigation of many biological aspects of functional annotations and metabolic 
pathways at the transcriptional level. Yet, genomic analysis alone is not enough to 
identify the resulting protein expressions profiles in biological systems under certain 
experimental conditions or during the complex life cycle of a particular parasite  
(Cuervo, Fernandes & de Jesus 2011; Walther & Mann 2010).  Moreover, little or 





different protozoan analysis (McNicoll et al. 2006; Cohen-Freue et al. 2007). Thus, 
quantitative proteomic analysis enables the exploring of protein expression analysis 
in host biological systems during infection and determines protein functions 
(Aebersold & Mann 2003).  
 
4.1.1 Label-free based quantitative investigations 
Label-free approaches use raw data directly from parallel mass spectrometry runs 
to enable the comparison relative protein abundance in different protein runs 
(Wastling et al. 2012), and have many advantages over labelling techniques 
including low cost, simplicity and less concentrations of samples are required.  
Currently, there are two different protein quantification schemes in label-free 
quantification: spectral counting and ion intensity measurements as discussed in 
detail in chapter one (1.9.4.2.1 and 1.9.4.2.2). 
Throughout this thesis, ion intensity based strategy was used for label-free 
quantification. It is believed to be more robust compared to spectral counting which 
does not use retention time (Elliott et al. 2009). It can be biased towards abundant 
peptides, in which many low values are considered statistically unreliable due to 
high variability (Lundgren et al. 2010). Tandem mass spectrometers (MS/MS) 
coupled with liquid chromatography instruments such as Ion trap mass 
spectrometers (the LTQ Orbitrap Velos (Thermo)) were used for label-free 
proteomic quantification in this thesis. Furthermore, specialised software was 
required to generate normalised quantification values for each protein. There are 
open source programs available such as MZmine 2 (Pluskal et al. 2010) and 










Figure 4.1: Overview of Label free workflow, samples are first prepared followed by protein 
extraction and digestion and later placed of the LC-MS/MS followed by protein identification and 
quantification using ion intensity generated by spectra or spectral counting, then analysed through 














4.1.2 Research of astrocytes and parasites using label free quantitative 
proteomics 
Limited investigations of the whole-cell proteome and secretome in astrocytes have 
been achieved (Skorupa et al. 2013; Yin et al. 2012). In particular, the whole-cell 
proteome of astrocytes has not been examined during parasitic invasion. An 
investigation done on neurons, astrocytes, oligodendrocytes and microglia in the 
human brain identified 1755 cell-type-specific nuclear proteins. These proteins are 
involved in histone modifications and the regulation of networks altered with 
normal brain aging or neurodegenerative disease (Dammer et al. 2013). Alzheimer’s 
disease, a neurodegenerative disorder has been studied using label-free methods 
(Donovan et al. 2012; Ringman et al. 2012). A total of 13 proteins that were 
considerably altered from post-mortem brains of Alzheimer’s disease patients 
compared to uninfected patients using spectral counting approach, such as Tau 
(MAPT), Ubiquitin carboxy-terminal hydrolase 1 (UCHL1), and syntaxin binding 
protein 1 (Munc-18) (Donovan et al. 2012). In a study done by Cutillas & 
Vanhaesebroeck, (2007); comparative proteomic profiling of five different mouse 
tissues (heart, brain, kidney, liver and lung) were analysed through label free ion 
intensity based method. A total of 1000 proteins were identified and biological 
processes in tissues were associated with transport, cell death, and development 
(Cutillas & Vanhaesebroeck 2007).  
Label-free approach has also been applied to parasite studies. A study done by 
Bennuru et al. (2011) identified more than half of the predicted gene products in 
the filarial worm Brugia malayi from adult microfilaria and L3 larvae stages of the 
parasite through simple spectral counting. Also, different developmental stages of 
the parasite S. japonicum along with tissues of both host and parasites proteomes 
were characterised in parallel with transcriptomic data (Liu et al. 2006). Proteomics 
of the early gametocyte stage in the deadly malarial parasite P. falciparum 
determined the cellular proteome of 1427 proteins and discovered that the proteins 





In general, these quantitative label-free proteomic studies in both parasite and host 
cells have enabled a broader view of global proteomic expression changes to be 
identified, quantified and detect protein that were previously overlooked due to 
their low protein abundances with higher reproducibility and minimum variation 
detected between experimental samples. 
To our knowledge, there have been no comparative studies investigating the host 
cell response in human astrocytes in vitro during infection with T. gondii and N. 
caninum through-label free quantitative method.  
 
 
4.1.3 Aims and objectives 
The main aim of this chapter was to compare proteomic changes occurring in 
human astrocytes during T. gondii to infected cells with N. caninum invasion using a 
label-free quantitative proteomics approach. In addition, the metabolic and 
functional annotations of the quantified proteins will be investigated which will 














 Materials and methods 
4.2.1  Cell culture 
Human astrocytes (HA) primary cell lines were used as a model system. Cells were 
grown and maintained as mentioned previously in chapter two (2.2.1). TgVEG strain 
and NcLIV strain were used for infection; three time points (0, 4 and 16 hour’s p.i) 
and three replicates per sample were selected for this experiment which is 
comparable to RNA-Seq chapter (3.2.1).  
 
4.2.2 Label free sample preparation of HA cells 
 Lysis of HA cells 
A total of 27 pellets of 1x107 cells (three replicates each of HA cells infected with 
TgVEG, HA cells infected NcLIV and uninfected HA cells) were solubilised using 25 
mM ammonium bicarbonate, followed by three cycles of the freeze/thaw/vortex 
method and two cycles of sonication in a sonicating water bath for 15 minutes each. 
The samples were centrifuged at 13,000 x g for 10 minutes at 4°C and the 
supernatant was collected. Protein concentration for each sample was determined 
by protein assay.  
 
4.2.2.1.1  Protein Assay 
Pierce Coomassie plus protein assay was used for protein concentration 
measurements of the 27 samples as mentioned previously in chapter two (2.2.2.3).  
 
 In-solution sample digestion  
A total of 100 µg of each sample was further diluted in 25 mM ammonium 
bicarbonate to a volume of 160 μl, prior to the addition of 10 μl of 1 % Rapigest 
(Waters) (0.05 % (w/v) final concentration). The samples were heated to 80°C for 10 





each sample, and incubated for 10 minutes at 60°C. A total of 10 μl of 33 mg/ml IAA 
(Iodoacetamide) was added to a final concentration of 9 mM and the samples were 
incubated in the dark for 30 minutes at room temperature. Trypsin was added at a 
50:1 protein: trypsin ratio (10 µl/ 100 µg) using a 0.2μg/μl trypsin (Roche) solution 
and the digests were incubated overnight at 37°C. Trifluoroacetic acid (TFA) was 
added to a final concentration of 0.5 % (v/v) and the digest incubated for 45 
minutes at 37°C. Finally, the samples were centrifuged for 15 minutes at 13000 x g 
at room temperature and the supernatant collected for subsequent mass 
spectrometric analysis (LC-MS/MS). 
For quality control measures (QC), the digests and the proteins were run on a 1D-
SDS PAGE to ensure complete digestion of the proteins to peptides prior to running 
them on the LC-MS/MS. 
 
 
4.2.3 Protein identification and quantification 
 Label-free quantitative mass spectrometry analysis  
The label-free quantitative mass spectrometry analysis of human astrocytes 
infected with TgVEG and NcLIV along with uninfected cells at three different time 
points was carried out by Dr. Dong Xia at the University of Liverpool using an 
Orbitrap Velos MS as described in chapter two (2.2.3.2).  
 
 Label-free peptide quantification of host cells  
Raw data generated from the Orbitrap Velos was imported to Progenesis™ QI 
software (version 1, Nonlinear Dynamics) for label-free quantification. Two sets of 
analysis were performed on Progenesis; 1) HA cells infected with TgVEG vs. 
uninfected HA cells and 2) HA infected cells with NcLIV vs. uninfected HA cells. 
Profile data of the MS scans were transformed to peak lists, a sample was 
automatically selected as reference after checking the 2-D mapping (m/z versus 





reproducibility of results and to produce combined data set. The retention times of 
the other samples within the experiment were aligned against the reference. 
Peptide maps created by peak picking were then applied to all replicates. Raw 
abundances were normalised to correct any experimental variation. Following peak 
picking the spectra produced for each feature were exported from Progenesis and 
used for peptide identification using Mascot (Matrix Science, version 2.3). against 
the UniProt reference and reviewed database for H. sapiens (Feb, 2014 version). 
Search parameters used were: 10ppm peptide mass tolerance (±10 ppm) and 0.8 Da 
fragment mass tolerance with one missed cleavage allowed. Fixed modification was 
set as carbamidomethylation while variable modification was set as methionine 
oxidation. Identified peptides with ion scores of > 13 (p < 0.05, FDR < 1%) were 
exported and re-imported into Progenesis™QI software. Statistical analysis was 
then performed on all detected features using normalized abundances for one-way 
analysis of variance (ANOVA). The results were further filtered to only include 
proteins ≥ 2 peptide hits and statistically significant (q value>0.05). Only the HA cells 
with infections at all three different time points (TgVEG infected and NcLIV infected) 















Figure 4.2: Workflow of label-free based protein quantification. Peptides that were digested from 
samples were inserted on Orbitrap (Thermo Fisher Scientific) (A).Raw peptide profiles were then 
aligned (B) and peptide intensities are quantified (C). Proteins are identified by MS/MS ion search in 
databases (Mascot) and peptide peak intensities assigned to each identified protein are accumulated 













4.2.4 Functional analysis and Annotation 
 Functional analysis of HA cell proteins that were found to be statistically significant 
were investigated using the functional analysis and clustering tool from the 
Database for Annotation, Visualisation, and Integrated Discovery (DAVID) (DAVID 
bioinformatics resources 6.7) (Huang et al. 2009). Proteins of HA cells infected with 
TgVEG and HA cells infected with NcLIV were searched in DAVID for metabolic 
pathway analysis (KEGG pathway) and functional annotations for their GO biological 
processes, molecular function and cellular components. The enriched metabolic 
pathways were compared to detect differences in the host’s protein regulation and 
also the similarities between them. 
 
 Ingenuity Pathway Analysis (IPA) 
Networks, functional analyses, and canonical pathways were produced through the 
use of the commercial software Ingenuity Pathway Analysis (IPA) (Ingenuity 
Systems, www.ingenuity.com). Functional analysis was used to identify the 
biological functions and diseases along with canonical pathways that were most 















A total of 1715 proteins were quantified and identified in the HA cells infected with 
T. gondii, while 1512 proteins were quantified in N. caninum infected HA cells. The 
proteins were then searched in DAVID for the enrichment of metabolic pathways, 
biological functions and cellular content.  
 
4.3.1 DAVID analysis of host cells infected with TgVEG 
Using DAVID analyses, a total of 30 statistically significant metabolic pathways were 
identified in infected HA cells with T. gondii. Pathways that were found with lower 
p-values and also differences in protein expressions between host cells infected 
with T. gondii and N. caninum were chosen (Table 4.1). Results from functional 
annotations of biological processes, cellular compartments and molecular functions 
are shown in table 4.2. Pathways selected with low p-values were ribosome, 
glycolysis, proteasome, focal adhesion and fatty acid metabolism (Table 4.1 and 
4.3). The biological processes of host cells proteins infected with T. gondii were 
mainly associated with translation, intracellular transport and RNA processing. 
Cellular compartment was found mainly in mitochondrion and membrane-enclosed 
lumen, and molecular function was associated with RNA processing and structural 













Table 4.1: Metabolic pathways of human astrocytes infected with T. gondii searched using DAVID 
functional analysis. 






KEGG_PATHWAY Ribosome 48 2.8 3.90E-18 7.00E-16 
KEGG_PATHWAY Spliceosome 58 3.4 4.70E-17 4.20E-15 
KEGG_PATHWAY Citrate cycle (TCA cycle) 25 1.5 6.20E-15 3.70E-13 
KEGG_PATHWAY Glycolysis / 
Gluconeogenesis 
32 1.9 1.20E-11 5.40E-10 
KEGG_PATHWAY Fatty acid metabolism 23 1.3 2.60E-09 9.40E-08 
KEGG_PATHWAY Valine, leucine and 
isoleucine degradation 
24 1.4 4.30E-09 1.30E-07 
KEGG_PATHWAY Oxidative phosphorylation 46 2.7 6.20E-09 1.60E-07 
KEGG_PATHWAY Proteasome 24 1.4 2.20E-08 4.90E-07 
KEGG_PATHWAY Huntington's disease 55 3.2 5.70E-08 1.10E-06 
KEGG_PATHWAY Pyruvate metabolism 21 1.2 1.20E-07 2.10E-06 
KEGG_PATHWAY Aminoacyl-tRNA 
biosynthesis 
21 1.2 2.00E-07 3.20E-06 
KEGG_PATHWAY Parkinson's disease 42 2.4 3.40E-07 5.10E-06 
KEGG_PATHWAY Propanoate metabolism 18 1 3.50E-07 4.80E-06 
KEGG_PATHWAY Focal adhesion 57 3.3 5.10E-07 6.50E-06 
KEGG_PATHWAY Valine, leucine and 
isoleucine biosynthesis 
9 0.5 2.20E-05 2.60E-04 
KEGG_PATHWAY Butanoate metabolism 16 0.9 3.20E-05 3.50E-04 
KEGG_PATHWAY Alzheimer's disease 44 2.6 4.80E-05 5.00E-04 
KEGG_PATHWAY Lysine degradation 18 1 7.50E-05 7.40E-04 















Table 4.2: Functional annotations of human astrocytes infected with T. gondii protein; Biological 
processes (BP), cellular compartment (CC) and molecular function (MF). 







translation 118 6.9 2.2E-33 7.8E-30 
translational elongation 58 3.4 2.4E-29 4.4E-26 
generation of precursor 
metabolites and energy 
105 6.1 3.1E-27 3.7E-24 
intracellular transport 166 9.7 1.2E-26 1.1E-23 
RNA processing 144 8.4 5.3E-25 3.8E-22 
Cellular 
compartment 
ribonucleoprotein complex 188 11 2.7E-49 1.8E-46 
mitochondrion 287 16.7 3.2E-43 1.1E-40 
membrane-enclosed lumen 403 23.5 2.7E-39 6.1E-37 
Molecular 
function 
RNA binding 207 12.1 1.1E-41 1.4E-38 
nucleotide binding 423 24.7 1.4E-34 9.3E-32 
structural molecule activity 174 10.1 6.6E-32 2.8E-29 
structural constituent of ribosome 66 3.8 4E-21 1.3E-18 




4.3.2 DAVID analysis of host cells infected with NcLIV 
A total of 34 statistically significant metabolic pathways were identified in HA cells 
infected with N. caninum. Pathways that were found with low p-values and also 
differences in protein expressions between host cells infected with T. gondii and N. 
caninum were selected (Table 4.1 and 4.3). Functional annotations of biological 
processes, cellular compartment and molecular functions were searched (Table 
4.4). The pathways with the lowest p-values were; ribosome, glycolysis, 
proteasome, focal adhesion and fatty acid metabolism pathways (Table 4.3). The 
biological processes of host cells infected with N. caninum were mostly related to 
translation, mRNA processing and oxidative reduction. Cellular compartment was 
mainly related to mitochondria and the molecular functions were associated with 







Table 4.3: KEGG metabolic pathways of human astrocytes infected with N. caninum searched using 
DAVID functional analysis. 





KEGG_PATHWAY Ribosome 46 3 2E-18 3E-16 
KEGG_PATHWAY Spliceosome 48 3.2 2E-12 2E-10 
KEGG_PATHWAY Glycolysis / Gluconeogenesis 29 1.9 2E-10 1E-08 
KEGG_PATHWAY Fatty acid metabolism 23 1.5 3E-10 1E-08 
KEGG_PATHWAY Citrate cycle (TCA cycle) 20 1.3 4E-10 1E-08 
KEGG_PATHWAY Aminoacyl-tRNA biosynthesis 23 1.5 5E-10 2E-08 
KEGG_PATHWAY Valine, leucine and isoleucine 
degradation 
23 1.5 3E-09 8E-08 
KEGG_PATHWAY Focal adhesion 53 3.5 4E-07 9E-06 
KEGG_PATHWAY Proteasome 21 1.4 5E-07 9E-06 
KEGG_PATHWAY Oxidative phosphorylation 39 2.6 6E-07 1E-05 
KEGG_PATHWAY Parkinson's disease 38 2.5 1E-06 2E-05 
KEGG_PATHWAY Propanoate metabolism 16 1.1 3E-06 5E-05 
KEGG_PATHWAY Pyruvate metabolism 17 1.1 2E-05 2E-04 
KEGG_PATHWAY Huntington's disease 44 2.9 4E-05 5E-04 
KEGG_PATHWAY Lysosome 32 2.1 6E-05 7E-04 
KEGG_PATHWAY Lysine degradation 17 1.1 7E-05 8E-04 
KEGG_PATHWAY ECM-receptor interaction 25 1.7 1E-04 0.001 
KEGG_PATHWAY Pathogenic Escherichia coli 
infection 
18 1.2 6E-04 0.006 
KEGG_PATHWAY Pentose phosphate pathway 11 0.7 7E-04 0.006 
 
 
Table 4.4: Functional annotation of human astrocytes infected with N. caninum proteins; Biological 
processes (BP), cellular compartment (CC) and molecular function (MF). 







translation 113 7.5 6.2E-35 2.1E-31 
translational elongation 57 3.8 4.5E-31 7.6E-28 
generation of precursor metabolites 
and energy 
97 6.4 2.6E-26 2.9E-23 
RNA processing 128 8.5 3.6E-22 3.1E-19 
intracellular transport 143 9.5 1.4E-21 9.7E-19 
Cellular 
compartment 
ribonucleoprotein complex 170 11.2 1.1E-45 7.4E-43 
mitochondrion 259 17.1 7.5E-41 2.5E-38 
mitochondrial part 174 11.5 7.4E-39 1.7E-36 
Molecular 
function 
structural molecule activity 164 10.8 9E-33 1.1E-29 
RNA binding 174 11.5 4.8E-31 2.9E-28 
nucleotide binding 378 25 7.1E-31 2.9E-28 






4.3.3 Comparison of metabolic pathways of host cells response during 
infection  
When investigating the differences in the metabolic pathways of HA cells infected 
with T. gondii and N. caninum, they generally had similar regulation patterns in their 
protein expressions; such as the citrate (TCA) cycle pathway, spliceosome and 
oxidation reduction pathway. The data was examined for differences between host 
cell protein expressions during TgVEG and NcLIV infection related to certain 
pathways; such as the ribosome (Figure 4.3), glycolysis (Figure 4.4), focal adhesion 
(Figure 4.5), fatty acid metabolism (Figure 4.6) and proteasome pathway (Figure 
4.7). 
In the ribosome pathway, four proteins showed differential expression between T. 
gondii and N. caninum infected cells. 60S ribosomal protein L14 (RL14) was up-
regulated in cells infected with T. gondii at 4 hours followed by down-regulated 
expression at 16 hours p.i. compared to N. caninum infected cells, while 60S 
ribosomal protein L22 (RL22) showed the opposite trend in protein expression 
(Figure 4.3). 40S ribosomal protein S30 (RS30) was down-regulated at 4 hours 
followed by up-regulated expression at 16 hours p.i. in both infected cells with a 
higher rise in T. gondii infected cells (Figure 4.3). 60S ribosomal protein L21 (RL21) 
was only detected in cells infected with N. caninum and was significantly down-
regulated (Figure 4.3). All the previous proteins are associated with RNA processing 
and translation.   
Proteins involved in glycolysis pathway generally showed similar protein expression 
patterns between infections (Figure 4.4), with the exception of 4-
trimethylaminobutyraldehyde dehydrogenase (AL9A1), which has roles in oxidation 
reduction and neurotransmitter biosynthetic process in the cell. AL9A1 was up-
regulated in HA cells infected with T. gondii at 4 hours p.i. compared to N. caninum 
infected cells followed by down-regulation at 16 hours p.i. in both infections (Figure 
4.4). ATP-dependent 6-phosphofructokinase, liver type (K6PL), involved in 





whereas down-regulated in HA cells infected with N. caninum at 4 hours p.i. (Figure 
4.4). 
In the focal adhesion pathway, serine/threonine-protein phosphatase PP1-gamma 
catalytic subunit enzyme (PP1G), and SHC-transforming protein 1 (SHC1) were both 
up-regulated in cells infected with T. gondii compared to cells infected with N. 
caninum (Figure 4.5).  PP1G is a protein essential for cell division, glycogen 
metabolism and protein synthesis. SHC1 is a signalling adapter that couples 
activated growth factor receptors to signalling pathways. Growth factor receptor-
bound protein 2 (GRB2) is associated with cell-cell signalling and axon guidance. It 
was up-regulated at 4hours in cells infected with T. gondii followed by down-
regulation at 16 hours p.i. Mitogen-activated protein kinase 8 (MK08) was only 
detected in N. caninum infected cells and was significantly down-regulated at 4 
hours and continued to decrease at 16 hours p.i. (Figure 4.5). MK08 is known to be 
associated with cell proliferation, differentiation, migration, transformation and 
programmed cell death.  
Proteins associated with the fatty acid metabolism pathway; such as Peroxisomal 
acyl-coenzyme A oxidase 3 (ACOX3); is involved in cellular lipid metabolic processes. 
It was up-regulated in both infected cells, but at a slightly higher extent in cells 
infected with N. caninum (Figure 4.6). Peroxisomal bifunctional enzyme (ECHP); is 
an enzyme associated with receptor binding function and was down-regulated at 4 
hours p.i followed by up-regulation at 16 hours p.i. in cells infected with N. 
caninum, while it was up-regulated in cells infected with T. gondii (Figure 4.6).  
Proteasome pathway displayed similar pattern expressions in both infections with 
the exception of proteasome subunit beta type-6 (PSB6), which is linked to DNA 
damage response, signal transduction by p53 and cell cycle arrest. PSB6 was down-
regulated in T. gondii infected cells and up-regulated in cells infected with N. 
caninum. 26S proteasome non-ATPase regulatory subunit 8 enzyme (PSMD8), which 
has similar functions as PSB6 was up-regulated at 4 hours followed by down-
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Figure 4.3: The ribosome pathway in HA cells infected with T. gondii and HA cells infected with N. caninum, RL14 (dark red line) was up regulated higher in HA cells infected with 
T. gondii at 4 hours then decreased at 16 hours p.i. compared to N. caninum infected cells. RL22 (dark green line) was decreased at 4 hours then slightly increased at 16 hours in 
HA cells infected with T. gondii, on the other hand it was increased at 4 hours then decreased at 16 hours p.i. in HA cells infected with N. caninum. RS30 (blue line) was found in 
both infections decreased at 4 hours followed by increased expression at 16 hours with a higher rise in T. gondii infected cells. RL21 (orange line) was only found in HA cells 
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Figure 4.4: Proteins involved in glycolysis pathway in HA cells infected with T. gondii and HA cells infected with N. caninum. Most of the proteins showed similar protein 
expression patterns but AL9A1 (red line)  was up regulated in T. gondii infected cell at 4 hours p.i. compared to N. caninum infected cells with no change in expression and 
down regulated in both infections. K6PL (blue line) was up regulated in T. gondii infected cells whereas down regulated in N. caninum infected cells at 4 hours and up 










                           HA cells infected with T. gondii                                                                                                  HA cells infected with N. caninum  
                                                                                            
Figure 4.5: Focal adhesion molecule pathway comparison between HA cells infected with T. gondii and HA cells infected with N. caninum. PP1G (purple line) and SHC1 (blue 
line) proteins were found up-regulated higher in T. gondii infected cells compared to infected HA cells with N. caninum. GRB2 (light green line) was up-regulated at 4hours 
followed by a decrease at 16 hours p.i, whereas a slight increase of GRB2 was found in cells infected with N. caninum. MK08 (light blue line) protein was only found in HA 












                         HA cells infected with T. gondii                                                                                                       HA cells infected with N. caninum
                                         
          
                                                                          
  
Figure 4.6: Fatty acid metabolism pathway comparison between HA cells infected with T. gondii and HA cells infected with N. caninum. ACOX3 (red arrow) and ECHP 
(black arrow) were found up-regulated in T. gondii infected cells, while ACOX3 was slightly higher up-regulated in N. caninum infected cells and ECHP was down 
regulated at 4 hours p.i then up regulated at 16 hours p.i. AL9A1 (blue arrow) also found in glycolysis pathway was up regulated at 4 hours then down regulated at 16 













                     HA cells infected with T. gondii                                                                                                          HA cells infected with N. caninum 
                                                                                                                                                                                                                     
Figure 4.7: Proteasome pathway showing proteins clustered in both T. gondii infected cells and N. caninum infected cells. PSB6 (red line) was down-regulated in T. gondii 
infected cells and up-regulated in N. caninum infected cells. PSMD8 protein was showing increased (two times higher than N. caninum infected cells fold change) 





4.3.4 Proteins with the highest fold changes during host cell infection 
Another approach was carried out to investigate individual protein expression changes (at 4 
hours and 16 hours p.i.) that were not associated with any individual pathways but had 
significantly increased expression changes (Figures 4.8, 4.9, 4.10 and 4.11).  
The significantly up-regulated proteins identified in T. gondii infected cells at 4 hours p.i. 
were compared with proteins found in N. caninum infected cells (Figure 4.8). Proteins such 
as pannexin-1 (PANX1), which is associated with calcium ion transport and 28S ribosomal 
protein S29, mitochondrial (RT29), which is involved in mediating interferon-gamma-
induced cell death were significantly increased. Proteins serine/arginine-rich splicing factor 
8 (SRSF8) which is involved in mRNA processing and caskin-2 (CSKI2) were also increased in 
cells infected with T. gondii but not in N. caninum infected cells.  
The significantly up-regulated protein expression changes in N. caninum infected cells 
compared to cells infected with T. gondii at 4 hours p.i. were 39S ribosomal protein L12, 
mitochondrial (RM12), which is involved in transcription and translation processes. DnaJ 
homolog subfamily C member 13 (DJC13), which is important in osteoblast differentiation, 
and histone H3.1 (H31), which is important in chromatin organization. Whereas other 
proteins were only found in N. caninum infection such as putative ATP-dependent RNA 
helicase DHX33 (DHX33), a protein involved in transcription, estradiol 17-beta-
dehydrogenase 11 (DHB11), which is associated with lipid biosynthesis and lactotransferrin 
(TRFL) that has antimicrobial activity (Figure 4.9).  
Significant up-regulated protein changes were also investigated at 16 hours p.i.  There were 
certain individual proteins that were found in one infection and not detected in the other 
infection. For example; non-histone chromosomal protein HMG-17 (HMGN2) and helicase 
SRCAP (SRCAP) protein both associated with DNA binding were only identified in T. gondii 
infected cells (Figure 4.10). In N. caninum infected cells at 16 hours p.i.; asparagine-tRNA 
ligase (SYNC) is associated with catalytic activity in the cell. Fructose-bisphosphate aldolase 
C (ALDOC) involved in glucose metabolic process was up-regulated in N. caninum infection 










Figure 4.8: Significantly up-regulated fold changes at 4 hours p.i. in T. gondii infected HA cells comparing to N. caninum infected cells. Some proteins were found in both 
infected HA cells with higher increased expression in T. gondii infected cells; such as PANX1 and RT29 (arrows), whereas others were only found in cells infected with T. 












Figure 4.9: Significantly up-regulated protein changes in HA cells infected with N. caninum at 4 hours p.i. compared to proteins in HA cells infected with T. gondii. Some 
proteins were found in both HA cells infections with higher increased expression in cells infected with N. caninum such as DJC13, H31 and RM12 (arrows), whereas others 





































Figure 4.10: Significantly up-regulated protein changes in HA cells infected with T. gondii compared to HA cells infected with N. caninum at 16 hours p.i. Proteins found in 
both infected HA cells with higher increased expression in T. gondii infected cells included PP1G, HMGN2 and SRCAP (arrows), whereas others were only found in cells 














Figure 4.11: significantly up-regulated protein changes N. caninum infected cells  compared to T. gondii infected cells at 16 hours p.i. Proteins found in with higher 






4.3.5 Ingenuity Pathway Analysis of infected HA cells 
The proteins quantified in both infected cells that have statistical significance (1715 in T. 
gondii infected cells and 1512 in N. caninum infected cells) were searched using Ingenuity 
Pathway Analysis (Qiagen). For the IPA mapping of the pathway, proteins with a ≥ 1.5 fold 
changes between the three time points were considered to be increased and were 
highlighted in red, proteins that were ≤ 0.66 fold change decreased were highlighted in 
green. The top enriched canonical pathway reported by IPA was the ERK/MAPK pathway in 
both T. gondii infected cells (Figure 4.12) and N. caninum infected cells (Figure 4.13), in 
which there were differences in some of the protein expressions in this pathway.  
In the ERK/MAPK pathway, a total of six proteins showed differential expression between 
the infected cells including 1433B, 2ABA, GRB2, PP1G, SHC1 and RASH. A description of 
these proteins along with their expression changes at three different time points are shown 









Table 4.5: Proteins associated with the ERK/MAPK pathway in cells infected with T. gondii at three different time points (0, 4, and 16 hours p.i.). 





q Value Description C0_FC T4_FC T16_FC 
P31946 1433B_HUMAN 4 914.27 9.71E-06 14-3-3 protein beta/alpha 1 0.494496 1.199595 
P63151 2ABA_HUMAN 2 190.96 0.038746 Serine/threonine-protein phosphatase 2A 
55 kDa regulatory subunit B alpha isoform 
1 1.454835 1.111854 
P62993 GRB2_HUMAN 3 25.03 0.01907 Growth factor receptor-bound protein 2  1 2.130628 1.219124 
P36873 PP1G_HUMAN 2 990.98 0.007038 Serine/threonine-protein phosphatase 
PP1-gamma catalytic subunit  
1 1.685766 18.57231 
P01112 RASH_HUMAN 3 168.54 0.001976 GTPase HRas  1 1.793393 1.165845 
P29353 SHC1_HUMAN 3 43.68 0.012909 SHC-transforming protein 1  1 1.455901 2.558603 
 
 Table 4.6: Proteins associated with the ERK/MAPK pathway in cells infected with N. caninum at three different time points (0, 4, and 16 hours p.i.). 





q Value Description C0_FC Neo4_FC Neo16_FC 
P31946 1433B_HUMAN 7 744.21 0.001527 14-3-3 protein beta/alpha 1 0.677575 0.911362 
P63151 2ABA_HUMAN 3 130.6 0.006356 Serine/threonine-protein phosphatase 2A 
55 kDa regulatory subunit B alpha isoform 
1 2.184887 1.236794 
P62993 GRB2_HUMAN 4 24.25 0.022018 Growth factor receptor-bound protein 2  1 1.111681 1.064958 
P36873 PP1G_HUMAN 2 619.8 0.04088 Serine/threonine-protein phosphatase 
PP1-gamma catalytic subunit  
1 1.593644 1.393359 
P01112 RASH_HUMAN 2 104.98 0.003716 GTPase HRas  1 1.805846 1.519057 









Figure 4.12: showing the ERK/MAPK pathway in HA cells infected with T. gondii at 4 hour p.i. using IPA analysis, the green colour indicates proteins that were down-
regulated and the red colour indicated the proteins that were up-regulated, the proteins that were highlighted with purple and grey coloured shading are the proteins 








Figure 4.13: showing the ERK/MAPK pathway in HA cells infected with N. caninum at 4hours p.i. using IPA analysis, the green colour indicates proteins that were down-
regulated and the red colour indicated the proteins that were up-regulated, the proteins that were highlighted with purple and grey coloured shading are the proteins 







In order for parasites to continue and multiply in host cells, they have evolved 
approaches to manipulate their hosts by modulating cell signalling pathways. In T. 
gondii; the parasite uses the host cells for proliferation through hijacking cells to 
disseminate in different areas of their hosts (Courret et al. 2006; Lambert & 
Barragan 2010). Tachyzoites of T. gondii have been proven to cross the blood brain 
barrier (BBB) and reach the brain.  
The main aim of this investigation was to explore proteomic expression changes 
occurring in human astrocytes during infection with T. gondii or N. caninum at three 
different time points of infection correlating to the time points chosen for the host’s 
transcriptomic analysis (Chapter three). Changes in transcriptional expressions 
between infections were observed and further confirmed through protein 
expression profile analysis between T. gondii and N. caninum carried out in this 
chapter. There was no correlation perceived between significant transcripts and 
differentially expressed proteins detected in this chapter. Most transcripts showing 
differential expression were linked to cytokine and cell signalling pathways, while in 
the proteomic expression profiles there were mostly related to metabolism 
(glycolysis and fatty acid metabolism).  
Comparison of metabolic pathway analysis between the host cells infected by two 
parasites revealed that similar host responses were observed in many pathways, 
such as the spliceosome pathway and citrate TCA cycle pathways. Differences in 
protein expressions were also observed in some metabolic pathways including 
ribosome, focal adhesion, proteasome, glycolysis and fatty acid metabolism.   
 
 
 Ribosome metabolic pathway of infected human astrocytes 
Ribosomes are complex molecules involved in the processing and biosynthesis of 
proteins, in which ribosome synthesis includes the assembly of two subunits, a large 





protein and transcript quality control (Kramer et al. 2009; Wilson & Beckmann 
2011). They are also involved in cell stability, cellular response to different stimuli, 
cell proliferation, DNA repair, and apoptosis and are associated with the many 
diseases such as metabolic disease and cancer (Wang et al. 2014; Lindstrom & 
Zhang, 2008; Volarevic et al. 2000). Three proteins were found differentially 
expressed between the two infections; RL14, RL22 and RS30. RL14 was up-regulated 
in T. gondii infected cells at 4 hour p.i. compared to N. caninum followed by down-
regulated expression at 16 hours p.i, whereas RL22 was up-regulated in HA cells 
infected with N. caninum at 4 hours p.i. compared to T. gondii infected cells. These 
differences were observed despite both RL14 and RL22 are 60S ribosomal proteins 
involved in gene expression and translation. RS30 was found up-regulated in both 
HA infected cells but at a higher extent in T. gondii. It is a 40S ribosomal protein 
associated with cellular metabolic process, gene expression and antibacterial 
humoral response. Previous investigations of the host global transcriptional 
expression profiles during T. gondii infection have found modulations taking place in 
host metabolic pathways such as the ribosome pathway (Blader et al. 2001). 
Transcriptional changes in the peripheral lymphocytes of mice infected with type I 
showed up regulation of genes related to CAM, olfactory transduction and 
ribosome pathways (Jia et al. 2013).  
Although differences between proteins were observed in this pathway, they werea 
very low number of proteins. Moreover, other proteins related to this pathway 
showed similar expression which may suggest protein expression changes of host 
cells between these two parasites may in general behave in a similar manner 
related to the main metabolic pathwaysfound in the host cells (Figure 4.3). 
Furthermore, the use of the less virulent strain TgVEG may also have induced host 
responses closely related to N. caninum as demonstrated in a comparative 







 Glycolysis pathway of infected human astrocytes 
Host cell induction of glycolysis supports the parasites growth and tachyzoites 
proliferation (Bohne & Roos, 1997; Dzierszinski et al. 2004). The preferred 
encystation sites for the parasite are the muscles and CNS are also tissues with 
increased glycolytic activities through increased lactate formation (Luft & Castro 
1991; Brooks 2002). In addition, T. gondii expresses glycolytic enzymes (Dzierszinski 
et al. 1999; Pomel, Luk & Beckers 2008). Host mitochondrial recruitment to the T. 
gondii PVM is implicated to supply the tachyzoites with energy, but it is not clear 
the exact form of this nutrient (e.g. in glucose or glutamine source) (Sibley 2003; 
Polonais & Soldati-Favre 2010). A study done by Blume et al. (2009) on a mutant 
strain of T. gondii with impaired glucose transport ability showed a light effect on 
the parasites growth but showed impairment in the parasites extracellular motility.  
Glycolysis metabolism is a 10-step process which produces ATP and pyruvate as the 
end product that may be linked to oxidative phosphorylation, and changes in the 
host metabolism can be a result of nutrient uptake by these parasites (Blader et al. 
2001; Ainscow & Brand 1999). Only two proteins from the glycolysis metabolic 
pathway showed differential expression between infected cells with T. gondii and N. 
caninum; 4-trimethylaminobutyraldehyde dehydrogenase (AL9A1) and ATP-
dependent 6-phosphofructokinase, liver type (K6PL). K6PL is from the initial steps of 
the glycolysis metabolism pathway, it catalyses the phosphorylation of D-fructose 6-
phosphate to fructose 1, 6-bisphosphate using ATP (Yin et al. 2012). This glycolytic 
enzyme was up-regulated in cells infected with T. gondii whereas it was down-
regulated at 4 hours followed by up-regulation at 16 hours post infection in cells 
infected with N. caninum. Due to the fact the parasite itself cannot produce the 
nutrients it needs, and obtains them directly from the host cells, the T. gondii PVM 
that surrounds and protects the parasites contains small pores that allow the 
exchange of nutrients, including glucose, iron, phospholipids and purines between 
the host cytoplasm and tachyzoites that enter through membrane transporters 
(Schwab et al. 1994, Charron & Sibley 2002; Blader & Saeij 2009). Host cells and 
specifically the mitochondria and ER are the main providers of essential products 





may suggest that T. gondii parasites have a higher need of glycolytic metabolism 
compared to cells infected with N. caninum. The AL9A1 enzyme  causes oxidation of 
aldehyde in an NAD-dependent reaction and is associated with neurotransmitter 
synthesis and oxidation reduction (Vaz et al. 2000). This may suggest that T. gondii 
increases AL9A1 for neurotransmitter biosynthetic production to enable 
modification of host cell behavioural responses during infection. T. gondii has been 
indicated to change host behaviour during infection in mice (Prandovszky et al. 
2011), in order to continue its life cycle by motivating the intermediate host to be 
ingested by the cat.  
The proteomic analysis showed it was up-regulated at 4 hours p.i. then down-
regulated at 16 hours p.i. in astrocytes infected with T. gondii, whereas no changes 
occurred in the first 4 hours of infection followed by decreased expression at 16 
hour p.i. in cells infected with N. caninum.  
 
 Focal adhesion of infected human astrocytes 
At the cell-extracellular matrix region, focal adhesion molecules are formed, where 
actin filaments are attached to transmembrane receptors of the integrin family. 
Focal adhesion molecules are macromolecule protein complexes that help to 
connect the cytoskeleton of a cell to the extracellular matrix (ECM) (Wozniak et al. 
2004). They have essential roles such as cell motility, cell proliferation, cell 
differentiation, regulation of gene expression and cell survival. In the CNS, 
astrocytes have been shown to be key sources of ECM and adhesion proteins, that 
controls neurite outgrowth in relation to developmental or injury causes (Wang & 
Bordey 2008).  Zhou et al. (2103 ), detected differences in regulation between the 
two strain infections, in which focal adhesion metabolism was up-regulated in TgRH 
infected brain tissue compared to TgME49 (Zhou et al. 2013). 
Three proteins were found with increased fold change expressions in T. gondii 
infected cells compared to N. caninum infected cells; serine/threonine-protein 
phosphatase PP1-gamma catalytic subunit (PP1G), SHC-transforming protein 1 





phosphatase that dephosphorylates biological targets and is involved in cell division, 
cell cycle, glycogen metabolism, protein synthesis and synaptic plasticity. SHC1 is a 
signalling adapter that links activated growth factor receptors to signalling 
pathways and is involved in signal transduction, apoptosis, cell migration, oxidative 
stress, and increased expression of this protein has been linked to cancer (Honda et 
al. 2008). GRB2 connects the cell surface growth factor receptors with the Ras 
signalling pathway that is involved in signal transduction and cell communication. 
Inhibition or dysfunction of GRB2 results in defects in developmental processes and 
impairs transformation and propagation of cells and may cause cell death. Up-
regulation of PP1G may suggest that T. gondii increases this protein for protein 
binding processes. Also, the parasite might increase PP1G for glycogen production 
and synthesis to increase the parasite growth and proliferation in cells. SHC1 and 
GRB2 are both associated with MAPK cascade and regulation of cell proliferation 
and growth and were also detected in IPA analysis (Table 4.5). This may indicate 
that T. gondii enhances their production for its establishment in the cells. They are 
also involved in innate immune responses in cells, which may also suggest that T. 
gondii regulate immune responses to convert to the dormant stage of infection in 
the cells. One of the proteins that were only found in N. caninum infected cells was 
Mitogen-activated protein kinase 8 (MK08) and was significantly down-regulated at 
16 hours post infection. Serine/threonine-protein kinase is involved in various 
processes such as cell proliferation, differentiation, migration, transformation and 
programmed cell death. The down-regulation of MK08 could enable the delay of 
cell death and apoptosis processes in the N. caninum infected cells. 
 
 Fatty acid metabolism of infected human astrocytes 
Parasites can permit the entry of small molecules from the host cells through the 
pores on the PVM such as lipid and fatty acid proteins (Schwab, Beckers & Joiner 
1994), which clearly indicates the necessity of tachyzoites to scavenge lipids and 
fatty acids from the host for parasite replication and growth (Charron & Sibley 
2002). Three proteins in the fatty acid metabolism pathway showed difference in 





oxidase 3 (ACOX3), 4-trimethylaminobutyraldehyde dehydrogenase (AL9A1) and 
peroxisomal bifunctional enzyme (ECHP) (Figure 4.6).  ACOX3 was up-regulated in 
cells infected with N. caninum at 4 hours post infection, while ECHP was down-
regulated in N. caninum at 4 hours post infection compared to T. gondii infected 
cells. Both Enzymes (ACOX3 and ECHP) are associated with lipid metabolic process 
(Oppermann et al. 2009; Muzny et al. 2006), which may suggest that both T. gondii 
and N. caninum infection result in elevating host’s fatty metabolism molecules. 
AL9A1 was up-regulated in T. gondii infected cells at 4 hours post infection. This 
enzyme is associated with cellular aldehyde metabolic and neurotransmitter 
biosynthetic processes (Kurys, Ambroziak & Pietruszko 1989). The fact that AL9A1 
was increased in T. gondii infected cells may be involved in increasing 
neurotransmitter production that may suggest a role in host behavioural 
modification by T. gondii in the brain.    
The organelles of the host are localized closely to the PVM, which may imply to 
direct protein transfer of lipids from the host mitochondria membrane to the PVM 
(Sinai & Joiner 2001). In addition, lipids created in the ER must transport to the 
mitochondria in order to enter the PVM (Sprong, van der Sluijs & van Meer 2001). 
The fact that only three proteins were found differentially expressed between both 
infected cells from a total of 18 proteins associated with this pathway, may indicate 
that T. gondii and N. caninum act in a similar way in the modification of cells related 
to fatty acid metabolism. The parasite therefore must satisfy its nutritional needs by 
scavenging essential nutrients from its host cells such as fatty acid and lipid 
nutrients for their growth process and development.  
 
 Proteasome pathway of infected human astrocytes 
Proteasomes consist of protein complexes found in the nucleus and cytoplasm of 
cells. When there are damaged or unneeded proteins in a cell, proteasomes 
degrade them through disrupting the peptide bonds of those protein by photolytic 
enzymes. The proteins that are no longer needed in cells are labelled with ubiquitin, 





attaches to a proteomic enzyme. This process is important in response to oxidative 
stress, gene expression and cell cycle processes (Hilt & Wolf 1996; Geng & Tansey 
2012). Two proteins showed differential expression between the infected HA cells; 
26S proteasome non-ATPase regulatory subunit 8 (PSMD8) and proteasome subunit 
beta type-6 (PSB6). PSMD8 was up-regulated in T. gondii infected cells at 4 hours 
post infection, while PSB6 was up-regulated in N. caninum infected cells (Figure 
4.6). PSMD8 consists of 20S proteasome and 19S particles (Voges, Zwickl & 
Baumeister 1999), it is involved in the ATP-dependent degradation of ubiquitin 
marked proteins and participate in many biological processes in the cell including 
mitotic cell cycle, apoptotic process and antigen presentation through MHC class I. 
The exact function of PSMD8 is not known, but is suggested that it may cause 
deubiquitination (Stone et al. 2004). PSB6 is an ATP-dependent proteinase complex 
that can cleave peptides with Arg, Phe, Tyr, Leu, and Glu and has similar functions 
as PSMD8 (DeMartino et al. 1991). It is associated with apoptotic processes in cells, 
this may suggest that N. caninum infected cells induce apoptosis to a higher extend 
compared to T. gondii infected astrocytes.  
 
4.4.2 Proteins with the highest fold changes during host cell infection 
The significantly differentially expressed proteins in T. gondii and N. caninum 
infected cells were related to ribosomal proteins; 39S ribosomal protein L12, 
mitochondrial (RM12) and 39S ribosomal protein L19, mitochondrial (RM19). They 
are known to be associated with translation and biosynthesis of protein and are 
localised in the mitochondria. Mitochondrial ribosomes in mammalian hosts 
comprise of small (28S) and large (39S) subunits (Pel & Grivell 1994; O’Brien 2003). 
In addition to that the top biological processes in HA cells infected with T. gondii or 
N. caninum infected cells were associated with mRNA processing, translation and 
oxidative reduction. Also cellular compartments were mainly located in the 
mitochondria and ER, which indicates the importance of these organelles for the 





In general, similarity in metabolic pathway between the infected cells were quite 
close, though differences in a few proteins were detected.  This may suggest that 
parasites might have similar modulation effects on host metabolic process related 
to nutrient and protein synthesis. Global transcriptional and proteomic analysis 
carried out on the tachyzoites of T. gondii and N. caninum found similar metabolic 
pathways in both parasites and were unable to distinguish differences between 
them (Reid et al. 2012). Moreover it is not known the exact function of the 
differentially expressed proteins in association with protozoan parasites or parasitic 
infections; such as GRB2 and SHC1 proteins that were found in both focal adhesion 
and MAPK pathway. 
 
 
4.4.3 Conclusion and future direction 
Although proteomic analysis of whole cell lysate enables the comparison of 
translated proteins expressed in a cell at a certain time and under certain 
conditions, the overall comparison of the HA cells during infection showed similar 
expression profiles in many pathways such as citrate (TCA) cycle and oxidative 
phosphorylation pathways. In addition, while some proteins were differentially 
expressed, the majority of proteins in many pathways explored shared similar 
protein expression patterns. This suggests that changes in metabolism may not play 
a large role in host restriction and zoonotic compatibility between T. gondii and N. 
caninum. This observation has inspired the investigation of secreted proteins of 
host cells, where key proteins secreted during infection can be identified. It has 
been found that astrocytes secrete many proteins outside the cell during injury or 
disease. Host cell secretome comparisons will be carried out in the following 






 Chapter five: Comparative secretome analysis of 




After the investigation of the whole cell proteome of human astrocytes during 
infection with T. gondii and N. caninum in chapter four, further analysis of the host 
cells secreted proteins during infection between these parasites were applied in 
order to identify differences in host cells secretion during infection.   
 
5.1.1 Secretome 
The secretome (or “secretomics”) can be defined as the global investigation of 
proteins secreted or shed from the cell surface and also proteins that are located in 
the extracellular matrix of the cells (Makridakis & Vlahou 2010). Protein secretion is 
believed to be a balanced procedure essential for the normal physiological 
functions in host cells. In mammalian cells, secreted proteins are complex and 
closely regulated and have vital roles in physiological and pathological processes 
(Hathout 2007). Tissues in the mammalian host such as the brain and muscle 
secrete several biological molecules. Any excess or enduring changes in the 
secretion of these secretory proteins may indicate signs of abnormalities or 
pathological conditions (Hathout 2007). During activation of a cell, different 
proteins may be secreted according to its response to the stimuli. For example; B 
cell activation causes the secretion of immunoglobulins (such as IgM or IgA) in 
response to the antigen presented to them (Askonas 1975). Therefore, a global 
analysis of host protein secretions during infection is a potent approach for 
diagnostic and biomarker discoveries.  
Secreted proteins are encoded by approximately 10% of the human genome 
(Pavlou & Diamandis 2010). Typical secreted proteins include serum proteins; such 





digestive enzymes. They are usually found in low concentration and include proteins 
such as growth factors, hormones and cytokines that are associated with cell 
regeneration and differentiation. In eukaryotic cells, there are two main ways for 
protein secretion by cells or tissues; classical and non-classical secretion pathways. 
 
 Classical Secretory Pathway 
In the classical secretion pathway, intracellular signalling pathways are stimulated 
and activated, the storage granules or vesicles are released into the extracellular 
space. Synthesized proteins are then placed into the lumen of endoplasmic 
reticulum (ER), transported through the Golgi complex and finally released into the 
extracellular space (Mellman & Warren 2000). Signal peptides in proteins are 
important for determining interaction with the transport system, in which can 
define the endpoint of the protein to be delivered. However, not all proteins 
contain signalling regions; proteins without signals are retained in the cytoplasm. 
Signal peptide predictions and sequence comparisons have been typically used for 
the identification of potentially secreted proteins in an organism, through the 
application of database sequence investigation and the use of available software 
(Chen et al. 2003).  
 
 Non-classical Secretory Pathway 
In the non-classical pathway, many proteins do not have a signal sequence and do 
not use the classical ER-Golgi pathway. There are four non-classical secretory 
pathways (Nickel & Seedorf 2008). These are; direct translocation of proteins 
through membrane transporters across the membrane, lysosomal secretion, 
blebbing and release through exosomes from multivescular bodies. Proteins can 
also be discharged from cells through mechanical wounding (McNeil & Steinhardt 
2003). Many proteins associated with the immune response regulation, cell growth 
and cell differentiation are secreted through the non-classical pathway, such as 






5.1.2 Challenges in secretome investigations 
There are many challenges associated with secretome analysis, this includes sample 
preparation, concentration and separation techniques (Dowling & Clynes 2011). 
Even with cautious sample preparation during cell culture secretome investigations; 
many non-secreted proteins can still be discovered during secretome analysis. One 
of the main challenges in culturing is eliminating traces of bovine serum and cellular 
debris that can contaminate the collection of secreted proteins used for analysis. 
The overlap between human and bovine protein sequences; such as fibronectin 
might cause a type of signal interference and identification of peptide sequences 
during quantitative measurements of secreted proteins as it has closely related 
homology to human fibronectin (Planque et al. 2009). The incubation period, along 
with the culture conditions, need to be optimized so that the metabolic stress does 
not affect secretomic analysis (Makridakis & Vlahou 2010). Moreover, many 
proteins are secreted in low concentrations in cells and then diluted further in the 
cell culture medium, making them difficult to detect and analyse. Secretomes can 
be concentrated by lyophilisation, speed vacuum centrifugation, precipitation by 
trichloroacetic acid (TCA) and ultrafiltration (Lim & Bodnar 2002).  
 
5.1.3 Research on the astrocyte secretome 
Major advances in the proteomic studies of the cells secretome have occurred 
during the past seven years, owing to the improvements in proteomic techniques 
and especially in mass spectrometry (Brown et al. 2012). Many studies of the 
secretome have been applied to different research areas and specifically in the 
clinical field of research. Studying the secreted proteins can enable the discovery of 
important biomarker therapeutic targets; especially in the area of cancer research 
(An et al. 2010; Formolo et al. 2011).   
The applications of appropriate concepts of systems biology and proteomic 





systematic investigation of secreted proteins of astrocytes, microglia and other glial 
cells (Greenbaum et al. 2001, Dowell, Johnson & Li 2009; Liu et al. 2008). In recent 
years, the secretome of astrocytes has gained interest in the neuroscience field. It 
has been demonstrated to have roles in the development of the nervous system 
along with roles in neurodegenerative diseases such as Alzheimer’s and multiple 
sclerosis (Cassina et al. 2005, Antony et al. 2004). During disease progression in the 
CNS, the blood brain barrier breaks down, allowing the entrance of immune cells, 
including macrophages and monocytes during chemokine production (Krumbholz et 
al. 2006). Although microglias are known to be a major source of chemokine 
secretion, astrocytes have also been identified as a source for chemokine secretion 
and may participate in this infiltration process (Krumbholz et al. 2006). A label-free 
study of the rat astrocyte secretome performed by Moore et al. (2009) identified 
many proteins involved in neuronal development, which included proteins of the 
extracellular matrix and protease systems induced by astrocyte cholinergic 
stimulation. Tarassishin et al. (2014) investigated glioma cells involvement in 
tumour development also through a label-free proteomic approach. A total of 190 
proteins were detected that included cytokines, chemokines, growth factors, cell 
adhesion molecules and extracellular matrix proteins (Tarassishin et al. 2014).  
Another study done by Hur et al. (2010) on microglia and astrocyte cells in vitro 
examined ischemia-induced damage to the CNS. It showed that ischemia induced 
the activation of inflammatory cytokines, cytochrome c, reactive oxygen species 
(ROS) and NADPH oxidase resulting in neuronal cell death (Hur et al. 2010).  
 
The damage caused by N. caninum in the CNS has been observed in congenitally 
infected young dogs and cattle (Dubey et al. 2004; Kobayashi et al. 2001). It has also 
been shown that N. caninum can successfully infect a wide range of host cell types 
in vitro (Dubey, Schares & Ortega-Mora 2007) and there still remains a potential 
concern whether it can be zoonotic (Tranas et al. 1996; Robert-Gangneux & Klein 
2009). Human cell lines have been used to study N. caninum response and found 
that cytokine production was induced during infection (Carvalho et al. 2010). In 





expression, and cell viability have been investigated at 24 and 72 hours post 
infection (Pinheiro et al. 2006). These studies have found astrocyte hypertrophy, 
gliofilament reorganization and metabolic changes occurred (Pinheiro et al. 2006). It 
has been demonstrated in a study done by Elsheikha et al. (2013) that N. caninum 
induced cellular death in an investigation in mitochondrial bioenergetics of brain 
microvascular endothelial cells (Elsheikha et al. 2013). Neuroinflammation of 
astrocyte-derived cytokines and chemokines play both neuroprotective and 
neurotoxic roles in brain lesions of human neurological diseases.  
 
 
5.1.4 Aims and objectives 
Further to the discoveries related to the global transcriptional and whole cell 
proteome expression analysis, secretome analysis was performed to explore 
differences in host protein secretions during T. gondii and N. caninum infection. This 
will help in the comprehensive understanding into why these parasites behave 
differently in host cells during infection in the CNS. As T. gondii seems to control its 
intermediate host more efficiently and has tropism for cells of the CNS while N. 
caninum has not been identified to induce any behaviour or neurological disorders 
in their hosts as efficient as T. gondii. The hypothesis is that host cells secretion 
during infection with T. gondii will differ from host cells secretion during N. caninum 
infection. Key proteins are constantly secreted outside the cells, and investigating 
these proteins can extend our understanding of the host-parasite interaction 










 Materials and methods 
 
5.2.1 Cell culture 
Human astrocyte (HA) cells, TgVEG and NcLIV strain were grown and maintained as 
mentioned previously in chapter two (2.2.1.).  
 
 Experimental infection and harvesting of host cells 
Tachyzoites of TgVEG and NcLIV were isolated from host cells by filtration through 
47mm diameter 3μm pore-sized Nucleopore™ polycarbonate membranes. Then 
they were washed twice in PBS pH 7.4 followed by centrifugation at 1,500 x g for 10 
minutes. The supernatant was discarded, and parasites were resuspended in 
DMEM-F12. Three replicates of HA cells were required for T. gondii and N. caninum 
infection and also uninfected HA cells in this project (a total of 12 samples). Prior to 
infection, confluent cells were washed three times with DPBS and the medium was 
replaced with phenol red free DMEM-F12 (Gibco, life technologies) supplemented 
with 1% P/S (v/v) and excluding the addition of serum FBS. Afterwards, the number 
of HA cells were calculated and infected with NcLIV and TgVEG with a M.O.I. of 8 
parasites per cell. The T75 cm2 flasks (infected and uninfected) were incubated for 
18-24 hours at 37oC and 5% CO2, astrocytes supernatant was collected and filtered 
using a 0.22 µm syringe filter units (Millex®, Sigma-Aldrich) to eliminate any debris, 
and the sample was concentrated using Vivaspin 20 ml centrifugal concentrator 
(Sigma-Aldrich) with a 5 kDa molecular weight (MW) cut-off. Samples were 
centrifuged following the manufacturer’s instructions for 40 minutes at 4000 x g at 
20oC and samples were concentrated from 20 ml to 700 µl and stored at -80oC until 
needed. 
 
5.2.2  Protein extraction and tryptic digestion of host cell secretome 
A total of 12 HA cell supernatants (three replicates each of HA cells infected with 





digested through a label-free quantitative approach as mentioned previously in 
chapter four (4.2.2).  
For peptide purification, concentration and high recovery from digests, samples 
were desalted and purified using C18 resin in the form of spin tips (Thermo 
Scientific) following the manufacturer’s instructions. Samples were then speed 
vacuumed (Concentrator plus, Eppendorf) to near dryness, resuspended with 0.1 % 
TFA in 3% ACN and stored at -20oC until later running the samples on the tandem 
mass spectrometer.   
 
 
5.2.3 Protein identification and relative quantification 
 
  Mass spectrometry analysis  
Mass spectrometry analysis of the samples was carried out by Dr. Dong Xia at the 
University of Liverpool. Peptide mixtures were analysed by on-line nanoflow liquid 
chromatography using the nanoACQUITY-nLC system (Waters MS technologies, 
Manchester, UK) coupled to an LTQ-Orbitrap Velos (ThermoFisher Scientific, 
Bremen, Germany) mass spectrometer equipped with the manufacturer’s 
nanospray ion source. The analytical column (nanoACQUITY UPLCTM BEH130 C18 
15cm x 75µm, 1.7µm capillary column) was maintained at 35⁰C and a flow-rate of 
300nl/min. The gradient consisted of 3-40% acetonitrile in 0.1% formic acid for 
90min then a ramp of 40-85% acetonitrile in 0.1% formic acid for 3 min. Full scan 
MS spectra (m/z range 300-2000) were acquired by the Orbitrap at a resolution of 
30,000. Analysis was performed in data dependant mode. The top 20 most intense 
ions from MS1 scan (full MS) were selected for tandem MS by collision induced 
dissociation (CID) and all product spectra were acquired in the LTQ ion trap. Ion trap 






  Label-free peptide quantification (Progenesis) 
Raw data generated from the LTQ Orbitrap Velos was inputted directly into the 
Progenesis™ QI software (version 1.0, Nonlinear Dynamics) for label-free 
quantification as previously mentioned in chapter four (4.2.3.2). The secretome of 
HA infected cells (N. caninum or T. gondii) was compared to uninfected controls 
using Progenesis.  
 
5.2.4 Functional analysis and annotation  
Normalized protein abundance (proteins with ≥2 unique peptides and peptide score 
>30) of host secreted proteins were illustrated using volcano plots (Figure 5.2). 
DAVID (Database for Annotation, Visualisation, and Integrated Discovery, v 6.7, 
Huang et al. 2009) was used for functional annotation of differentially expressed 
proteins (p< 0.05, ± 1.5 fold change). Proteins accession numbers were searched 
against Homo sapiens genes background. An illustration of the overall label-free 
workflow in this experiment can be seen in Figure 5.1. 
 
  Predicted protein secretion 
Identified proteins were searched against the Secreted Protein Database 
(http://spd.cbi.pku.edu.cn/) (Chen et al. 2005), SignalP database prediction server 
(4.1 server) (http://www.cbs.dtu.dk/services/SignalP/ ) and SecretomeP prediction 
server (v 2.0) (http://www.cbs.dtu.dk/services/SecretomeP/) (Bendtsen et al. 2004). 
All proteins were searched against mammalian database. The SignalP database was 
used for the investigation of the secreted proteins through the classical pathway of 
secretion. SecretomeP was used for identifying the secreted proteins through the 
non- classical pathway. Basically any proteins identified with a threshold of more 






  Protein interaction analysis 
Protein network analysis was carried out with STRING (Search Tool for Retrieval of 
Interacting Genes/Proteins v 9.1 (http://string-db.org/) (Jensen et al. 2009) on 
differentially expressed proteins (p< 0.05, ± 1.5 fold change). Statistically significant 
proteins accession numbers were inserted and searched against Homo sapiens 
proteins. The protein interaction maps were created by allowing for experimental 
evidence. Protein interaction maps were generated by enabling experimental 
evidence along with predicted functional links between the proteins; co-occurrence, 
co-expression, gene fusion, databases and text-mining. The minimum required 
confidence was set at 0.7 (hi confidence) search for the software.    
 
  Pathway analysis 
Networks, functional analyses, and canonical pathways were produced through the 
use of the commercial software Ingenuity pathway analysis (IPA) (Ingenuity 
Systems, www.ingenuity.com). Settings included the search against a human 
database of the differentially expressed proteins (p< 0.05, ± 1.5 fold changes). The 
functional analysis managed to identify the biological functions and diseases along 
with canonical pathways that were most relevant and statistically significant to the 







Figue5.1: Overview of label-free workflow of human astrocyte secretome. Cells were grown until 
confluent followed by infection of the cells with either T. gondii/ N. caninum or left uninfected as 
controls. Supernatants were carefully collected at 18-24 hours p.i. followed by filtration, 
concentration, protein extraction and digestion and later were placed on the LC-MS/MS. Protein 
identification and quantification was done using Progenesis along with Mascot. Functional 

















Mass spectra for the proteins secreted from HA cells infected with T. gondii or N. 
caninum and uninfected cells were analysed using Progenesis to identify and 
quantify proteins. The total number of human astrocyte proteins in T. gondii 
infected HA cells were 667 and in N. caninum infected HA cells 973 proteins (≥ 2 
unique peptides) (Appendix V).  
The secretomes of HA cells infected with either T. gondii or N. caninum compared 
to uninfected controls are displayed as volcano plots (Figure 5.2). The y-axis is the 
log10 of p-values (a lower value indicates greater significance) and the x-axis is the 
difference in secreted protein expression between the infected and non-infected 
cells measured in log2 fold change. Tables below the volcano plots indicate 
examples of significant up-regulated and down-regulated proteins, which are 
highlighted in different colours in the volcano plot. In T. gondii infected cells; 
examples of up-regulated proteins were CCL2, ICAM1, CXCL1 and MMP10 and 
down-regulated were VIME, RS28 and CALU (Figure 5.2). In cells infected with N. 
caninum, examples of significant up-regulated secreted proteins compared to 
uninfected cells were LOXL1, IL8, CXCL2 and IL6, whereas the down-regulated 











Figure 5.2: Volcano plots of the secreted proteins in HA cells infected with T. gondii (left) compared to uninfected cells, and cells infected with N. caninum compared to 
uninfected cells (right). These proteins were identified and quantified using Progenesis. The volcano plot displays the relationship between fold-change and significance 
between the infected and non-infected cells. The y-axis is the reverse log10 of p-values (a higher value indicates greater significance) and the x-axis is the difference in 
secreted protein expression between the infected and non-infected cells measured in log2 fold change. Tables below the volcano plots indicate the top significant up-






5.3.1  Predication of host protein secretions 
In order to confirm that the proteins identified were predicted to be secreted 
proteins, protein ID’s were searched against SPD, SignalP and SecretomeP using 
protein sequences (fasta) of the secreted proteins. Only statistical significant 
proteins were included in the search (p-value< 0.05 and ±1.5 fold change) resulting 
in a total of 132 proteins identified in T. gondii infected cells (out of 667 proteins) 
and 252 proteins (out of 973 proteins) in N. caninum infected cells. Out of the 
identified proteins 64% was predicted to be secreted in T. gondii infected cells and 
56% in cells infected with N. caninum. In the Secreted Protein Database, 40 
predicted proteins were identified as secreted proteins in cells infected with T. 
gondii and 56 proteins in N. caninum infected cells.  This is likely to be an 
underrepresentation of the secreted proteins as the database was last updated in 
2006. SignalP database identified 53 proteins predicted to be secreted through the 
classical-pathway in cells infected with T. gondii and 68 predicted secreted proteins 
in N. caninum infected cells. The secreted proteins through non- classical pathway 
was searched using SecretomeP; 80 proteins were predicted to be secreted in T. 
gondii infected cells and 123 predicted secreted proteins in N. caninum infected 
cells. A Venn diagram of the overall number of predicted secreted proteins and the 
overlapping proteins identified in cells infected with T. gondii and cells infected with 


















Figure 5.3: Venn diagram of the secreted proteins of T. gondii infected cells (top) and N. caninum 
infected cells (bottom). Proteins were searched against the Secreted protein database and the online 
prediction tools, SignalP and SecretomeP.  
 
 
N. caninum infected HA secretome 





 Key differences in the astrocyte secretome in response to T. 
gondii or N. caninum infection 
 The significant up-regulated proteins between host cells infected with T. gondii 
compared to N. caninum showed differences in key cytokines and other secreted 
proteins (Figure 5.4). CXCL1 (GROA); involved in inflammatory responses and 
chemokine CCL2 was up-regulated higher in T. gondii infected cells compared to N. 
caninum infected cells (Figure 5.4 and Table 5.1, 5.2).  Other secreted proteins that 
were up-regulated in T. gondii infected cells and not detected in N. caninum 
infected cells included proteins such as; MMP10, ICAM1 and VCAM1 (Figure5.4 and 
Table 5.1).  
Secreted proteins that were up-regulated in cells infected with N. caninum 
compared to T. gondii include proteins such as; chemokine CXCL2,  (60 fold) that 
was found not to be statistically significant in T. gondii infected cells, interluikin-6 
(IL6), lysyl oxidase homolog 1 (LOXL1), latent-transforming growth factor beta-
binding protein 2 (LTBP2) and Interluekin-8 (IL8). IL8 was detected in infected cells 
with T. gondii but was not significant (p-value=0.33 and 1.5 fold increase) (Figure 
5.4 and Table 5.1, 5.2).  
Pentraxin-related protein-3 (PTX3); that plays a role in the regulation of innate 
resistance to pathogens and inflammatory reactions was up-regulated 4 fold in T. 
gondii infection but was found with no change in the N. caninum infected cells 












Table 5.1: A subset of statistically significant differentially expressed human astrocyte secreted 
proteins during T. gondii infection (with greatest fold changes). A total of 132 secreted proteins were 
identified (p<0.05 and ±1.5 fold change). Proteins showing up-regulation are highlighted in red and 




Protein Description Anova (p) Log2 FC 
Toxo 
P09341 GROA_HUMAN Growth-regulated alpha protein  0.000108 5.25 
P09238 MMP10_HUMAN Stromelysin-2  0.000263 4.62 
P05362 ICAM1_HUMAN Intercellular adhesion molecule 1  0.000103 4.19 
P13500 CCL2_HUMAN C-C motif chemokine 2  4.31E-05 3.65 
Q08397 LOXL1_HUMAN Lysyl oxidase homolog 1 0.002837 2.72 
P19320 VCAM1_HUMAN Vascular cell adhesion protein 1  0.002893 2.36 
P05231 IL6_HUMAN Interleukin-6  0.016789 1.99 
P26022 PTX3_HUMAN Pentraxin-related protein PTX3  0.001155 1.97 
Q14767 LTBP2_HUMAN Latent-transforming growth factor 
beta-binding protein 2  
0.02889 1.01 
P16949 STMN1_HUMAN Stathmin  0.028402 -1.27 
Q13443 ADAM9_HUMAN Disintegrin and metalloproteinase 
domain-containing protein 9  
0.007574 -1.79 
Q6NZI2 PTRF_HUMAN Polymerase I and transcript release 
factor  
0.00886 -3.73 
Q93063 EXT2_HUMAN Exostosin-2  0.009943 -3.85 
P15502 ELN_HUMAN Elastin  0.001098 -4.24 















Table 5.2: A subset of statistically significant human astrocyte secreted proteins during N. caninum 
infection (with greatest fold changes). A total of 252 secreted proteins were identified (p<0.05 and 
±1.5 fold change). Proteins showing up-regulation are highlighted in red and proteins showing down-
regulation are highlighted in green (all proteins in table are predicted to be secreted). 
Accession 
no 
Protein Description Anova (p) Log2 Neo 
P19875 CXCL2_HUMAN C-X-C motif chemokine 2  0.004193 5.89 
P10145 IL8_HUMAN Interleukin-8 7.23E-05 4.93 
P05231 IL6_HUMAN Interleukin-6  0.003763 4.54 
Q08397 LOXL1_HUMAN Lysyl oxidase homolog 1  2.02E-05 3.32 
P09341 GROA_HUMAN Growth-regulated alpha protein  0.048183 2.31 
P13500 CCL2_HUMAN C-C motif chemokine 2  0.016222 2.11 
Q14767 LTBP2_HUMAN Latent-transforming growth factor 
beta-binding protein 2  
8.47E-05 1.99 
P30048 PRDX3_HUMAN Thioredoxin-dependent peroxide 
reductase, mitochondrial  
0.005613 1.98 
Q93063 EXT2_HUMAN Exostosin-2  0.009555 -0.60 
Q6NZI2 PTRF_HUMAN Polymerase I and transcript release 
factor  
0.002841 -2.28 
P16949 STMN1_HUMAN Stathmin  0.000838 -3.27 
O75787 RENR_HUMAN Renin receptor  0.015457 -3.85 
Q13443 ADAM9_HUMAN Disintegrin and metalloproteinase 
domain-containing protein 9  
0.001098 -5.16 
O95450 ATS2_HUMAN A disintegrin and metalloproteinase 










Figure 5.4: The secreted proteins significantly up-regulated (log2 fold changes) in infected HA cells 
with T. gondii (red) and N. caninum (blue). Increased secreted protein expressions in T. gondii 
infected cells were found in chemokines such as CCL2 and CXCL1; whereas IL6 and LTBP2 were 
increased in cells infected with N. caninum. Some secreted proteins were only found in one infection 
and not detected in the other; such as VCAM1 and ICAM1 found secreted in cells infected with T. 
gondii and not detected in N. caninum infected cells. 
 
 
 Down-regulated secreted proteins of astrocytes in response to T. 
gondii or N .caninum infection 
The investigation of the significant down-regulated proteins secreted in HA cells 
infected with T. gondii and N. caninum was carried out. Secreted proteins that were 
down-regulated in T. gondii infected cells included proteins such as; the renin 
receptor (RENR), Elastin (ELN) and Exostosin-2 (EXT2); a protein involved in 
carbohydrate metabolic process and cell differentiation (Figure 5.5 and Table 5.1, 
5.2).  





























Secreted proteins found significantly down-regulated in cells infected with N. 
caninum compared to T. gondii infected cells are proteins including; polymerase I 
and transcript release factor (PTRF), disintegrin and metalloproteinase domain-
containing protein 9 (ADAM9) and stathmin (STMN1) (Figure 5.5 and Table 5.1, 5.2). 
In relation to proteases secretion, A disintegrin and metalloproteinase with 
thrombospondin motifs 2 (ATS2) that is associated with collagen degradation was 
only detected in N. caninum infected cells with a 38 decreased fold change (Figure 
5.5 and Table 5.2). 
 
 
Figure 5.5: The secreted proteins significantly down-regulated (log2 fold changes) detected in HA 
cells infected with T. gondii (red) compared to cells infected with N. caninum secretions (blue). 
ADAM9 and STMN1 proteins were significantly decreased in cells infected with N. caninum 
compared to T. gondii infected cells. Some secreted proteins were only found in one infection and 
not detected in the other; such as ATS2 found secreted in cells infected with N. caninum and not 
detected in T. gondii infected cells. 




































5.3.2 Functional analysis of infected human astrocytes secretome 
Proteins predicted to be secreted  by SignalP, SPD and SecretomeP tools were 
combined together and only proteins with more than ±1.5 fold changes were 
searched. Using DAVID enabled the identification of metabolic pathways of the HA 
cells secreted proteins during infection with T. gondii (Table 5.1) or N. caninum 
(Table 5.2). In addition, functional annotation of the top biological functions, 
cellular contents and molecular functions were searched. 
 
 
 Functional annotation of T. gondii infected cells secretome 
In the supernatant of HA cells infected with T. gondii,  KEGG pathway analysis 
showed that the NOD-like receptor signalling pathway (containing CCL2 with 12.5 
fold increase, CXCL1 with 38.2 fold increase and IL6 with a 4 fold increase), also 
Ribosome and Leukocyte transendothelial migration (Table 5.3), in which the latter 
pathway contains adhesion molecules with significant fold changes (ICAM-1 with 18 
fold change increased and VCAM-1 with 5 fold change). The significant biological 
processes showed functions related to cell migration, cell communication and 
extracellular matrix orginization. The cellular content demonstrated also that the 
proteins were found in the extracellular region and molecular functions showed 
their involvement in extracellular matrix binding, cytokine activity and calcium ion 
binding (Table 5.4). 
 
Table 5.3: Metabolic pathway analysis identified of human astrocytes infected with T. gondii 
secretome, proteins identified as secreted using SPD, SignalP and SecretomeP were only searched in 







NOD-like receptor signalling pathway 4 4.7 8.60E-03 
Ribosome 4 4.7 2.10E-02 






Table 5.4: Functional annotations of the secreted human astrocytes infected with T. gondii. The 
significantly differentially expressed proteins biological processes, cellular content and molecular 







negative regulation of signal 
transduction 10 11.6 5.40E-06 
negative regulation of cell 
communication 10 11.6 1.40E-05 
regulation of cell migration 8 9.3 5.70E-05 
regulation of locomotion 8 9.3 1.30E-04 
regulation of cell motion 8 9.3 1.30E-04 
regulation of actin cytoskeleton 
organization 6 7 1.70E-04 
regulation of actin filament-based 
process 6 7 2.00E-04 
regulation of leukocyte migration 4 4.7 2.00E-04 
actin cytoskeleton organization 8 9.3 3.50E-04 
extracellular matrix organization 6 7 3.50E-04 
Cellular content 
extracellular region part 36 41.9 4.80E-19 
extracellular region 43 50 2.40E-14 
Molecular function 
extracellular matrix binding 5 5.8 1.90E-05 
structural molecule activity 14 16.3 9.30E-05 
cytokine activity 8 9.3 1.70E-04 




 Functional annotation of N. caninum infected cells secretome  
The metabolic pathways associated with the secreted proteins of human astrocytes 
during N. caninum infection were; ribosome, complement and coagulation cascades 
and NOD-like receptor signalling pathway (Table 5.5). The NOD-like pathway 
contained chemokines with significant fold changes (CCL2, CXCL1, CXCL2, IL6 and 
IL8). The biological processes were related to translation and inflammatory 
responses. The cellular content demonstrated that  these proteins were in the 
extracellular region part and molecular functions showed their involvement in 






Table 5.5: Metabolic pathway analysis of the secreted human astrocyte proteins infected with N. 
caninum, proteins identified as secreted using SPD, SignalP and SecretomeP were only searched in 







Ribosome 15 10.6 5.80E-13 
Complement and coagulation cascades 8 5.7 1.40E-05 
NOD-like receptor signalling pathway 5 3.5 5.90E-03 
Hypertrophic cardiomyopathy (HCM) 5 3.5 1.70E-02 






Table 5.6: Functional annotation of the secreted human astrocyte proteins infected with N. caninum. 
The biological processes, cellular content and molecular functions of proteins identified as secreted 







translation 20 14.2 2.50E-10 
response to wounding 24 17 6.90E-10 
inflammatory response 18 12.8 9.50E-09 
acute inflammatory response 11 7.8 2.60E-08 
defence response 21 14.9 1.10E-06 
protein maturation by peptide bond 
cleavage 9 6.4 1.40E-06 
regulation of response to external 
stimulus 11 7.8 2.40E-06 
humoral immune response 8 5.7 9.00E-06 
protein processing 9 6.4 1.00E-05 
protein maturation 9 6.4 1.90E-05 
acute-phase response 6 4.3 3.40E-05 
Cellular content 
extracellular region part 42 29.8 5.00E-16 
extracellular region 55 39 9.20E-13 
    
Molecular 
function 
structural molecule activity 28 19.9 5.50E-11 
structural constituent of ribosome 16 11.3 7.60E-11 





5.3.3 Protein interaction analysis of infected host secretome 
Protein network analysis was carried out (Proteins with fold change >± 1.5 fold) 
using STRING (version 9.1). The up-regulated and down-regulated proteins were 
searched separately for their protein interactions in both infected cells secretions. 
In T. gondii infected cells; the total number of proteins inserted were 87 with ±1.5 
fold changes or more increased and decreased expressions and in N. caninum HA 
cell infection; the total number of proteins were 138. . Proteins showingincreased 
fold changes in T. gondii infected cells were clustered together (cytokines, 
proteases, cell adhesion molecules and heat shock proteins), these included 
secreted proteins such as CCL2, CXCL1, IL6, MMP1, ICAM1 and VCAM1 (Figure 5.6). 
The down-regulated secreted proteins did not show connected network 
interactions and were clustered in five small groups of only three to five proteins 
involved in each cluster in cells infected with T. gondii (Figure 5.7).  
 N. caninum up-regulated secreted proteins (>1.5 fold) were grouped into one large 
cluster, which included cytokines, chemokines and other proteins such as CXCL1, 
CXCL2, IL6 and IL8 (Figure5.8). Decreased expression of N. caninum infection (Figure 
5.8) were mainly clustered into one large cluster involved in ribosome pathway  and 







Figure 5.6: STRING generated protein-protein network interactions of significantly up-regulated 
secreted proteins in cells infected with T. gondii (>+1.5 fold,p<0.05). Protein search parameter was 
set at high confidence (0.7) in STRING. The cytokines and chemokines (CCL2, CXCL1, IL6) were 
clustered together with matrix metalloproteinases (MMP1 and MMP10) and cell adhesion molecules 
(ICAM1 and VCAM1), indicating protein-protein interactions between these molecules.  
 
 
                                            
 
Figure 5.7: STRING generated protein-protein network interactions of significantly down-regulated 
secreted proteins in cells infected with T. gondii. Basically, the top decreased fold changes were 
inserted with -1.5 fold change or more. Five small grouped proteins were grouped. Protein search 












Figure 5.8: STRING generated protein-protein network interactions of significantly up-regulated 
secreted proteins in cells infected with N. caninum. Basically, the top increased fold changes were 
inserted with more than 1.5 fold change. Mainly one large cluster of proteins was grouped. 
Cytokines and chemokines were grouped together, including CXCL1, CXCL2, IL6 and IL8. Protein 









Figure 5.9: STRING generated protein-protein network interactions of significantly down-regulated 
secreted proteins in cells infected with N. caninum. Basically, the top decreased fold changes were 
inserted with more than -1.5 fold change. Mainly one large and three small clusters of proteins was 




5.3.4 Ingenuity pathway analysis  
Pathway analysis using IPA enables the identification of significant proteins from an 
enriched p-value. It also predicts if canonical pathways are increased or decreased 
based on differentially expressed proteins inserted. The host cell secreted proteins 
were also investigated using IPA analysis. Only secreted proteins identified using 
SPD, SignalP and SecretomeP were imported in the software with secreted proteins 
containing ± 1.5 fold changes. T. gondii infected cells compared with the uninfected 






The enriched canonical pathways, diseases and disorders and molecular functions 
returned from IPA analysis in both infected cell secretions can be seen in Table 5.7. 
In T. gondii infected HA cells; an example of the enriched canonical pathways was 
the agranulocyte adhesion and diapedesis (Figure 5.10), involved in the migration of 
leukocytes from the vascular system to sites of pathogenic exposure during 
inflammation. An example of enriched canonical pathway detected in N. caninum 
infected cells secretions was the acute phase response signalling pathway (Figure 
5.11). Molecular and cellular functions included in both infected cell secretions 
were associated with cell movements (Figures 5.12 and 5.13). 
 
Table 5.7: Canonical pathways, diseases and disorder and molecular function detected using IPA 
pathway analysis in host cells infected with T. gondii and cell infected with N. caninum protein 
secretions (p-value and number of proteins detected (no. of proteins) 
Type of 
infection 







Agranulocyte Adhesion and Diapedesis 5.93E-06 7 
Differential Regulation of Cytokine 
Production in Macrophages and T Helper 
Cells by IL17A and IL17F 
4.68E-05 3 
Granulocyte Adhesion and Diapedesis 4.89E-05 6 
Diseases and 
disorders 




Cellular Growth and Proliferation 7.17E-11 37 







EIF2 Signaling 2.40E-13 15 
Acute Phase Response Signalling 9.24E-09 11 
Regulation of eIF4 and p70S6K Signalling 2.25E-08 10 
Diseases and 
disorders 




Cell-To-Cell Signaling and Interaction 5.48E-07 27 











Figure 5.10: T. gondii infected human astrocyte secretome pathway analysis using IPA. On the left there are the proteins found in the agranulocyte adhesion and diapedesis 
pathway with red indicating the increased protein expression and green decreased expression. Proteins with grey shading were proteins not detected in the differentially 








Figure 5.11: showing the acute phase response signalling pathway in HA cells secreted proteins infected with N. caninum. Proteins highlighted in red indicate increased 







Figure 5.12: Functional annotation of host cells infected with T. gondii secretions involved in 
migration of cells. Secreted proteins highlighted in red show increased expression and in green 
decreased expression. Orange dashed lines connecting the protein to the function (cell movement) 
indicate activation of proteins relationship and yellow lines between the proteins indicate findings 





Figure 5.13: Functional annotation of host cells infected with N. caninum involved in migration of 
cells. Proteins highlighted in red indicate increased expression and with green indicate decreased 
expression of proteins. Orange dashed lines indicate activation of proteins relationship; yellow 
disconnected lines indicate findings inconsistent with downstream application and grey lines show 








Comparative investigation of the secreted proteins of host cells, especially cells 
relating to the CNS during infection with T. gondii and N. caninum was the main aim 
in this chapter.  
There are many reported studies in the investigation and identification of the 
mouse astrocyte secretome (Perera et al. 2008; Dowell, Johnson & Li 2009; Delcourt 
et al. 2005). Astrocytes secrete proteins that are important for neuronal growth, 
neurogenesis, development and survival and synaptic development. These are 
mediated by the release of proteins and peptides, such as extracellular matrix 
proteins, growth factors and proteases (Bachoo et al. 2004). Astrocytes have an 
important role in the control of the immune response against T. gondii within the 
CNS; they activate and produce inflammatory cytokines such as IL1β, IL6 and TNFα 
in response to infection (Fischer et al. 1997).  
Chemokines are involved in inflammatory responses and are essential for the 
recruitment and leukocyte activation. Secreted proteins, such as cytokines, 
chemokines, hormones, digestive enzymes, antibodies and components of the 
extra-cellular matrix are secreted from the cell into the extracellular media and play 
essential biological roles and are important foundations for protein therapeutics, 
these proteins are referred to as secretome. In recent years, some groups began to 
study secreted proteins from a genomic angle and helped to create publicly 
available databases for secreted proteins (Clark et al. 2003; Klee et al. 2004; Chen et 
al. 2005). There are many essential roles that secreted proteins may be involved in 
and it was necessary not only to look at the expression of the proteomic profiles of 
the infected cells, but also to explore the proteomic profiles of proteins secreted 
outside the cells, which can help in our understanding of the host-parasite 
interaction pathways involved. Up to date, there have been no studies looking into 
the differences of astrocyte proteomic responses during infection with T. gondii and 





(973 proteins) was higher than the number of proteins identified in cells infected 
with T. gondii (666 proteins), which might suggest elevated responses of astrocytes 
during N. caninum infection compared to T. gondii. Nevertheless, differences in the 
total number of proteins between infections could be related also to technical 
variations during culturing condition, sample preparation or through LC-MS/MS 
procedure. After identification and quantification of differentially expressed 
proteins of HA cells infected with either T. gondii or N. caninum and compared to 
uninfected controls, further analysis was used to highlight predicted secreted 
proteins were applied using online search databases such as SPD, SignalP and 
SecretomeP for functional annotation and network analysis.  
 
 Significant up-regulation differences between cells infected with 
T. gondii and N. caninum 
Chemokines are key regulators of leukocyte trafficking (Adams & Lloyds, 1997). It 
has been established that chemokines can be secreted during T. gondii infection 
both in vitro and in vivo (Brenier-Pinchart et al. 2000; Brenier-Pinchart et al. 2002; 
Kim et al. 2001). Significant differences were noticed in chemokine expression 
between T. gondii and N. caninum infected cells. The C-X-C motif chemokine 2 
(CXCL2), is produced by activated monocytes and neutrophils and expressed at sites 
of inflammation. A 60 fold up-regulation of CXCL2 was observed in the secretome of 
N. caninum infected HA cells compared to uninfected controls.  No significant 
changes were observed in the secretome of T. gondii infected HA cells. This 
contradicts earlier studies that showed increased expression of CXCL2 in T. gondii 
infected cells secretome done by Kikumura, Ishikawa & Norose (2012), which 
explored leukocyte migration during ocular toxoplasmosis in murine models and 
found increased expression of CXCL2 and CCL2. But there were no investigations 
looking into the secretion of CXCL2 in N. caninum infected cells. Immune response 
during T. gondii infection at the transcriptional level were explored using human 
Muller cells, which also showed increase expression of CXCL2 in infected cells with 





Knight et al., (2006) study were comparable to the results obtained from this 
experiment, in which increased expression level of cytokine and chemokines such as 
CCL2, IL6 were also detected in human astrocyte infections (Knight et al. 2006).  
CXCL1; is also involved in inflammatory responses and has a chemotactic activity for 
neutrophils. Although, it would be expected that the secretion of CXCL1 chemokine 
would be similar to CXCL2 as both of them are involved in the recruitment of 
neutrophils to sites of inflammation; CXCL1 was significantly up-regulated in 
astrocytes infected with T. gondii with more than 38 fold compared to only 5 fold 
up-regulation in N. caninum infected cells. CXCL1 is involved in the processes of 
angiogenesis, inflammation, wound healing, and tumorigenesis (Tsai et al. 2002).  
The innate immune response of neutrophils has been shown to be critical for the 
successful resolution of T. gondii infection (Sayles & Johnson 1996). CXCL1 has also 
been found increased in ocular cells infected with T. gondii and in the brain in the 
acute stage of infection independent from IFN-ϒ (Kikumura et al. 2012). Another 
cytokine involved in neutrophil recruitment to sites of inflammation was IL8; it 
induces chemotaxis in target cells, primarily neutrophils but also other 
granulocytes, causing them to migrate toward the site of infection. IL8 also induces 
phagocytosis and is known to be a potent promoter of angiogenesis (Muller et al. 
2006). IL8 was significantly up-regulated in N. caninum infected cells compared to T. 
gondii infected cells (that was not detected significant). An up-regulated expression 
of IL8 in T. gondii infected HFF and HeLa cells was reported by Denney, Eckmann & 
Reed (1999), which do not correlate with the findings from this experiment. It has 
been previously reported that neutrophils in peripheral blood increased in mice 
after T. gondii infection (Norose et al. 2008). Absence of IFN-γ function may cause 
neutrophil activation, as it is involved in the down-regulation of IL8 production. 
Neutrophils have been shown to be involved in the dissemination of the parasite in 
vivo in susceptible mice. Dunay et al. (2010) reported that neutrophils are not 
protective against T. gondii infection but contribute to the pathology outcome. 
However, up to date, no investigations of IL8 secretion in N. caninum infected cells 
have been found in the literature, thus no comparable studies either in vivo or in 





closely related parasites. Many studies done on the involvement of IL6 secretion in 
the pathogenesis of different bacterial, viral and parasitic diseases have been 
investigated (van der Poll et al. 1997; Banks, Kastin & Gutierrez 1994).   IL6 was up-
regulated in both infected cells, but with to a higher extent in N. caninum infected 
cells (six times higher) compared to T. gondii. IL6 is secreted by T cells and 
macrophages to stimulate immune response and has vital roles in fighting infection, 
as demonstrated in mice that IL6 was required for resistance against bacterium 
Streptococcus pneumonia (van der Poll et al. 1997). IL6 can also cross the blood 
brain barrier (BBB) which explains its secretion in CNS cells as in astrocytes. IL6's 
role as an anti-inflammatory cytokine is mediated through its inhibitory effects on 
TNF-alpha and IL1, and activation of IL1ra and IL10. It was found to stimulate 
inflammatory and auto-immune processes in many diseases such as depression and 
Alzheimer's disease (Dowlati et al. 2010; Swardfager et al. 2010). IL6 in the CNS may 
have protective effects, stimulating neuroregeneration and neuronal growth factor 
(NGF) production in astrocytes (Otten et al. 2000), which parasites can benefit from 
during infection. Abe et al. (2014) also demonstrated increased secretion of IL6 in 
murine macrophages infected with N. caninum suggested that macrophages play an 
immunity protective role during Neospora infection. Moreover, activation of 
astrocytes and microglial cells was associated with the production of IL6 and IL10 in 
in rat mixed glial cells infected with N. caninum in vitro which may suggest a 
protective action by these glial cell types in the CNS (Pinheiro et al. 2010).  
Astrocytes secrete IL6 as a protective action against infection that may suggest that 
the acute phase response to infection in astrocytes is induced higher in cells 
infected with N. caninum compared to T. gondii as IL6 is associated with the acute 
phase response during infection. This could also indicate that T. gondii may 
supresses the host innate response at early stage of infection for a better 
establishment of infection in cells compared to N. caninum infected cells.  
Proteins associated with the cell adhesion molecule pathway; ICAM1 and VCAM1 
were both found in T. gondii infected cells secretome and not in N. caninum. 
Interestingly, ICAM1 was found to increase with 18 fold change and VCAM1 with a 5 





T-cell receptors. It is an endothelial- and leukocyte-associated transmembrane 
protein possessing an amino-terminus at the extracellular domain and known for its 
importance in stabilizing cell-cell interactions and facilitating leukocyte endothelial 
transmigration. Usually these proteins are secreted in low concentration; upon 
cytokine stimulus their concentrations increase (Dustin et al. 1986; Rothlein et al. 
1986). ICAM1 also became recognized for its involvement in plasmodium 
falciparum-infected erythrocytes pathogenesis (Turner et al. 1994). VCAM1 is 
expressed on both large and small blood vessels after cytokine stimulation of the 
endothelial cells. It mediates the adhesion of lymphocytes, monocytes, eosinophils, 
and basophils to vascular endothelium and is involved in leukocyte-endothelial cell 
signal transduction (Schmitz et al. 2013). 
Both ICAM1 and VCAM1 are expressed on inflamed BBB endothelial cells and are 
critical for the transmigration of lymphocytes and monocytes (Carman & Springer 
2004; Ifergan et al. 2006). Toxoplasma encephalitis (TE) involves strong activation of 
major histocompatibility complex (MHC) class I and II antigens as well as of the 
ICAM1 on cerebral endothelia, microglia and choroid plexus epithelium and VCAM1 
on endothelial cells (Deckert-Schluter et al. 1994). The up-regulation of ICAM1 and 
VCAM1 in secreted cells infected with T. gondii could indicate increased 
permeability of inflammatory cell migration through the BBB, in which infected cells 
with T. gondii could successfully enter and establish infection in the CNS. 
One of the chemokines that has been extensively explored during cells infection 
with T. gondii is CCL2. This chemokine was up-regulated in T. gondii infected cells 
compared to cells infected with N. caninum secretions. CCL2, is an attractant for 
monocyte/ macrophages, CD4 and CD8 memory T lymphocytes (Adams & Lloyds 
1997; Luther & Cyster 2001). It plays an important role in the CNS as a 
neuroinflammation mediator of leukocyte infiltration and has been associated with 
many neurological disorders (Bajetto et al. 2001). It has been illustrated that Hff and 
HeLa cells secreted CCL2. In addition, investigations done on murine models in vivo, 
showed that chemokines expressed by microglia, neurons and astrocytes  may be 
involved in the leukocyte migration in the CNS (Schluter et al. 2001; Strack et al. 





of CCL2 (MCP-1) (Strack et al. 2002). This also correlates to the findings in human 
astrocytes infected with T. gondii analysis. Chemokine secretion causes enhanced 
neuro-invasion of leukocytes, and astrocyte derived CCL2 monocytes can migrate 
across an in vitro model of the BBB (Weiss et al. 1998). This may suggest that up-
regulation of CCL2 during human astrocyte infection with T. gondii enables 
successful migration of T. gondii parasites through the BBB and establishment and 
localization of the parasites in the CNS.  
Key mediators of tissue remodelling after brain injury or disease include the MMPs 
(matrix metalloproteinases). MMP10 was only found in T. gondii infected cells with 
an increased expression of 25 fold change. MMP10 also known as Stromelysin-2 is 
an enzyme from the matrix metalloproteinase (MMP) family involved in the 
breakdown of extracellular matrix in both normal and disease processes and 
enables the degradation of proteoglycans and fibronectin. Increased expression of 
MMPs has been associated in diverse processes during disease; such as cancer and 
infectious pathologies (Ethell & Ethell 2007). During Toxoplasma infection, 
increased expression of MMP8 and MMP10 was observed in the brain, CD4+ and 
CD8+ T-cells are involved in MMP8 and MMP10 production (Clark et al. 2011). This 
may indicate the importance of the MMP in the trafficking of infiltrating cells into 
sites of infection with T. gondii in the CNS. Furthermore, regulation of 
metalloproteinases is vital for the immune populations to access infected CNS 
tissues that may be key to the balanced immune response that is related to the 
establishment of chronic infection with T. gondii.  
Pentraxin-related protein PTX3; also known as TNF-inducible gene 14 protein, 
regulates innate resistance to pathogen and inflammatory reaction, control of 
autoimmunity and is produced in a variety of tissues during inflammation (Rovere et 
al. 2000; Christersdottir Bjorklund et al. 2013). It was found up-regulated in T. gondii 
infected cells and no changes were found in N. caninum infected cells. PTX3 acts as 
an acute phase response protein, as the blood levels of PTX3 are low in normal 
conditions and increases during inflammatory and infectious conditions. The 
secretome of mixed glial cells stimulated with lipopolysaccharide and IFN-γ were 





Pentraxin-3 (PTX3), which is involved in the phagocytic activity of microglia and may 
serve as a potential diagnostic biomarker of inflammatory brain disorders. This may 
propose PTX3 to be a marker of malignancy in infected cells that increases in cells 
infected with T. gondii to signal immune responses that in response to immune 
stresses by the host will lead to the conversion of the dormant stage of the 
parasites in the CNS. 
 
 Protein down-regulation in astrocyte infected secretome 
In T. gondii and N. caninum infected cells secretome, the renin receptor (RENR) was 
down-regulated compared to uninfected cells in T. gondii infected cells. RENR is 
expressed in the brain and functions as a renin and prorenin cellular receptor, cell 
death and the regulation of MAPK cascade. Exostosin-2 (EXT2) is a 
glycosyltransferase required for the biosynthesis of heparan-sulfate. It acts as a 
tumour suppressor and is also involved in carbohydrate metabolic process and cell 
differentiation. EXT2 was found significantly down-regulated in cells infected with T. 
gondii compared to N. caninum infected cells secretion with only 1.5 fold decrease.  
Down-regulation of RENR and EXT2 in cells infected with T. gondii secretion could 
suggest that the parasite delays apoptosis in infected cells compared to N. caninum.  
Stathmin STMN1, also called Leukemia-associated phosphoprotein p18, is a highly 
conserved 17 kDa protein involved in the regulation of the microtubule filament 
system and may be required for axon formation during neurogenesis. STMN1 was 
down-regulated in cells infected with N. caninum (10 fold decrease) compared to T. 
gondii infected cells secretion. It is found in the brain, spinal cord and cerebellum 
and is involved in intracellular signal transduction.   
In relation to protease secretions, A disintegrin and metalloproteinase with 
thrombospondin motifs 2 (ATS2) was only detected in N. caninum infected cells 
with a 38 decrease reverse fold change. This enzyme is found weakly expressed in 
the brain and is associated with collagen degradation and extracellular matrix 
organization. This might suggest that N. caninum supresses the production of the 





result, collagen fibrils are not assembled properly; chemical interactions, between 
collagen fibrils are also affected which as a result, weakens the connective tissue. 
Disintegrin and metalloproteinase domain-containing protein 9 (ADAM9), mediates 
cell-matrix interactions and is involved in cell adhesion and monocyte activation. 
ADAM9 was down-regulated with 36 fold change in N. caninum infected astrocytes 
compared to only 3 fold decrease in T. gondii infected cells. Decreased protease 
protein secretions in N. caninum infected cells may suggest that N. caninum does 
not establish successful cell adhesion signalling interactions and ECM organization 
as T. gondii parasites and could be implicated in down-regulation of neurogenesis.  
 
5.4.2 Pathway analysis of host secretome  
It was essential to look at the metabolic pathways in order to have a more 
comprehensive view of the host-parasite interaction. Secreted proteins of both 
infections were investigated for their involvement in metabolic pathways. 
Agranulocyte adhesion and diapedesis pathway (IPA analysis in Figure 5.10) was 
associated with T. gondii infected cells secretome. This pathway is associated with 
leukocyte migration of cells during inflammation which is also correlated with 
previous findings of the transcriptome analysis. The other significant enriched 
pathway in N. caninum infected cells secretome was the acute phase response 
pathway (IPA analysis Figure 5.11). This pathway is also correlated with previous 
findings associated with the up-regulation of molecules related to acute infection 
response in the transcriptome analysis.  Both infected astrocytes with T. gondii and 
N. caninum secretions were involved in the NOD-like receptor (NLR) signalling 
pathway in DAVID analysis (Tables 5.3 and 5.5). Proteins involved in this pathway 
were up-regulated and include cytokines and chemokines such as CCL2, CXCL1, 
CXCL2, IL6 and IL8. This pathway involves specific families of pattern recognition 
receptors that are in charge of detecting various pathogens and producing innate 
immune responses. This family of proteins contain more than 20 members in 
mammals and plays essential roles in the recognition of intracellular ligands. NOD1 
and NOD2, sense the presence of the bacterial peptidoglycan fragments that 





cytokine production and apoptosis. In contrast, a different set of NLRs induces 
caspase-1 activation through the assembly of multi protein complexes called 
inflammasomes that are critical for causing mature proinflammatory cytokines 
along with Toll-like receptor signalling pathway. Secreted proteins identified in this 
pathway are mainly involved in neutrophil recruitment, T cell differentiation and 
antigen T and B cell responses. Functional annotations of infected astrocytes were 
also related to inflammatory responses and regulation of cell migration, which was 
also correlated to previous findings (Norose et al. 2011; Murdoch & Finn 2000). 
Moreover the cellular content investigations of both infected cells also 
demonstrated that proteins were of extracellular secretion. 
 
  
5.4.3 Protein network analysis of host cell secretome during infection   
Supporting evidence of protein-protein interactions were perceived through 
functional protein network analysis, although not all proteins showed connectivity 
between molecules during up-regulation or down-regulation expression changes. 
Cytokine, chemokine, cell adhesion molecules and proteases were clustered 
together in up-regulated expressed cells during T. gondii infection (Figure 5.6) (such 
as CCL2, IL6, CXCL1, ICAM1 and MMP10). Secreted host proteins up-regulated 
during N. caninum infection (Figure 5.8) also clustered cytokines and chemokines 
(such as IL6, IL8 and CXCL2), suggesting that predicted functional associations 
between grouped proteins are related to evidence of homology and text-mining. 
Down-regulated secreted proteins of both T. gondii and N. caninum infected cells 
(Figures 5.7 and 5.9) had proteins that constitute to the ribosome pathway, with a 
greater number of molecules associated with N. caninum infected cells. Proteins are 
synthesized in ribosomes which remain in the cytosol. The presence of high number 
of ribosomes in the secreted cells may indicate the presence cell lysis and cytosol 
contamination that could have occurred during cell secretome preparation and 
collection. This may also suggest potential involvement of exosomes.  Exosomes are 





different types of cells (Pan & Johnstone 1983). They are formed through inward 
budding of endosomal membranes in a cell that result in the intiation of 
intraluminal vesicles (Sotelo 1959). Exosomes can be considered as a non-classical 
secretion process of proteins and is involved in the transfer of RNA and proteins 
(Amzallag et al. 2004 Valadi et al. 2007). Mammalian cell types have been illustrated 
to discharge exosomes into culture medium in vitro; such as murine microglial and 




5.4.4 Comparative analysis of transcriptome and secretome results of 
host cells 
Compared to the proteomic study of HA cells at three different time points (chapter 
four), changes in secreted expression of these cells during infection showed obvious 
differences in both increased and decreased expression changes. The main findings 
in the transcriptome chapter (chapter three) were compared with the results of the 
secretome analysis. The proteome data was not included in the comparison due to 
similarities found in most metabolic pathways and functional annotations of the 
host expression profiles analysis (chapter four).  In illustration of the key findings of 
similarities and differences in host cells transcriptional and secreted proteome 
expression levels can be seen in Table 5.8. Some molecules in the transcriptome 
analysis correlated with the findings in the secretome analysis of the host cells, 
proteins such as CXCL2, IL8 and CCL2 (Table 5.8). CXCL2 is a chemoattractant mainly 
for neutrophils was up-regulated in both N. caninum infected cells RNA and 
secretome analysis while down-regulated in T. gondii infected cells. IL8 is also 
associated with neutrophil recruitment to sites of inflammation was up-regulated in 
both sets of analysis. CXCL1 is also involved in neutrophil recruitment was up-
regulated in N. caninum infected cells compared to T. gondii in RNA-Seq analysis, 





observed in neutrophil recruitment during host infection do not clearly indicate the 
parasites association with neutrophil migration to sites of inflammation. But the 
RNA-Seq analysis does show a strong association of N. caninum infection to recruit 
molecules such as CXCL1, IL8, CXCL2 and CXCL3 to sites of infection. This may 
suggest that both parasites are able to trigger neutrophil migration to sites of 
inflammation but might be at a higher induction in N. caninum infection. IL6 
cytokine was down-regulated in T. gondii infected cells while moderately up-
regulated in N. caninum transcript analysis. This did not relate to the secretome 
analysis in which both infected cells showed up-regulation of IL6 secretion in cells 
infected with N. caninum (Table 5.8).   
CCL2 was up-regulated in T. gondii infected cells transcript analysis and detected 
up-regulated in the secretome analysis. CCL2 has been associated with the 
pathology of the CNS and has been linked to the establishment of toxoplasma 
encephalitis in the brain (Sukhumavasi, Egan & Denkers 2007). Results from both 
RNA and secretome analysis propose that T. gondii increase the regulation of CCL2 
in order to establish host cell infection and persist in host cell of the CNS.  Cell 
adhesion molecules ICAM1 and VCAM1 were up-regulated in RNA analysis in both 
infected cells, but VCAM1 was up-regulated in cells infected with T. gondii. In the 
secreted cells protein expressions; ICAM1 and VCAM1 were only detected in cells 
infected with T. gondii and were found significantly up-regulated. Cell adhesion 
molecules have been linked to the ability of pathogens to cross the BBB and enter 
the brain. Increased expression of cytokines, chemokines and cell adhesion 
molecules all together suggest that the parasite uses these cells to migrate and 
filtrate through the tight junction and BBB in order to reach the CNS.  
MMP10 was down-regulated in N. caninum infected cells transcript analysis, 
whereas it was only detected in T. gondii infected cell secretions with an increased 
expression. This may indicate that MMP10 enables the trafficking of infiltrating cells 





Other molecules showing no association between the RNA and secretome analysis 
were ATS2 and EXT2. These molecules were up-regulated in cells infected with N. 
caninum RNA analysis but were down-regulated in the secretome analysis. 
In conclusion, some results correlated between RNA and secretome analysis such as 
IL8, while other molecules did not such as ATS2. The lack of correlation might be 
related to the imbalanced association between transcriptome and secretome 
analysis along with the different time points associated with the comparison. 
Therefore, a clear conclusion cannot be obtained. Nevertheless, comparative 
analysis highlighted the importance of key molecules involvement in cell migration 









Table 5.8: Comparative analysis of host cell transcripts involved in cell adhesion pathway and cytokine receptor interaction pathway compared to the differentially 
expressed secretome analysis of host cells during T. gondii and N. caninum infection. Three different time points (0h, 4h and 16h p.i.) were used in the transcriptomic 
analysis in both infected cells (TgVEG infected cells and NcLIV infected cells), whereas secreted protein of infected cells (secretome) were collected from (18-24 hour p.i.) 
Log2 fold changes highlighted in red indicate increased expression changes and fold changes highlighted in green show decreased transcript expressions.  
 







Transcriptome Log2 FC Secretome Log2 FC 
N 0h N 4h N 16h T 0h T 4h T 16h 
Neo inf     Toxo inf 
ENSG00000163739 CXCL1 P09341 growth-regulated alpha 
protein 
0 2.28 4.82 0 0.576 0.620 2.31 5.257 
ENSG00000081041 CXCL2 P19875  C-X-C motif chemokine 2 0 2.27 3.561 0 -1.85 -2.086 5.89 -0.08 * 
 
ENSG00000169429 IL8 P10145 Interleukin-8 0 1.267 3.46 0 -0.22 1.064 4.93 0.713* 
 
ENSG00000136244 IL6 P05231  Interleukin-6 0 0.137 0.37 0 -0.10 -0.862 4.54 1.99 
ENSG00000108691 CCL2 P13500 C-C motif chemokine 2 0 0.061 0.716 0 0.60 1.82 2.11 3.65 
ENSG00000090339 ICAM1 P05362 Intercellular adhesion 
molecule 1 
0 0.209 1.349 0 -0.10 1.254 - 4.19 
ENSG00000182220 ATP6AP2 O75787 Renin receptor (RENR) 0 0.374 0.044 0 -0.114 -0.463 -3.855 -4.29 
ENSG00000166670 MMP10 P09238 Stromelysin-2 0 0.355 -2.63 0 -0.58 -1.64 - 4.624 
ENSG00000129038 LOXL1 Q08397 Lysyl oxidase homolog 1 0 0.46 0.562 0 0.008 -0.165 3.327 2.72 
ENSG00000168615 ADAM9 Q13443 Disintegrin and 
metalloproteinase 
domain-containing 








protein 9  
ENSG00000119681 LTBP2 Q14767 Latent-transforming 
growth factor beta-
binding protein 2 
0 0.121 0.017 0 0.182 -0.069 1.99 1.017 
ENSG00000151348 EXT2 Q93063 Exostosin-2 0 1.021 0.948 0 0.0016 -0.037 -0.60 -3.85 
ENSG00000087116 ADAMTS2 O95450 A disintegrin and 
metalloproteinase with 
thrombospondin motifs 2 
(ATS2) 
0 0.032 0.458 0 0.221 0.116 -5.24 - 
ENSG00000163661 PTX3 P26022 Pentraxin-related protein 
PTX3 
0 0.040 0.837 0 -1.068 -1.068 0.04* 
 
1.97 
ENSG00000162692 VCAM1 P19320 Vascular cell adhesion 
protein 1 
0 0.591 2.083 0 0.445 3.404 - 2.36 








5.4.5 Conclusions and future direction 
In summary, differentially expressed secreted proteins; cytokines chemokines (such 
as CCL2 and CXCL1), proteases (MMP10) and cell adhesion molecules (ICAM1 and 
VCAM1) were up-regulated in secretome analysis of human astrocytes infected with 
T. gondii. That may indicate the parasites involvement in the modulation of cells 
relating to increase permeability and filtration of the infected cells through the BBB 
to the CNS more efficiently compared to N. caninum infection of cells. This may 
answer the question to why T. gondii is found more frequently in intermediate host 
cells CNS compared to N. caninum infection. On the other hand, N. caninum 
increases more efficiently neutrophil recruitment to infected cells compared to T. 
gondii (such as IL8 and CXCL2) which initiates an innate immune response and may 
lead to a more limited outcome of infection in cells. 
Further immune-based investigations should be carried out; such as 
immunohistochemistry assays and transmigration assays, which will enable further 
confirmation of the differentially expressed cytokines and cell adhesion secreted 
proteins along with the other interesting findings in this chapter. Moreover, other 
experimental investigations can be carried out as supportive evidence of these 
secreted molecules. Cell migration assays and immunohistochemistry assays with 
specific antibodies to these secreted molecules (such as IL8, ICAM1 and VCAM1) can 












 Chapter six: Comparative analysis of dopamine 
measurements in host cells during infection with T. 




The behavioural manipulation hypothesis proposed that a parasite such as T. gondii 
manipulates host behaviours needed for its own success and survival (Barnard 
1990; Berdoy, Webster & Macdonald 1995; Webster 2007). Since the sexual cycle of 
T. gondii can only occur in the cat, there is the need for the parasite to evolve ways 
for its transmission to the definitive host (Webster et al. 2006). Localization of the 
parasite in important parts of the body such as the brain of the intermediate host 
can enable it to manipulate its host (Werner, Masihi & Senk 1981). It has been 
suggested that the chronic stage of T. gondii infection in the central nervous system 
(CNS) may also modify behavioural changes in humans (Flegr 2007). 
 
6.1.1 Dopamine changes during T. gondii infection 
Dopamine is a monoamine neurotransmitter formed in the brain by the 
decarboxylation of dopa and is needed for normal performance of the central 
nervous system. It is involved in important roles related to behaviour, cognition, 
voluntary movement and attention. Dopamine secretion is known to be associated 
with the modulation of neuronal activities linked to learning and memory functions 
in the hippocampus region of the brain (Backman et al. 2010).  
Remarkably, T. gondii infection has shown evidence to increase dopamine 
secretion. A study done on the chronic stage of T. gondii infection proved that 
parasites can control the hippocampus that may result in decreased memory 
functions (Berenreiterova et al. 2011). Modulation in the brain can be accomplished 





chronically infected mice, dopamine levels were 114% (1.14 fold) higher compared 
to their controls, and no changes were detected in other neurotransmitters (Stibbs 
1985). In addition, Prandovsky et al. (2011) also found high concentrations of 
dopamine in neural cells infected with T. gondii in an in vitro experiment. The 
parasite itself was found to synthesize tyrosine hydroxylase and transforms to L-
DOPA amino acid, which is a precursor of dopamine. From the T. gondii genome 
(http://www.toxodb.org), two tyrosine hydroxylase genes were identified (TgAaaH1 
and TgAaaH2) (Whitaker et al. 2009). Tyrosine hydroxylase are enzymes belonging 
to the aromatic amino acid hydroxylases family. Moreover, tyrosine hydroxylase 
was also found in N. caninum but was not detected in P. falciparum or Eimeria 
(McConkey et al. 2013). In brain cells infected with T. gondii tissue cysts, cells 
contained tyrosine hydroxylase secreted by the parasite and is localised with the 
parasitophorous vacuoles (Gaskell et al. 2009; Prandovsky et al. 2011). Gaskell et al. 
(2009) revealed that T. gondii TgAaaH1 and TgAaaH2 genes are switched on during 
parasite conversion from tachyzoite to bradyzoite stage. Host genes may also be 
associated with the complex interaction between parasite and neurochemical 
alterations in the brain (Carter 2009). 
 
 
6.1.2 N. caninum infections in hosts 
There have been no studies investigating the secretion of dopamine in cells infected 
with N. caninum. N. caninum is known to infect animals, such as sheep, deer, goats 
and cattle. When a host is infected, parasites can cross the intestinal epithelium and 
reach the circulating blood and infect cells such as macrophages and lymphocytes. 
Tachyzoites convert to the cyst stage through stress caused by the hosts’ immune 
responses (Buxton, McAllister & Dubey 2002) and are detected in the CNS (Peters et 
al. 2001). Although tissue cysts have not yet been detected in histological sections 
of infected adult cattle, it is thought that N. caninum can encyst in the tissues of 
adult cattle. It has been observed in the brains of two normal cows that gave birth 





investigated a total of 82 foetuses of cattle infected with N. caninum in California, 
USA and found clinical symptoms including encephalitis, myocarditis and adrenalitis 
accompanied with the disease (Barr et al. 1991a; Barr et al. 1991b). Invasion by N. 
caninum and cyst formation in the CNS and damage caused by this parasite has 
been detected, which leads to abortion in cattle or neurological diseases in dogs 
(Dubey & Lindsay 1996; Hemphill, Gottstein & Kaufmann 1996).  
 
6.1.3 Importance of parasite strain used in cyst stage investigations 
When studying behaviour changes in hosts, the type of parasite strain used for the 
investigation is important. Most T. gondii strains found in North America and 
Europe can be categorized into three typical lineages, type; I, II and III (Howe et al. 
1997). Type I strains are the most virulent, type II and III strains are the less virulent 
which can form cysts and initiate the chronic stage of infection. This can cause 
motor and behavioural changes in infected rodents. Type I parasites are typically 
highly lethal in mice and are mainly associated with the acute stage of infection and 
also cause ocular toxoplasmosis (Saeij et al. 2006; Reese & Boothroyd 2011). While 
type III can cause encystation and brain inflammation, it results in fewer cyst 
numbers and causes less pathology in the brain (Suzuki & Joh 1994). Therefore, 
most studies investigating the behavioural changes in hosts have used Type II 
strains, due to its high parasite-cyst burden found in the brains of mice in which 
result in elevated immune mediated responses in the brain (Hermes et al. 2008; 
Gulinello et al. 2010; Gatkowska et al. 2012). And also have higher expression of 
tyrosine hydroxylase and thereby establish the chronic infection (Howe, Summers & 
Sibley 1996; Sibley & Boothroyd 1992; Sibley et al. 2002; Gaskell et al. 2009). 
 
 
6.1.4 Bradyzoite formation in vitro methods 
Investigation of the tissue cyst of T. gondii during chronic infection should provide 





changes and neuropathology of the disease. The importance of understanding host-
parasite interactions in vitro and specifically in the chronic stage of the infection has 
led to the development of different methods for studying the tissue formation of T. 
gondii and N. caninum. In order to study the effect of dopamine levels secreted 
during T. gondii and N. caninum infection in cells of the brain, parasite conversion to 
bradyzoite stage in vitro is essential. Bradyzoite stage induction in T. gondii and N. 
caninum can be achieved using various methods such as alkaline induction, heat 
shock and chemical induction; such as the use of sodium nitroprusside (Skariah, 
McIntyre & Mordue 2010; Soete, Camus & Dubremetz 1994; Tobin, Pollard & Knoll 
2010; Vonlaufen et al. 2004). Increasing the pH in culture media was found to be an 
effective method for tachyzoite to bradyzoite conversion in vitro (Soete, Camus & 
Dubremetz 1994; Tobin, Pollard & Knoll 2010). A study done by AlKuraishi et al. 
(2011), found that N. caninum transformation from tachyzoite to bradyzoite was 
enabled through pH alkaline method. For in vitro bradyzoite formation in N. 
caninum, the virulent strain NcLIV is preferred for cyst formation compared to less 
virulent strains Nc-1 and NcSweB1, which was observed to produce very small 
amounts of tissue cysts in vitro (Vonlaufen et al. 2002). 
N. caninum conversion in vitro is thought to be more difficult compared to T. gondii 
and is more restricted to both host cell lines used and the type of parasite isolate 
(Weiss et al. 1999). Another issue related to N. caninum bradyzoite detection is the 
difficulty to distinguish the tachyzoite from bradyzoite stage using haematoxylin 
and eosin stained sections, due to the thickness of the bradyzoite wall which may 
be thin and difficult to identify (Dubey et al. 2002). Therefore, in order to 
differentiate between them in N. caninum, immunohistochemical assays were 
applied through labelling with a bradyzoite specific antibody such as BAG1 
(McAllister et al. 1996). NcBAG1 is a small heat shock protein that is expressed 






6.1.5 Aims and objectives 
The main aim was to investigate dopamine induction in cells infected with N. 
caninum bradyzoites compared to cells infected with T. gondii by measuring 
dopamine levels using the HPLC. 
 The involvement/effect of dopamine elevation in T. gondii infected cells in the CNS 
has been clearly investigated. However, the involvement of closely related parasite 
N. caninum in host cell dopamine secretion has not been examined.  N. caninum 
also contains two genes in its genome that are involved in the production of 
tyrosine hydroxylase. The hypothesis is that N. caninum does not have any effect on 




















 Materials and Methods 
 
This experiment was done in collaboration with Dr. Glenn Mcconkey’s Group at the 
University of Leeds.  
 
6.2.1 Cell culture 
Dopaminergic primary rat cell line PC12 (ECACC, Salisbury) was used in this 
experiment. PC12 is a cell line derived from a pheochromocytoma of the rat adrenal 
medulla that has an embryonic origin from the neural crest and has been used to 
study diseases related to the brain. This cell line has been previously used in the 
investigation of the dopamine induction measurement during infection with T. 
gondii bradyzoites by Glenn Mcconkeys lab. As this chapter was in collaboration 
with Glenn’s lab and the fact that T. gondii and N. caninum can infect rodents such 
as rats, it is a valid model for the investigation. Cells were prepared and maintained 
by Isra Alsaady; a PhD student at the University of Leeds. In order for the cells to 
attach,  800 µl poly-L- lysine was added to each well and incubated for 2 hours in 
the incubator at 37°C and 5 % CO2 followed by removal of the excess poly-L-Lysine.  
Then, cells were placed at a density of 5 x 103 per well (3ml per well including the 
RPMI medium) and left to incubate for 24 hours in the incubator. Cells were 
observed the following day under the microscope for attachment.  A total of 600 ng 
nerve growth factor (NGF) was placed to each well and incubated for 24 hours then 
replaced by fresh NGF every 24 hours until the cells were ready for the 
experimental infection.  A total of six plates were needed (three biological replicates 
for each of the N. caninum and T. gondii infection).  
 
 
 Preparation of Alkaline medium 
In order for parasites to successfully convert from tachyzoite to bradyzoite stage in 





10% (v/v) FBS and 1% P/S (v/v), the medium was pH adjusted to 8.2 before 
filtration.  
 
6.2.1.1.1 Alkaline shocking of tachyzoites 
T. gondii Prugniard strain (type II) tachyzoites and N. caninum (NcLIV) were 
maintained in HFF cells, parasites were scraped and host cells were ruptured 
through flushing them many times in a 20g  gauge needle followed by the 
purification of the parasites through 47mm diameter 3μm pore-sized Nucleopore™ 
polycarbonate membranes (Whatman). Then, they were washed twice in 
phosphate-buffered saline (PBS) pH 7.4 by centrifugation at 1500 x g for 10 minutes. 
The supernatant was discarded and tachyzoites were resuspended in alkaline 
medium and incubated overnight for 18 hours at 37oC and 5% CO2.  Finally, 
tachyzoites were centrifuged at 500 x g for 10 minutes and supernatant was 




 Infection of PC-12 cells 
Parasites were counted using a haemocytometer under a light microscope and the 
required amount for each well for all three replicates were added to PC-12 cells 
with T. gondii and N. caninum as seen in Table 6.1. Parasites were then left five days 
for bradyzoite conversion in PC-12 cells with daily observation of the cells for 











Table 6.1: The total number of parasites inserted per well for both T. gondii and N. caninum. 




1 Uninfected (0 parasites) 
2 0.125 x104 
3 0.25 x104 





6.2.2 Antibody detection of N. caninum conversion 
In order to confirm bradyzoite conversion of N. caninum tachyzoites, 
immunofluorescence assay (IFA) was carried out. Cells were grown in chamber 
slides and infected with alkaline shocked N. caninum parasites and left five days for 
cyst formation. Media from wells were removed and washed three times with PBS, 
cells were then fixed and permeablised (with PBS, 4% (v/v) formaldehyde and 0.5% 
(v/v) TritonX-100) and incubated at room temperature for 15 minutes. Slides were 
then washed three times with PBS and blocked with 5 % (v/v) normal goat serum 
(NGS) with 5% (v/v) FBS/PBS twice for ten minutes. Then, the slides were rinsed 
three times with 1 % (v/v) FBS/PBS. Primary antibody for N. caninum (BAG-1) 
polyclonal rabbit antiserum was diluted (1:200) in 1% (v/v) FBS/PBS and was left to 
incubate at room temperature for one hour and washed six times quickly with PBS. 
The antibody was kindly provided by Professor Andrew Hemphill at the University of 
Bern in Switzerland. Secondary antibody (Lectin-Tetramethylrhodamine (TRITC)) as 
prepared and diluted in 1% (v/v) FBS/PBS and was also incubated at room 
temperature for one hour. Slides were rinsed briefly in 1% (v/v) FBS /PBS six times. 
The blue-fluorescent DAPI nucleic acid stain was prepared from stock solution 
(5mg/ml). The DAPI stock solution was further diluted to 300nM in PBS and applied 
to the slides for around 5 minutes. Slides were rinsed in PBS followed by six washes 





6.2.3 Dopamine release assay 
For the dopamine release assay, preparation of a low potassium chloride (KCl) 
containing wash buffer (140 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl2, 2.5 mM CaCl2, 11 
mM dextrose, 10 mM HEPES, pH 7.4) and high KCl containing release buffer (40 mM 
NaCl, 100 mM KCl, 1.2 mM MgCl2, 2.5 mM CaCl2, 11 mM dextrose, 10 mM HEPES, 
pH 7.4) were needed. Medium from infected cells was first removed and 1 ml of low 
KCl was added to each well and left to incubate for 30 minutes at 37 oC. After 2 
minutes an aliquot of 250 µl was taken for spontaneous release measurements 
along with 125 µl 0.1 M PCA (perchloric acid) and filtered with 1ml syringes and 0.2 
µm Millipore filters. The samples were then stored in -80oC and later run on HPLC. 
After 30 minutes, the remaining 750 µl were removed from the wells and the 
sample was resuspended with 250 µl of the high KCl release buffer followed by 2 
minutes incubation at room temperature. The release buffer was collected in 
Eppendorf tubes containing 125 µl of 0.1M PCA and filtered with 0.2 µm Millipore 




6.2.4 Harvesting of PC-12 cells 
After low KCl and high KCl washing steps, cells were scraped for collection by adding 
1ml of RPMI medium to each well and then transferred to Eppendorf tubes, cells 
were then centrifuged at 400 x g for 5 minutes and the supernatant was discarded 
and resuspended in 1 ml of PBS. An aliquot of 100µl of the suspension was acquired 
for CyQUANT™ assay (Life technologies), which accurately determine the number of 
cells (proliferation assay). Samples were again centrifuged at 400 x g for 5 minutes 
at 4 oC, supernatants were discarded and pellets were stored at -80 oC. The 
remaining 900 µl of PBS suspensions were centrifuged at 400 x g for 5 minutes, 
supernatants were discarded and cells were resuspended in 350 µl 0.1 M PCA. 
Suspensions were then subjected to sonication for 20 seconds using the probe 





supernatants were then transferred to fresh Eppendorf tubes and stored at -80 oC 




6.2.5 Sample analysis on the HPLC 
Samples were run on the reverse phase chromatography coupled with 
electrochemical detection (HPLC-ED) by Isra Alsaady at the University of Leeds. A 
brief centrifugation was applied to all the samples, cell homogenates were assayed 
by HPLC-ED. This was achieved with a Dionex HPLC system consisting of a P580 
Pump (Dionex) and Ultimate 3000 Auto sampler Column Compartment with a C18 
Acclaim 120 column (5 mm, 4.66150 mm) and an ESA Coulochem III cell, fitted with 
a glassy carbon electrode used at 700 mV versus Ag/AgCl reference electrode for 
detection of monoamines. The concentration of compounds was determined using 
Chromeleon software.  























For this experiment, PC12 cell line was used as it is known to be a good model of 
dopaminergic neurons. In order to confirm bradyzoite formation of N. caninum in 
PC12 cells, an immunofluorescence assay was performed. Images taken of the 
infected cells show staining of parasites with the bradyzoite biomarker BAG-1 and 
confirm cyst formation of N. caninum in PC12 cells using an alkaline shock method 
(Figure 6.1).  
Infected cells of T. gondii accumulated higher levels of dopamine which correlated 
with the infection rate (Figure 6.2). A set of cells were also incubated in high KCl and 
was measured through HPLC-ED. Dopamine release assays were carried out to 
assess effects of infection on dopamine signalling.  Infected cells with different 
numbers of alkaline shocked parasites were induced to release dopamine with 
potassium as K+ causes discharge of dopamine in vesicles as detected in other 
studies methods (Yamboliev et al. 2009) (Figure 6.2). As a result, dopamine release 
increased in infected cultures in a dose-dependent manner with the number of 
parasites in the culture correlating with the amount of dopamine released in 
infected PC12 with T. gondii (Figure 6.2). An increase in dopamine content and 
dopamine release were observed in neural cells as a direct response to T. gondii 
infection. On the other hand, the production of total dopamine content measured 
in PC12 cells were not induced in N. caninum infection compared to T. gondii 
infection in both dopamine release assay and total dopamine content. This suggests 
that there are low significant changes in the dopamine synthesis in the host cells 
during N. caninum cyst formation compared to T. gondii infected cells (Figure 6.2). 
The total dopamine concentrations were compared between cells infected with T. 
gondii and with N. caninum (bradyzoite stages) through paired t-test using Prism 
software (version 6) (Figure 6.3). Results were statistically significant and showed 











Figure 6.1: Immunofluorescence staining of PC12 cells infected with alkaline induced N. caninum parasites. Cells were infected and left for cyst formation, followed by 








Figure 6.2: Dopamine concentration measurement of PC12 cells infected with T. gondii and N. caninum parasites using HPLC-ED. Both dopamine release assay and total 
dopamine content were measured Three replicates were used per infection and different ratios of alkaline shocked parasites were used per well. The x axis shows the cell/ 
parasite ratio per well, the y axis shows the percentage of dopamine concentration measurements of cells. A standard curve was used to convert HPLC dopamine readings 
to concentrations. Dopamine induced from KCL release cultures in T. gondii infection (black circles), total dopamine measured in T. gondii infection is shown in (light grey 
squares) and increases in correlation with the number of parasites per infection. PC12 cells cell numbers in N. caninum infection was also measured according to the 








































Figure 6.3: Box and whiskers plot of dopamine induction in T. gondii infected PC12 cells (bradyzoites) 
compared to N. caninum infected cells (bradyzoites) using Prism software (version 6). The y axis shows the 
percentage measurement of the dopamine concentrations in infected cells. A standard curve was used to 
convert HPLC dopamine readings to concentrations. A paired t-test was done to compare total dopamine 















In this chapter, the main aim was to investigate dopamine induction in cells infected with N. 
caninum compared to cells infected with T. gondii. Parasites were first converted to the 
bradyzoite stage using an alkaline shock procedure. Confirmation of conversion was 
assessed in cells infected with N. caninum using immunostaining with BAG1. Results of 
dopamine measurements in PC12 cells clearly indicated that N. caninum did not induce any 
distinct changes in dopamine production in infected cells compared to T. gondii (Figure 6.2 
and 6.3). 
Behavioral changes in hosts may be a direct or an indirect effect of T. gondii infection. It has 
already been presented that T. gondii increases the dopamine level both in vivo and in vitro 
(Prandovsky et al. 2011). The parasite itself was found to contain two genes involved in the 
dopamine synthesis along with its close relative N. caninum; these were not detected in 
other Apicomplexa parasites such as P. falciparum or Eimeria spp. (McConkey et al. 2013).  
In order for the parasite to successfully complete its life cycle, it must modulate and alter its 
intermediate host responses and behaviour (Barnard 1990).  Since the sexual cycle can only 
take place in the cat, it is crucial for the parasite to evolve ways for its transmission to the 
definitive host (Webster et al. 2006). Webster, Brunton & MacDonald (1994) demonstrated 
that T. gondii causes an increase activity and also minimizes fear behaviour in rodents.  
The cat and mouse cycle has appeared to be successful for the parasites survival and 
persistence. As proven by many studies, this can be done through alteration of behaviour of 
the intermediate host during the chronic stage of infection. These interesting findings 
showed dramatic changes in the behaviour of infected mice towards their predators (the 
cat); causing them to be attracted to their odour rather than escaping from it (Berdoy, 
Webster & Macdonald 2000; Kaushik, Lamberton & Webster 2012). It has been speculated 
that T. gondii cysts might be associated with the modulation of dopamine production, or 
interfere directly with neuronal activity of the host (Gaskell et al. 2009; Prandovszky et al. 
2011; Mitra, Sapolsky & Vyas 2013). Furthermore, there have been reports of higher cyst 
burden found in the amygdalar regions of the brain in the intermediate host, which is 





The findings in this chapter related to T. gondii dopamine induction in cells were in 
agreement with previous findings related to the increase dopamine signaling of neural cells 
during T. gondii infection. Dopamine levels were found increased by 114% comparing to 
controls, in which no changes were detected in chronically infected mice with T. gondii 
(Stibbs 1985). Prandovsky et al. (2011) also found higher concentration of dopamine 
signalling in an in vitro experiment in neural cells infected with T. gondii.  
On the other hand, cells infected with N. caninum did not exhibit any significant changes in 
dopamine secretion, suggesting that that parasite does not alter dopamine levels in the 
brain. This may be associated with the successful vertical transmission of N. caninum 
through the vertical route from the mother to the fetus in cattle, therefore does not require 
the alteration of the behavior of its intermediate hosts such as in rodents. It was suggested 
that T. gondii and N. caninum diverged from their common ancestor around 28 million years 
ago where both genomes and gene expression are conserved (Reid et al. 2012). This could 
explain why the two genes involved in dopamine synthesis were found in both N. caninum 
and T. gondii and not in other apicomplexan parasites. Another explanation to why N. 
caninum does not induce dopamine changes in infected cells could be associated with 
recent findings related to Rop18 gene which is a virulent gene found in T. gondii was 
discovered to be a pseudo gene in N. caninum (Reid et al. 2012).This study has provided 
new insights in differences between these closely related parasites toward host 
manipulation and specifically in dopamine secretion in the brain.  
Further work can be done to confirm the findings detected in vitro through the examination 
of dopamine induction in mouse models (in vivo) during infection with T. gondii compared 
to N. caninum along with uninfected (control) models. Another novel approach would be to 
explore dopamine induction in cattle. There is a lack in the number of studies related to N. 
caninum infections; and specifically in the study of possible behavioral changes in 






 Chapter seven: Discussion and future perspectives 
 
The work presented in this thesis supports the hypothesis that there are differences in 
human astrocyte responses during infection with T. gondii compared to N. caninum. The 
comparative study was achieved through the application of advanced global analysis of the 
host cells transcriptome, proteome and secretome during infection. The tachyzoite stage for 
both parasites were used in most of the experiments, as it is known to be the highly invasive 
stage involved in the pathogenesis outcome in both Toxoplasmosis and Neosporosis, in 
which both parasites can reach critical sites and tissue of the infected host, such as the CNS. 
The basis of the selection of T. gondii and N. caninum comparative analysis during host cell 
infection was that these two parasites have very similar histological appearance but behave 
differently. N. caninum was first distinguished from T. gondii in 1984 (Bjerkas et al. 1984) 
along with the high syntenic genome structure (Reid et al. 2012). Another fact is the wide 
host range that T. gondii has in which it can infect many warm blooded animals including 
humans (Montoya & Liesenfeld 2004), whereas N. caninum is mainly successful in cattle and 
has a more restricted host range (Lindsay et al. 1999; McAllister et al. 1998).  The CNS 
contains different cells and one of the most abundant cell types are astrocytes that also 
harbour parasites during infection (Hulinska et al. 1990; Halonen et al. 1996). There have 
been limited transcriptomic and proteomic studies investigating N. caninum infection, 
where no comparative studies in astrocytes during T. gondii and N. caninum infection have 
been published. 
The main findings associated with this thesis were the identification of transcripts and 
secreted proteins differentially expressed between the host cells infected with T. gondii and 
those infected with N. caninum that were related to cytokines, chemokines and cell 
adhesion molecules. Previous studies have found that during infection or injury of 
astrocytes; they result in the migration of leukocytes to the site of infection (Brenier-
Pinchart et al. 2004; Strack et al. 2002).  
In chapter two, 2D-DIGE followed by LC-MS/MS analysis was used for the comparative study 





technique is believed to be a sensitive, high resolution method for the detection of 
differentially expressed proteins; it is time consuming, laborious and technical difficulties 
were present. The number of proteins identified and quantified as differentially expressed 
were very low. Coupled with the fact that more than one protein was identified under the 
same protein spot of interest, which made it difficult to distinguish the exact protein found 
differentially expressed. Proteins have been identified, such as enzyme L-lactate 
dehydrogenase A chain, that is involved in the glycolysis, as well as Ankyrin3 were found 
differentially modulated between the infected cells, in which were up-modulated in T. 
gondii infected cells. That may suggest that T. gondii modulates proteins for nutritional 
uptake and regulation of ion transport for the parasites propagation and establishment in 
cells. While proteins such as Vimentin and Syne2 were up-modulated in N. caninum infected 
cells compared to T. gondii, suggesting that N. caninum may modify the cytoskeleton of host 
cells for parasites invasion and entry. In order to understand results obtained from 2D-DIGE, 
considerations in separation limitations and the frequently observed phenomena of 
multiple proteins migrating to the same spot must be taken in mind.  Therefore, a non-gel 
based method using label-free quantitative approach was carried out through the 
application of high resolution tandem mass spectrometry.   
In chapter three, changes in the transcriptome of astrocytes during the early stage of 
parasitic infection was investigated at three different time points, through the application of 
high resolution RNA-Seq. This has provided valuable insights into the potential biological 
roles of the expressed mRNA molecules and detection of differences in the host’s transcripts 
between the two infections. These differences were mostly related to metabolic and cell 
signalling pathways and biological and cellular localization, such as cytokine-cytokine 
receptor pathway and CAM pathway. Significant differences were observed between HA 
cells infected with T. gondii or N. caninum in expressed transcripts, such as CXCL1, CCL2, 
CXCL2, IL8, VCAM1 and NCAM2. Differences identified in cytokine, chemokine and cell 
adhesion molecules are key findings in this chapter and may indicate increased cell 
transmigration across the blood brain barrier (BBB) in HA cells infected with T. gondii 
compared to N. caninum infection. CCL2, VCAM1 have been demonstrated to be involved in 
parasite migration across the BBB and their involvement in toxoplasmic encephalitis 





with neutrophil migration were greater in HA cells infected with N. caninum, which 
contradicts other studies that have demonstrated up-regulation of neutrophils in T. gondii 
infection (Kikumura et al. 2012; Denney et al. 1999). Differences with the previous studies 
could be related to the use of different cell lines (HeLA and Hff cells) and the period of 
infection incubation (which was higher 24-48 hours p.i.), which may suggest that cells 
respond differently to parasitic infection with T. gondii or N. caninum. The validation of the 
expression of these transcripts in vivo will further confirm similarities or differences 
between in vivo and in vitro cell transcriptional analysis.. One of the main challenges 
associated with the RNA-Seq approach was the high cost and difficulties associated with the 
availability of sufficient amounts of mRNA for sequencing. In this analysis, two replicates 
were pooled for all three time points and a total of six samples were sequenced and 
analysed. Although it is recommended to use replicates in transcriptomic analysis, collecting 
enough mRNA material at each point and the high cost were two of the drawbacks in this 
investigation. However, many published studies used no replicates in their investigations 
owing to the use of RNA-Seq deep sequencing (Brawand et al. 2011; Graveley et al. 2011).   
In chapter four, global proteomic profiling of human astrocytes during infection (at 0, 4 and 
16 hours p.i.) was carried out across the time series for the mRNA analysis using label free 
quantitative proteomics. This method was more accurate, less time consuming and 
identified more than 1000 statistically significant proteins in both infected HA cells 
compared to gel-based quantitative analysis. Cellular localization and metabolic functions 
were associated with host mitochondria and ER, along with biological processes mainly 
related to transcription and translational processes. Similarities in the host’s proteome 
profiles were highly observed. This may indicate that at early stages of infection, both 
parasites modulate the hosts’ proteins in a similar matter. Further analysis of early stages of 
host cell invasion in astrocytes, along with 24-48 hours post infection, may enable the 
detection of changes that might have only occurred in very early stages or that are in the 
process of changing between host infections that might have been missed out in the time 
points chosen for the experiment. Nonetheless, this method has proven to be of higher 
sensitivity and increased identification and quantification of expressed proteins compared 





The secretome has gained the attention of many researchers and is considered to be a 
biomarker and diagnostic tool for the investigation in many areas of research; including 
cancer, host-pathogen interactions and vaccine drug development (Ochsenbein 2002; 
Sibbald et al. 2009; Brey 2005). In addition, studies of parasites excretory secretory antigens 
(ESA) was found to be a successful tool in diagnostics, as found in a study done on T. gondii 
ESA that enabled to differentiate between active infected  and asymptomatic HIV patients 
with cerebral toxoplasmosis (Meira et al. 2011). Astrocytes are known to secrete cytokines, 
chemokines and signalling proteins outside the cell during inflammation or injury (Fischer et 
al. 1997).  
In chapter five, expression profiles of secreted proteins were investigated using label-free 
quantitative proteomics. A comparative analysis of proteins secreted from human 
astrocytes during T. gondii and N. caninum infection was performed. This was done through 
the collection of secreted proteins and were analysed by mass spectrometry LC-MS/MS and 
bioinformatic analysis. Interestingly, significant differences were noticed between 
infections, mostly related to cytokines, chemokines, protein kinases and cell adhesion 
molecules. Molecules associated with the pathogenesis of T. gondii in the brain such as 
CXCL1 and CCL2, were up-regulated in astrocytes infected with this parasite when compared 
to N. caninum infected cells. Researchers have linked the up-regulation of these proteins 
during infection with T. gondii with toxoplasmic encephalitis (Strack et al. 2002; Hunter et al. 
1992b). Cell adhesion molecules are associated with many diseases in the brain, especially 
related to cerebral parasitic infections such as cerebral malaria, toxoplasmosis and 
trypanasomiasis (Kadl & Leitinger 2005; Coisne et al. 2006). ICAM1 and VCAM1 were up-
regulated in astrocytes infected with T. gondii, which may be associated with the 
transmigration of the parasites through the BBB and the ability to successfully reach the 
brain (Carman & Springer 2004; Ifergan et al. 2006). There were significantly up regulated 
expressed chemokines in one infection compared to the other. For example; CXCL1, CXCL2 
and IL8 are mainly involved in the recruitment of neutrophils. Yet, differences in their 
secretion during astrocyte infection with T. gondii and N. caninum were detected. Whereas 
CXCL1 was up-regulated in astrocytes infected with T. gondii (more than 38 fold), CXCL2 and 
IL8 were up-regulated in N. caninum with nearly 60 fold change in CXCL2 and more than 30 





associated with neutrophil migration to sites of inflammation, differences were observed in 
their secretions. This may suggest that additional functions may be associated with this 
family of chemokines, or that T. gondii is delaying increased induction of these chemokines 
for its benefit to establish itself in the brain. These key findings in chemokine and CAM 
protein differences in expression profiles clearly demonstrate the importance in studying 
the cells secreted proteins, which was not detected in the proteome study of host cells 
(chapter four).  
When comparing transcriptome analysis of infected astrocytes with the secretome analysis, 
similarities in expression profiles of certain molecules were found. For instance, IL8 and 
CXCL2 were up-regulated in both the mRNA and the secretome analysis of astrocytes 
infected with N. caninum compared to T. gondii. Also, CCL2 and VCAM1 were up regulated 
in both analysis of astrocytes infected with T. gondii. These changes were also not detected 
in host proteome analysis during infection (chapter four). On the other hand, there were 
some differences found between both studies; such as CXCL1 that was transcriptionally up-
regulated in astrocytes infected with N. caninum compared to T. gondii infected cells. 
Whereas CXCL1 in the secretome data was up-regulated in astrocytes infected with T. gondii 
compared to N. caninum infection.   
Another key investigation in this thesis was the examination of neurotransmitter stimulation 
through dopamine production in neural cells during infection with both parasites. 
In chapter six, the study aimed to compare dopamine induction in neural host cells infected 
with the N. caninum bradyzoite cyst stage to infected cells with T. gondii cysts. The results in 
this chapter supports the hypothesis that N. caninum will not induce dopamine production 
in neural infected cells compared to the findings in cells infected with T. gondii. Previous 
work has already shown the ability of T. gondii to increase dopamine production in the brain 
both in vivo and in vitro (Gaskell et al. 2009; Prandovszky et al. 2011). This suggested the 
possible role of dopamine induction in chronically infected mice with T. gondii to 
behavioural changes of the host. This study found that rodents were more attracted to their 
predator’s (the cat) odour for the parasites advantage to continue its life cycle (through the 
cat mouse cycle) (Berdoy et al. 2000; Kaushik et al. 2012). It has also been linked to other 





It has been hypothesised that reduced virulence is associated with the evolution of vertical 
transmission in viruses (Stewart, Logsdon & Kelley 2005). Moreover, speciation of N. 
caninum and T. gondii was estimated to have occurred 28 million years ago after the 
divergence of their respective definitive hosts, the cat and dog. This may be related to 
findings associated with dopamine induction differences observed between T. gondii and N. 
caninum. The identification of ROP18; a secretory gene known to be associated with 
virulence in T. gondii was found to be a pseudo gene in N. caninum (Reid et al., 2012) may 
also be associated with host behavioural outcome. The loss of ROP18 function in N. caninum 
may signify the fact that the wide range in intermediate host species are less important to 
N. caninum, and the importance of the cat-mouse cycle in the epidemiology of T. gondii may 
explain the necessity of ROP18-mediated inactivation of immunity-related GTPases (IRG) in 
mice (Reid et al. 2012). The expansion of antigen proteins in N. caninum compared to T. 
gondii may also propose that N. caninum has become more specialized in its host range, and 
is known to be successfully transmitted through the vertical route in cattle. Thus, N. 
caninum does not need to alter or induce dopamine production in host cells in the CNS 
during infection compared to T. gondii.  
 
 Future perspectives 
Continuing the research in this thesis, a deeper comparative investigation of astrocyte 
infection with T. gondii and N. caninum can be further expanded in many ways. Proteomic 
analysis between virulent and less virulent strains of T. gondii and N. caninum in astrocytes 
will assist in comparative analysis and differences pathogen outcome in host cell responses 
in association with the parasite strain. Neurons are also important cells of the CNS, the 
comparison of both transcriptomic and proteomic expression of these cells alongside 
astrocytes during T. gondii and N. caninum infection would provide valuable insights in 
differences related to infection and disease contributions in the CNS. This can be applied 
through immune studies in vivo on mouse model infections alongside the use of primary cell 
lines in vitro. 
The latent stage of infection is an important stage to explore as it can be found in both 





bradyzoites to tachyzoites can result in severe TE or even death in T. gondii infections (Luft 
& Chua 2000). Therefore, observations in expression changes in vivo in different mouse 
strains, susceptible and resistant to infection can deliver valuable knowledge to both the 
biological and clinical aspects of brain infection and pathogenesis.  
Further confirmation of the expression of key molecules identified at the transcriptional and 
proteomic level will enlighten further detailed studies. Functional investigations of key 
molecule findings in this thesis; such as cytokine and cell adhesion molecules through host 
RNA-interference (RNAi) silencing of certain molecules (such as VCAM1 and CCL2) in host 
cells could enable the determination of why changes in these cells occur. The application of 
knockout genes in tachyzoites; such as ROP18 proteins related to virulence can be applied 
to compare between N. caninum and T. gondii in response to the possible involvement of 
this gene in neural cell modulations or vice versa through knock-in gene of ROP18 in N. 
caninum tachyzoites. 
Finally, transmigration adhesion assays involves the migration of cells across the 
endothelium. This can be applied through the use of BBB in vitro models and 3D well models 
to assist in the validation of infected astrocytes in the migration of leukocytes that can 
highlight significant changes that may be observed inside the host’s brain. Neutrophil assays 
can be used in astrocyte conditioned media to explore the differences in cytokines 
associated with neutrophil activation identified between the two infections. As neutrophil 
activation (such as IL8 and CXCL2) was detected to be up-regulated in host cells infected 





Overall, this work provided the first large scale transcriptomic and proteomic profiling of 
human astrocytes infected with T. gondii and N. caninum tachyzoites and significantly 
increased the knowledge of host cell response during parasitic infection in the CNS. State of 





global expression changes occurring in human astrocytes during infection. Two different 
proteomic techniques have been used; gel-based and non-gel based methods were applied 
to characterize the proteome of infected host cells. The results have aided the identification 
of differences in host cell proteins during infection with T. gondii compared to N. caninum in 
chemokine and cell adhesion molecules (CCL2, CXCL2, ICAM1 and VCAM1) and the 
identification of differences in the expression and regulation of molecules related to 
immune responses and cell signalling processes. Transcriptional analysis identified 
differences in key molecules in metabolic pathways between infected cells, such as cytokine 
and CAM metabolic pathways. Changes in dopamine secretion in dopaminergic cells 
infected with N. caninum compared to T. gondii showed no significant increase in dopamine 
production, which may suggest that N. caninum does not alter behaviour changes in the 
intermediate hosts brain. This study has provided new insights in differences between these 
closely related parasites toward host manipulation and specifically in dopamine secretion in 
the brain.      
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 Appendix I: Differentially expressed proteins of host cells using 2D-DIGE approach (total of 26 proteins) 
 
 
Table I: Protein spots differentially expressed in 2D-DIGE pick gel, the top five hits (according to the protein score and protein matches) for each pot were selected, The spot 
number (Spot no), protein hit number (prot hit num),  name (Prot name),  description (prot desc), score (prot score), match (prot match), t-test and fold change (FC) were 


















2418 1 Q8WZ42 TITIN_HUMAN Titin  133 3843119 75 61 2.3 6.01 0.045 -4.57 
 2 Q12955 ANK3_HUMAN Ankyrin-3 67 482394 19 16 4.7 6.07   
 3 Q9UPN3 MACF1_HUMAN Microtubule-actin cross-linking factor 
1, isoforms 1/2/3/5  
62 623626 17 15 3 5.27   
 4 Q12789 TF3C1_HUMAN General transcription factor 3C 
polypeptide 1  
56 241062 9 9 4.1 7.01   
 5 Q5VST9 OBSCN_HUMAN Obscurin  51 879630 10 10 1.6 5.69   
             
4436 1 P00338 LDHA_HUMAN L-lactate dehydrogenase A chain  225 37061 6 4 19.8 8.44 0.026 -2.39 
 2 P12277 KCRB_HUMAN Creatine kinase B-type  222 43013 5 4 13.4 5.34   
 3 P06733 ENOA_HUMAN Alpha-enolase  181 47592 9 6 21.8 7.01   
 4  GSTA1_HUMAN ; TOPep_Count=14  170 25652 25 3 30.6 8.92   
 5 P08670 VIME_HUMAN Vimentin  165 53787 5 4 9.2 5.05   
             
2638 1  TRYP_PIG ; TOPep_Count=12  111 25189 24 23 3 7 0.0047 -1.77 
 2  K1C10_HUMAN ; TOPep_Count=27  86 59822 2 1 2 5.13   
 3  K2C1_HUMAN ; TOPep_Count=35  72 66129 3 2 3 8.16   








 5 P08670 VIME_HUMAN Vimentin 43 53787 3 1 3 5.05   
             
3534 1 P25705 ATPA_HUMAN ATP synthase subunit alpha, 
mitochondrial 
658 59939 16 15 30.1 9.16 0.036 -1.51 
 2 P10809 CH60_HUMAN 60 kDa heat shock protein, 
mitochondrial 
488 61298 20 13 38.7 5.7   
 3 P06733 ENOA_HUMAN Alpha-enolase  475 47592 16 9 30.8 7.01   
 4 P60709 ACTB_HUMAN Actin, cytoplasmic 1  462 42163 18 10 39.1 5.29   
 5  K1C10_HUMAN ; TOPep_Count=27  429 59822 11 10 18.5 5.13   
             
2293 1  K2C1_HUMAN ; TOPep_Count=35  844 66281 22 22 32.1 8.15 0.026 -1.51 
 2 Q01995 TAGL_HUMAN Transgelin  348 22764 14 10 45 8.87   
 3 P37802 TAGL2_HUMAN Transgelin-2  336 22659 11 9 48.5 8.41   
 4 P48047 ATPO_HUMAN ATP synthase subunit O, mitochondrial   287 23488 6 6 27.6 9.97   
 5 P40926 MDHM_HUMAN Malate dehydrogenase, mitochondrial  216 36048 6 6 16.8 8.92   
             
2125 1 P10809 CH60_HUMAN 60 kDa heat shock protein, 
mitochondrial 
366 61298 13 8 25.8 5.7 0.045 1.53 
 2 O43707 ACTN4_HUMAN Alpha-actinin-4 349 105356 7 6 10.1 5.27   
 3 P12277 KCRB_HUMAN Creatine kinase B-type  341 43013 5 5 31.2 5.34   
 4 P00338 LDHA_HUMAN L-lactate dehydrogenase A chain  299 37061 8 5 23.1 8.44   
 5 P60709 ACTB_HUMAN Actin, cytoplasmic 1 270 42163 9 6 29 5.29   
             
3070 1 P12277 KCRB_HUMAN Creatine kinase B-type 319 43013 8 6 31.2 5.34 0.021 2.03 
 2 P06733 ENOA_HUMAN Alpha-enolase  298 47592 13 6 21.8 7.01   
 3 P10809 CH60_HUMAN 60 kDa heat shock protein, 
mitochondrial  
280 61298 9 6 19.5 5.7   
 4 P05023 AT1A1_HUMAN Sodium/potassium-transporting 
ATPase subunit alpha-1  








 5 O43707 ACTN4_HUMAN Alpha-actinin-4  254 105356 7 6 10.1 5.27   
             
2620 1 P05023 AT1A1_HUMAN Sodium/potassium-transporting 
ATPase subunit alpha-1  
353 114246 6 5 6.5 5.33 0.027 2.54 
 2 O43707 ACTN4_HUMAN Alpha-actinin-4  352 105356 7 6 10.1 5.27   
 3 P10809 CH60_HUMAN 60 kDa heat shock protein, 
mitochondrial  
337 61298 14 9 25.1 5.7   
 4 P60709 ACTB_HUMAN Actin, cytoplasmic 1  321 42163 32 10 33.5 5.29   
 5 P13929 ENOB_HUMAN Beta-enolase  289 47410 8 4 16.1 7.59   
             
2227 1 Q8WZ42 TITIN_HUMAN Titin  85 3843119 61 48 1.8 6.01 0.013 2.67 
 2 Q8WXH0 SYNE2_HUMAN Nesprin-2  72 801817 18 13 2 5.26   
 3 O94833 BPAEA_HUMAN Bullous pemphigoid antigen 1, isoforms 
6/9/10  
71 593763 17 11 2.6 5.49   
 4 A7E2Y1 MYH7B_HUMAN Myosin-7B 62 222393 8 8 5.3 5.73   
 5 Q9P2D7 DYH1_HUMAN Dynein heavy chain 1, axonemal  60 497704 9 8 2.8 5.66   
             
2023 1  TRYP_PIG ; TOPep_Count=12  129 25189 25 4 19 7 0.00063 2.07 
 2 P11021 GRP78_HUMAN 78 kDa glucose-regulated protein  90 72513 3 3 6.7 5.06   
 3 P60709 ACTB_HUMAN Actin, cytoplasmic 1  58 42163 3 3 10.4 5.29   
 4  K2C1_HUMAN ; TOPep_Count=35  43 66129 1 1 3.1 8.16   
 5 Q8TF72 SHRM3_HUMAN Protein Shroom3  40 218432 1 1 0.5 7.87   
             
2307 1 P60709 ACTB_HUMAN Actin, cytoplasmic 1  221 42163 6 4 15.2 5.29 0.028 1.89 
 2 Q6UWP8 SBSN_HUMAN Suprabasin 200 60673 7 4 8.5 6.5   
 3 P00338 LDHA_HUMAN L-lactate dehydrogenase A chain  162 37061 5 3 14.4 8.44   
 4 P07148 FABPL_HUMAN Fatty acid-binding protein, liver  141 14367 5 3 44.5 6.6   








             
2782 1 P08670 VIME_HUMAN Vimentin 639 53787 16 16 31.3 5.05 0.02 -1.68 
 2  K1C10_HUMAN ; TOPep_Count=27  402 59822 11 11 20.2 5.13   
 3  K2C1_HUMAN ; TOPep_Count=35  305 66129 11 11 15.2 8.16   
 4  K22E_HUMAN ; TOPep_Count=41  232 66222 8 8 12.8 8.07   
 5 P67936 TPM4_HUMAN Tropomyosin alpha-4 chain  230 28730 10 10 28.9 4.67   
             
4081 1 P08670 VIME_HUMAN Vimentin  980 53787 29 24 48.4 5.05 0.045 -1.54 
 2 Q04695 K1C17_HUMAN Keratin, type I cytoskeletal 17  478 48472 14 14 29.6 4.97   
 3 Q9P2E9 RRBP1_HUMAN Ribosome-binding protein 1  478 152891 14 14 10.4 8.69   
 4 Q9BRK5 CAB45_HUMAN 45 kDa calcium-binding protein  357 42006 11 10 28.1 4.76   
 5 P02533 K1C14_HUMAN Keratin, type I cytoskeletal 14   305 51983 9 9 16.3 5.09   
             
2023 1 P06733 ENOA_HUMAN Alpha-enolase  376 47592 14 8 26.2 7.01 0.0002 2.44 
 2 P60709 ACTB_HUMAN Actin, cytoplasmic 1  309 42163 15 9 36.7 5.29   
 3 P10809 CH60_HUMAN 60 kDa heat shock protein, 
mitochondrial  
289 61298 10 6 19.5 5.7   
 4 P09104 ENOG_HUMAN Gamma-enolase  238 47692 6 4 15.6 4.91   
 5 P12277 KCRB_HUMAN Creatine kinase B-type  216 43013 7 5 17.8 5.34   
             
3608 1 P06733 ENOA_HUMAN Alpha-enolase  489 47592 20 8 28.3 7.01 0.045 -1.54 
 2 P10809 CH60_HUMAN 60 kDa heat shock protein, 
mitochondrial  
477 61298 15 10 28.9 5.7   
 3 P60709 ACTB_HUMAN Actin, cytoplasmic 1  428 42163 24 14 46 5.29   
 4 O43707 ACTN4_HUMAN Alpha-actinin-4  363 105356 8 6 10.1 5.27   
 5 Q9BQE3 TBA1C_HUMAN Tubulin alpha-1C chain  334 50659 9 5 21.3 4.96   








3608 1 P25705 ATPA_HUMAN ATP synthase subunit alpha, 
mitochondrial  
658 59939 16 15 30.1 9.16 0.045 -1.54 
 2 P10809 CH60_HUMAN 60 kDa heat shock protein, 
mitochondrial  
488 61298 20 13 38.7 5.7   
 3 P06733 ENOA_HUMAN Alpha-enolase  475 47592 16 9 30.8 7.01   
 4 P60709 ACTB_HUMAN Actin, cytoplasmic 1  462 42163 18 10 39.1 5.29   
 5  K1C10_HUMAN ; TOPep_Count=27  429 59822 11 10 18.5 5.13   
             
1301 1 P60709 ACTB_HUMAN Actin, cytoplasmic 1  488 42163 25 10 33.5 5.29 0.0085 -1.96 
 2 P06733 ENOA_HUMAN Alpha-enolase 461 47592 14 6 23.4 7.01   
 3 O43707 ACTN4_HUMAN Alpha-actinin-4  360 105356 7 6 10.1 5.27   
 4 P10809 CH60_HUMAN 60 kDa heat shock protein, 
mitochondrial  
358 61298 13 9 28.2 5.7   
 5 P09104 ENOG_HUMAN Gamma-enolase  342 47692 8 4 15.6 4.91   
             
2029 1 P60709 ACTB_HUMAN Actin, cytoplasmic 1  213 42163 7 5 23.7 5.29 0.015 -2.3 
 2 P00338 LDHA_HUMAN L-lactate dehydrogenase A chain  200 37061 6 4 18.3 8.44   
 3 P06733 ENOA_HUMAN Alpha-enolase   182 47592 10 6 21.8 7.01   
 4 P12277 KCRB_HUMAN Creatine kinase B-type  156 43013 6 4 13.4 5.34   
 5 P00558 PGK1_HUMAN Phosphoglycerate kinase 1  149 45096 5 4 13.6 8.3   
             
4473 1 P07237 PDIA1_HUMAN Protein disulfide-isomerase  229 57591 10 8 15.5 4.76 0.019 -2.57 
 2  TRYP_PIG ; TOPep_Count=12  113 25189 42 4 19 7   
 3 P43243 MATR3_HUMAN Matrin-3 41 95189 2 2 2.7 5.87   
 4  ALBU_HUMAN ; TOPep_Count=42  35 71428 1 1 2.8 5.92   
 5  K2C1_HUMAN ; TOPep_Count=35  32 66129 1 1 3.1 8.16   
             








 2 Q8TF72 SHRM3_HUMAN Protein Shroom3  85 218125 12 12 7.3 7.75   
 3 Q8NF91 SYNE1_HUMAN Nesprin-1  83 1017069 21 21 3.3 5.38   
 4 Q09666 AHNK_HUMAN Neuroblast differentiation-associated 
protein AHNAK  
77 629213 28 22 4.4 5.8   
 5 Q9NU22 MDN1_HUMAN Midasin  65 638008 16 13 3.7 5.46   
             
1674 1 P60709 ACTB_HUMAN Actin, cytoplasmic 1  392 42163 22 10 35.9 5.29 0.028 -1.69 
 2 P06733 ENOA_HUMAN Alpha-enolase 347 47592 14 7 24.8 7.01   
 3 P07148 FABPL_HUMAN Fatty acid-binding protein, liver  309 14367 14 5 57 6.6   
 4 P10809 CH60_HUMAN 60 kDa heat shock protein, 
mitochondrial  
302 61298 11 7 19.5 5.7   
 5 O43707 ACTN4_HUMAN Alpha-actinin-4  290 105356 7 6 10.1 5.27   
             
1379 1 P06733 ENOA_HUMAN Alpha-enolase   275 47592 12 7 28.7 7.01 0.033 1.71 
 2 P10809 CH60_HUMAN 60 kDa heat shock protein, 
mitochondrial  
233 61298 7 5 14.3 5.7   
 3 P60709 ACTB_HUMAN Actin, cytoplasmic 1   185 42163 11 5 21 5.29   
 4 P00338 LDHA_HUMAN L-lactate dehydrogenase A chain  180 37061 6 4 19.8 8.44   
 5 P12277 KCRB_HUMAN Creatine kinase B-type 174 43013 6 4 13.4 5.34   
             
3070 1 P60709 ACTB_HUMAN Actin, cytoplasmic 1  284 42163 16 9 5 5.29 0.012 -1.73 
 2 P06733 ENOA_HUMAN Alpha-enolase  263 47592 14 9 4 7.01   
 3 P10809 CH60_HUMAN 60 kDa heat shock protein, 
mitochondrial  
258 61298 10 8 6 5.7   
 4 P00558 PGK1_HUMAN Phosphoglycerate kinase 1  236 45096 7 5 4 8.3   
 5 P08727 K1C19_HUMAN Keratin, type I cytoskeletal 19  231 44190 6 5 3 5.04   
             








 2 P00338 LDHA_HUMAN L-lactate dehydrogenase A chain  186 37061 5 3 15 8.44   
 3 P10809 CH60_HUMAN 60 kDa heat shock protein, 
mitochondrial  
181 61298 6 5 17.4 5.7   
 4 P60709 ACTB_HUMAN Actin, cytoplasmic 1  167 42163 8 5 26.1 5.29   
 5  GSTA1_HUMAN ; TOPep_Count=14  163 25652 24 3 30.6 8.92   
             
4321 1 P06733 ENOA_HUMAN Alpha-enolase  333 47592 11 6 21.8 7.01 0.023 1.71 
 2 P60709 ACTB_HUMAN Actin, cytoplasmic 1  276 42163 12 8 34.6 5.29   
 3 P12277 KCRB_HUMAN Creatine kinase B-type   235 43013 7 5 17.8 5.34   
 4 P00338 LDHA_HUMAN L-lactate dehydrogenase A chain  226 37061 6 4 19.8 8.44   
 5 P00558 PGK1_HUMAN Phosphoglycerate kinase 1  202 45096 6 4 13.6 8.3   
             
1833 1 P06733 ENOA_HUMAN Alpha-enolase 262 47592 12 6 21.8 7.01 0.04 2.87 
 2 P60709 ACTB_HUMAN Actin, cytoplasmic 1  213 42163 9 6 27.7 5.29   
 3 P00338 LDHA_HUMAN L-lactate dehydrogenase A chain 186 37061 6 4 16.8 8.44   
 4 O43707 ACTN4_HUMAN Alpha-actinin-4  167 105356 3 3 5.4 5.27   








Appendix IV: Statistically significant secreted proteins of human astrocytes during 
infection with T. gondii compared to secreted host cells infected with N. caninum. 
  
Table IV: Statistically significant human astrocyte proteins during T. gondii infection. Up-regulated 
secreted proteins are highlighted in red and down-regulated proteins are highlighted in green. 
Predicted proteins identified as secreted (Pred secr) (SecretomeP, SignalP or SPD) are labelled with 












P09341 GROA_HUMAN Growth-regulated alpha protein  0.000108 0 5.257845 Yes 
P09238 MMP10_HUMAN Stromelysin-2  0.000263 0 4.624676 Yes 
P05362 ICAM1_HUMAN Intercellular adhesion molecule 
1  
0.000103 0 4.19749 YES 
P13500 CCL2_HUMAN C-C motif chemokine 2  4.31E-05 0 3.654107 Yes 
P15121 ALDR_HUMAN Aldose reductase 0.008836 0 3.361175 No 
Q08397 LOXL1_HUMAN Lysyl oxidase homolog 1 0.002837 0 2.726979 Yes 
P19320 VCAM1_HUMAN Vascular cell adhesion protein 1  0.002893 0 2.365301 Yes 
P25786 PSA1_HUMAN Proteasome subunit alpha type-
1  
0.004337 0 2.211186 No 
P06454 PTMA_HUMAN Prothymosin alpha 0.046505 0 2.013212 No 
P05231 IL6_HUMAN Interleukin-6  0.016789 0 1.999948 Yes 
P26022 PTX3_HUMAN Pentraxin-related protein PTX3  0.001155 0 1.977178 Yes 
P31153 METK2_HUMAN S-adenosylmethionine synthase 
isoform type-2  
0.001737 0 1.915867 Yes 
P61163 ACTZ_HUMAN Alpha-centractin  0.033373 0 1.883014 No 
O14818 PSA7_HUMAN Proteasome subunit alpha type-
7  
0.048428 0 1.403476 No 
P17987 TCPA_HUMAN T-complex protein 1 subunit 
alpha  
0.017136 0 1.346837 Yes 
O43493 TGON2_HUMAN Trans-Golgi network integral 
membrane protein 2  
0.017583 0 1.307799 No 
P59998 ARPC4_HUMAN Actin-related protein 2/3 
complex subunit 4  
0.008322 0 1.291607 Yes 
P38646 GRP75_HUMAN Stress-70 protein, 
mitochondrial OS 
0.000697 0 1.260346 No 
P28074 PSB5_HUMAN Proteasome subunit beta type-
5  
0.001689 0 1.252413 Yes 
P50990 TCPQ_HUMAN T-complex protein 1 subunit 
theta  
0.00156 0 1.236334 No 
P21291 CSRP1_HUMAN Cysteine and glycine-rich 
protein 1  
0.011696 0 1.017476 No 
Q14767 LTBP2_HUMAN Latent-transforming growth 
factor beta-binding protein 2  
0.02889 0 1.017025 Yes 
P07900 HS90A_HUMAN Heat shock protein HSP 90-
alpha  
0.010883 0 1.008597 No 
O15511 ARPC5_HUMAN Actin-related protein 2/3 
complex subunit 5  
0.003562 0 0.992675 Yes 





P63313 TYB10_HUMAN Thymosin beta-10  0.021646 0 0.961515 Yes 
P14550 AK1A1_HUMAN Alcohol dehydrogenase 
[NADP(+)]  
0.002491 0 0.957828 No 
P07437 TBB5_HUMAN Tubulin beta chain  0.009428 0 0.947041 No 
O76003 GLRX3_HUMAN Glutaredoxin-3  0.047604 0 0.936697 Yes 
P03956 MMP1_HUMAN Interstitial collagenase  0.036559 0 0.930272 Yes 
P11021 GRP78_HUMAN 78 kDa glucose-regulated 
protein  
0.000481 0 0.927743 Yes 
P25788 PSA3_HUMAN Proteasome subunit alpha type-
3  
0.008862 0 0.897865 No 
P09972 ALDOC_HUMAN Fructose-bisphosphate aldolase 
C  
0.01806 0 0.88451 No 
P14314 GLU2B_HUMAN Glucosidase 2 subunit beta  0.003944 0 0.866184 Yes 
Q01082 SPTB2_HUMAN Spectrin beta chain, non-
erythrocytic 1  
0.027778 0 0.861815 No 
P30050 RL12_HUMAN 60S ribosomal protein L12  0.005206 0 0.8578 Yes 
P30086 PEBP1_HUMAN Phosphatidylethanolamine-
binding protein 1  
0.004218 0 0.856006 Yes 
P80723 BASP1_HUMAN Brain acid soluble protein 1  0.043949 0 0.849623 No 
P08238 HS90B_HUMAN Heat shock protein HSP 90-beta  0.01094 0 0.837652 No 
P53396 ACLY_HUMAN ATP-citrate synthase  0.016232 0 0.83065 Yes 
P27797 CALR_HUMAN Calreticulin  0.017732 0 0.823313 No 
P49588 SYAC_HUMAN Alanine--tRNA ligase, 
cytoplasmic  
0.02464 0 0.820437 No 
A6NMY6 AXA2L_HUMAN Putative annexin A2-like protein  0.000404 0 0.801217 Yes 
Q16527 CSRP2_HUMAN Cysteine and glycine-rich 
protein 2  
0.029279 0 0.800834 Yes 
P62328 TYB4_HUMAN Thymosin beta-4  0.011207 0 0.795066 Yes 
P23381 SYWC_HUMAN Tryptophan--tRNA ligase, 
cytoplasmic  
0.010216 0 0.788698 No 
P07195 LDHB_HUMAN L-lactate dehydrogenase B 
chain  
0.004474 0 0.780505 Yes 
P02795 MT2_HUMAN Metallothionein-2  0.003684 0 0.773442 Yes 
Q71U36 TBA1A_HUMAN Tubulin alpha-1A chain  0.01182 0 0.763696 No 
P34931 HS71L_HUMAN Heat shock 70 kDa protein 1-
like  
0.018605 0 0.757331 No 
Q9NQR4 NIT2_HUMAN Omega-amidase NIT2 OS 0.034322 0 0.744647 Yes 
P62805 H4_HUMAN Histone H4 OS 0.047206 0 0.743187 No 
Q14315 FLNC_HUMAN Filamin-C OS 0.021335 0 0.733525 No 
Q15365 PCBP1_HUMAN Poly(rC)-binding protein 1  0.031335 0 0.730129 Yes 
Q9BRA2 TXD17_HUMAN Thioredoxin domain-containing 
protein 17  
0.000712 0 0.721117 No 
P55209 NP1L1_HUMAN Nucleosome assembly protein 
1-like 1  
0.029703 0 0.714747 No 
P60842 IF4A1_HUMAN Eukaryotic initiation factor 4A-I  0.013077 0 0.711941 Yes 
P02760 AMBP_HUMAN Protein AMBP  0.030574 0 0.709603 Yes 
P04075 ALDOA_HUMAN Fructose-bisphosphate aldolase 
A  
0.005546 0 0.705727 No 
P60983 GMFB_HUMAN Glia maturation factor beta  0.014842 0 0.677299 Yes 





P14625 ENPL_HUMAN Endoplasmin  0.008421 0 0.648768 No 
P14174 MIF_HUMAN Macrophage migration 
inhibitory factor  
0.001703 0 0.647196 Yes 
P18669 PGAM1_HUMAN Phosphoglycerate mutase 1  0.038812 0 0.636581 No 
P54727 RD23B_HUMAN UV excision repair protein 
RAD23 homolog B  
0.038491 0 0.615021 No 
P07355 ANXA2_HUMAN Annexin A2  0.025654 0 0.612429 Yes 
P04004 VTNC_HUMAN Vitronectin  0.005287 0 0.610916 Yes 
P68104 EF1A1_HUMAN Elongation factor 1-alpha 1  0.022367 0 0.603369 No 
P23284 PPIB_HUMAN Peptidyl-prolyl cis-trans 
isomerase B  
0.011181 0 0.59286 Yes 
P09486 SPRC_HUMAN SPARC  0.029222 0 -0.64863 Yes 
P09493 TPM1_HUMAN Tropomyosin alpha-1 chain  0.004885 0 -0.66525 Yes 
O00391 QSOX1_HUMAN Sulfhydryl oxidase 1  0.016832 0 -0.72541 Yes 
P35555 FBN1_HUMAN Fibrillin-1  0.011265 0 -0.73377 Yes 
P18065 IBP2_HUMAN Insulin-like growth factor-
binding protein 2  
0.015588 0 -0.75658 Yes 
Q92743 HTRA1_HUMAN Serine protease HTRA1  0.032223 0 -0.85143 Yes 
Q96IZ0 PAWR_HUMAN PRKC apoptosis WT1 regulator 
protein  
0.041202 0 -0.8957 Yes 
Q16610 ECM1_HUMAN Extracellular matrix protein 1  0.038878 0 -0.91286 Yes 
P12107 COBA1_HUMAN Collagen alpha-1(XI) chain  0.049795 0 -0.91288 Yes 
P24593 IBP5_HUMAN Insulin-like growth factor-
binding protein 5  
0.018139 0 -0.91306 Yes 
P63261 ACTG_HUMAN Actin, cytoplasmic 2  0.033869 0 -0.93031 No 
P55285 CADH6_HUMAN Cadherin-6  0.027749 0 -0.93272 No 
P48061 SDF1_HUMAN Stromal cell-derived factor 1  0.01213 0 -0.93275 Yes 
P17936 IBP3_HUMAN Insulin-like growth factor-
binding protein 3  
0.008403 0 -0.95564 Yes 
P24534 EF1B_HUMAN Elongation factor 1-beta  0.005794 0 -0.96469 Yes 
P61978 HNRPK_HUMAN Heterogeneous nuclear 
ribonucleoprotein K  
0.010264 0 -0.99162 No 
Q9UBP4 DKK3_HUMAN Dickkopf-related protein 3  0.003557 0 -1.03339 Yes 
P27658 CO8A1_HUMAN Collagen alpha-1(VIII) chain  0.026119 0 -1.036 Yes 
P68032 ACTC_HUMAN Actin, alpha cardiac muscle 1  0.049451 0 -1.07526 No 
Q05682 CALD1_HUMAN Caldesmon  0.008266 0 -1.08126 No 
O60565 GREM1_HUMAN Gremlin-1  0.008403 0 -1.08995 Yes 
P08476 INHBA_HUMAN Inhibin beta A chain  0.041069 0 -1.09314 Yes 
P28300 LYOX_HUMAN Protein-lysine 6-oxidase  0.0088 0 -1.12782 Yes 
O95633 FSTL3_HUMAN Follistatin-related protein 3  0.0369 0 -1.1306 Yes 
P02545 LMNA_HUMAN Prelamin-A/C  0.009051 0 -1.1379 No 
P24844 MYL9_HUMAN Myosin regulatory light 
polypeptide 9  
0.043409 0 -1.14577 Yes 
P25940 CO5A3_HUMAN Collagen alpha-3(V) chain  0.041054 0 -1.20935 Yes 
P25398 RS12_HUMAN 40S ribosomal protein S12  0.034829 0 -1.23693 Yes 
P16949 STMN1_HUMAN Stathmin  0.028402 0 -1.27325 Yes 
Q9UI42 CBPA4_HUMAN Carboxypeptidase A4  0.013366 0 -1.37723 Yes 
P27816 MAP4_HUMAN Microtubule-associated protein 
4  





Q02818 NUCB1_HUMAN Nucleobindin-1  0.00856 0 -1.51679 No 
P41219 PERI_HUMAN Peripherin  0.001806 0 -1.51762 Yes 
Q15056 IF4H_HUMAN Eukaryotic translation initiation 
factor 4H  
0.001988 0 -1.52172 Yes 
O43852 CALU_HUMAN Calumenin  0.000302 0 -1.65663 Yes 
P55058 PLTP_HUMAN Phospholipid transfer protein  0.002739 0 -1.66905 Yes 
Q02952 AKA12_HUMAN A-kinase anchor protein 12  0.027524 0 -1.7027 No 
P38159 RBMX_HUMAN RNA-binding motif protein, X 
chromosome  
0.002406 0 -1.75489 No 
Q13443 ADAM9_HUMAN Disintegrin and 
metalloproteinase domain-
containing protein 9  
0.007574 0 -1.7928 Yes 
O14979 HNRDL_HUMAN Heterogeneous nuclear 
ribonucleoprotein D-like  
0.049791 0 -1.84856 Yes 
Q16643 DREB_HUMAN Drebrin  0.004587 0 -1.89107 No 
Q96TA1 NIBL1_HUMAN Niban-like protein 1  0.033447 0 -1.91785 No 
P17661 DESM_HUMAN Desmin  0.001407 0 -1.95785 Yes 
P08670 VIME_HUMAN Vimentin  3.39E-05 0 -1.95913 Yes 
P62857 RS28_HUMAN 40S ribosomal protein S28  6.79E-05 0 -2.1068 Yes 
P07602 SAP_HUMAN Prosaposin  0.005073 0 -2.11668 Yes 
O43390 HNRPR_HUMAN Heterogeneous nuclear 
ribonucleoprotein R  
0.040803 0 -2.36523 No 
O43399 TPD54_HUMAN Tumor protein D54  0.005077 0 -2.38273 Yes 
P13497 BMP1_HUMAN Bone morphogenetic protein 1  0.004657 0 -2.47727 Yes 
Q8NC51 PAIRB_HUMAN Plasminogen activator inhibitor 
1 RNA-binding protein  
0.000374 0 -2.71477 No 
Q68BL8 OLM2B_HUMAN Olfactomedin-like protein 2B  0.004609 0 -2.71667 No 
Q00688 FKBP3_HUMAN Peptidyl-prolyl cis-trans 
isomerase FKBP3  
0.001 0 -2.77179 Yes 
O95084 PRS23_HUMAN Serine protease 23  0.001414 0 -2.81696 Yes 
Q9H4D0 CSTN2_HUMAN Calsyntenin-2  0.020465 0 -3.01607 No 
P62701 RS4X_HUMAN 40S ribosomal protein S4, X 
isoform  
0.013136 0 -3.05041 Yes 
Q15233 NONO_HUMAN Non-POU domain-containing 
octamer-binding protein  
0.018906 0 -3.06885 No 
P53999 TCP4_HUMAN Activated RNA polymerase II 
transcriptional coactivator p15  
0.021747 0 -3.50275 Yes 
P35637 FUS_HUMAN RNA-binding protein FUS  0.034132 0 -3.54684 No 
Q6NZI2 PTRF_HUMAN Polymerase I and transcript 
release factor  
0.00886 0 -3.73683 Yes 
P62854 RS26_HUMAN 40S ribosomal protein S26  0.029222 0 -3.84154 No 
Q93063 EXT2_HUMAN Exostosin-2  0.009943 0 -3.85753 Yes 
P15502 ELN_HUMAN Elastin  0.001098 0 -4.2452 Yes 











Table V: Statistically significant human astrocyte proteins during N. caninum infection. Up-regulated 
secreted proteins are highlighted in red and down-regulated proteins are highlighted in green. 
Predicted proteins identified as secreted (Pred secr) (SecretomeP, SignalP or SPD) are labelled with 
'Yes' and secreted proteins predicted not to be secreted are labelled with 'No'.  
Accession 
no 




Log2 Neo Pred 
secr 
P19875 CXCL2_HUMAN C-X-C motif chemokine 2  0.004193 0 5.896856 Yes 
P10145 IL8_HUMAN Interleukin-8 7.23E-05 0 4.932294 Yes 
P05231 IL6_HUMAN Interleukin-6  0.003763 0 4.547647 Yes 
Q9Y5K6 CD2AP_HUMAN CD2-associated protein  0.001248 0 3.855305 No 
Q08397 LOXL1_HUMAN Lysyl oxidase homolog 1  2.02E-05 0 3.327341 Yes 
P09341 GROA_HUMAN Growth-regulated alpha protein  0.048183 0 2.317003 Yes 
P13500 CCL2_HUMAN C-C motif chemokine 2  0.016222 0 2.116471 Yes 
Q14767 LTBP2_HUMAN Latent-transforming growth 
factor beta-binding protein 2  
8.47E-05 0 1.999367 Yes 
P30048 PRDX3_HUMAN Thioredoxin-dependent peroxide 
reductase, mitochondrial  
0.005613 0 1.987092 Yes 
P68431 H31_HUMAN Histone H3.1  0.011383 0 1.344802 Yes 
P05556 ITB1_HUMAN Integrin beta-1  0.013207 0 1.343346 No 
Q14624 ITIH4_HUMAN Inter-alpha-trypsin inhibitor 
heavy chain H4  
0.006484 0 1.317681 Yes 
P04114 APOB_HUMAN Apolipoprotein B-100  0.00136 0 1.298246 Yes 
P48307 TFPI2_HUMAN Tissue factor pathway inhibitor 2  0.000265 0 1.270384 Yes 
O95373 IPO7_HUMAN Importin-7  0.014602 0 1.260445 Yes 
P04278 SHBG_HUMAN Sex hormone-binding globulin  0.002403 0 1.190953 Yes 
P08697 A2AP_HUMAN Alpha-2-antiplasmin  0.004238 0 1.189347 Yes 
P00734 THRB_HUMAN Prothrombin  0.015799 0 1.147557 Yes 
P02774 VTDB_HUMAN Vitamin D-binding protein  0.013655 0 1.124911 Yes 
P09871 C1S_HUMAN Complement C1s subcomponent  0.001142 0 1.12364 Yes 
P13611 CSPG2_HUMAN Versican core protein  0.005848 0 1.119053 Yes 
P01042 KNG1_HUMAN Kininogen-1  0.022292 0 1.109376 Yes 
P05155 IC1_HUMAN Plasma protease C1 inhibitor  0.002318 0 1.078543 Yes 
P62888 RL30_HUMAN 60S ribosomal protein L30  0.007565 0 1.054243 No 
O95445 APOM_HUMAN Apolipoprotein M  0.005913 0 1.027931 Yes 
P02765 FETUA_HUMAN Alpha-2-HS-glycoprotein  0.003949 0 0.964087 Yes 
P60033 CD81_HUMAN CD81 antigen  0.019602 0 0.963493 No 
P05156 CFAI_HUMAN Complement factor I  0.041823 0 0.95824 Yes 
P43652 AFAM_HUMAN Afamin  0.021232 0 0.88913 Yes 
P07355 ANXA2_HUMAN Annexin A2  0.045594 0 0.884813 Yes 
Q9UBQ6 EXTL2_HUMAN Exostosin-like 2  0.043217 0 0.876997 Yes 





P02787 TRFE_HUMAN Serotransferrin  0.003646 0 0.849204 Yes 
P02753 RET4_HUMAN Retinol-binding protein 4  0.027072 0 0.841751 Yes 
P07942 LAMB1_HUMAN Laminin subunit beta-1  0.019793 0 0.813016 Yes 
P04217 A1BG_HUMAN Alpha-1B-glycoprotein  0.044014 0 0.809553 Yes 
Q2TAA2 IAH1_HUMAN Isoamyl acetate-hydrolyzing 
esterase 1 homolog  
0.033829 0 0.79734 No 
P02788 TRFL_HUMAN Lactotransferrin  0.004901 0 0.7829 Yes 
P01008 ANT3_HUMAN Antithrombin-III  0.009356 0 0.767951 Yes 
Q06033 ITIH3_HUMAN Inter-alpha-trypsin inhibitor 
heavy chain H3  
0.016263 0 0.758894 Yes 
O14773 TPP1_HUMAN Tripeptidyl-peptidase 1  0.009003 0 0.751712 Yes 
Q96RW7 HMCN1_HUMAN Hemicentin-1  0.015014 0 0.735199 Yes 
Q9UJ70 NAGK_HUMAN N-acetyl-D-glucosamine kinase  0.020945 0 0.728763 Yes 
P07602 SAP_HUMAN Prosaposin  0.041079 0 0.722354 Yes 
P05543 THBG_HUMAN Thyroxine-binding globulin  0.034971 0 0.692797 Yes 
O75095 MEGF6_HUMAN Multiple epidermal growth 
factor-like domains protein 6  
0.006864 0 0.625488 No 
P02790 HEMO_HUMAN Hemopexin  0.041066 0 0.607574 Yes 
O76061 STC2_HUMAN Stanniocalcin-2  0.044448 0 0.60245 Yes 
P69905 HBA_HUMAN Hemoglobin subunit alpha  0.004738 0 0.585297 No 
Q01955 CO4A3_HUMAN Collagen alpha-3(IV) chain  0.02057 0 -0.59476 No 
Q16658 FSCN1_HUMAN Fascin  0.014835 0 -0.60687 No 
Q93063 EXT2_HUMAN Exostosin-2  0.009555 0 -0.60711 Yes 
O15131 IMA6_HUMAN Importin subunit alpha-6  0.045424 0 -0.63944 No 
P52565 GDIR1_HUMAN Rho GDP-dissociation inhibitor 1  0.001439 0 -0.65415 No 
P21399 ACOC_HUMAN Cytoplasmic aconitate hydratase  0.0083 0 -0.66004 No 
Q9Y4L1 HYOU1_HUMAN Hypoxia up-regulated protein 1  0.042532 0 -0.67882 No 
Q9Y3B8 ORN_HUMAN Oligoribonuclease, 
mitochondrial  
0.032857 0 -0.6852 Yes 
P21333 FLNA_HUMAN Filamin-A  0.036551 0 -0.70203 No 
Q9Y696 CLIC4_HUMAN Chloride intracellular channel 
protein 4  
0.039115 0 -0.70242 Yes 
Q13643 FHL3_HUMAN Four and a half LIM domains 
protein 3  
0.030363 0 -0.71357 Yes 
Q15366 PCBP2_HUMAN Poly(rC)-binding protein 2  0.041669 0 -0.73183 Yes 
P29692 EF1D_HUMAN Elongation factor 1-delta  0.037069 0 -0.74074 Yes 
Crap_sp IGF2_HUMAN ; TOPep_Count 0.015622 0 -0.74341 No 
Q00610 CLH1_HUMAN Clathrin heavy chain 1  0.044838 0 -0.74668 No 
P26038 MOES_HUMAN Moesin  0.036645 0 -0.74743 No 
P61081 UBC12_HUMAN NEDD8-conjugating enzyme 
Ubc12  
0.039068 0 -0.75347 Yes 
P34931 HS71L_HUMAN Heat shock 70 kDa protein 1-like  0.031944 0 -0.75646 No 
P68104 EF1A1_HUMAN Elongation factor 1-alpha 1  0.03463 0 -0.76633 No 
Q15185 TEBP_HUMAN Prostaglandin E synthase 3  0.034712 0 -0.7838 Yes 
P07814 SYEP_HUMAN Bifunctional glutamate/proline--
tRNA ligase  
0.010643 0 -0.79573 No 
Q92598 HS105_HUMAN Heat shock protein 105 kDa  0.016439 0 -0.79828 No 





Q9H4M9 EHD1_HUMAN EH domain-containing protein 1  0.042251 0 -0.80582 No 
Q15393 SF3B3_HUMAN Splicing factor 3B subunit 3  0.032923 0 -0.80858 Yes 
P37108 SRP14_HUMAN Signal recognition particle 14 
kDa protein  
0.018586 0 -0.81516 No 
P11940 PABP1_HUMAN Polyadenylate-binding protein 1  0.029906 0 -0.82132 No 
P62244 RS15A_HUMAN 40S ribosomal protein S15a  0.00922 0 -0.82468 Yes 
Q9BR76 COR1B_HUMAN Coronin-1B  0.049361 0 -0.82815 No 
P54652 HSP72_HUMAN Heat shock-related 70 kDa 
protein 2  
0.013418 0 -0.84171 No 
Q15435 PP1R7_HUMAN Protein phosphatase 1 
regulatory subunit 7  
0.003406 0 -0.8575 Yes 
Q86V81 THOC4_HUMAN THO complex subunit 4  0.016018 0 -0.8585 No 
Q14103 HNRPD_HUMAN Heterogeneous nuclear 
ribonucleoprotein D0  
0.008204 0 -0.8608 No 
P05198 IF2A_HUMAN Eukaryotic translation initiation 
factor 2 subunit 1  
0.01074 0 -0.87124 No 
P14735 IDE_HUMAN Insulin-degrading enzyme  0.049522 0 -0.87584 No 
P28300 LYOX_HUMAN Protein-lysine 6-oxidase  0.042412 0 -0.87822 Yes 
Q9BXS5 AP1M1_HUMAN AP-1 complex subunit mu-1  0.035891 0 -0.88176 Yes 
Q9Y5S9 RBM8A_HUMAN RNA-binding protein 8A  0.033068 0 -0.8931 No 
P62633 CNBP_HUMAN Cellular nucleic acid-binding 
protein  
0.021278 0 -0.89334 Yes 
Q15262 PTPRK_HUMAN Receptor-type tyrosine-protein 
phosphatase kappa  
0.041837 0 -0.89497 No 
P54577 SYYC_HUMAN Tyrosine--tRNA ligase, 
cytoplasmic  
0.00479 0 -0.89745 No 
P35579 MYH9_HUMAN Myosin-9  0.033139 0 -0.8984 No 
P11142 HSP7C_HUMAN Heat shock cognate 71 kDa 
protein  
0.032782 0 -0.92003 No 
P14618 KPYM_HUMAN Pyruvate kinase PKM  0.027482 0 -0.9419 No 
P10124 SRGN_HUMAN Serglycin  0.036848 0 -0.95154 Yes 
P63241 IF5A1_HUMAN Eukaryotic translation initiation 
factor 5A-1  
0.018876 0 -0.95814 No 
P60709 ACTB_HUMAN Actin, cytoplasmic 1  0.015704 0 -0.96231 No 
Q14847 LASP1_HUMAN LIM and SH3 domain protein 1  0.003552 0 -0.96854 Yes 
P30740 ILEU_HUMAN Leukocyte elastase inhibitor  0.045763 0 -0.97168 Yes 
Q15637 SF01_HUMAN Splicing factor 1  0.008246 0 -0.9757 No 
Q13200 PSMD2_HUMAN 26S proteasome non-ATPase 
regulatory subunit 2  
0.025768 0 -0.98281 Yes 
P00568 KAD1_HUMAN Adenylate kinase isoenzyme 1  0.039498 0 -0.99018 Yes 
P54920 SNAA_HUMAN Alpha-soluble NSF attachment 
protein  
0.031812 0 -0.99161 Yes 
Q13283 G3BP1_HUMAN Ras GTPase-activating protein-
binding protein 1  
0.003941 0 -0.99459 No 
P09651 ROA1_HUMAN Heterogeneous nuclear 
ribonucleoprotein A1  
0.020638 0 -0.99541 No 
Q96AE4 FUBP1_HUMAN Far upstream element-binding 
protein 1  
0.00298 0 -1.00105 No 
P08133 ANXA6_HUMAN Annexin A6  0.047675 0 -1.02685 No 
Q14194 DPYL1_HUMAN Dihydropyrimidinase-related 
protein 1  





P67936 TPM4_HUMAN Tropomyosin alpha-4 chain  0.0373 0 -1.03846 No 
P41271 NBL1_HUMAN Neuroblastoma suppressor of 
tumorigenicity 1  
0.001165 0 -1.03862 Yes 
Q14240 IF4A2_HUMAN Eukaryotic initiation factor 4A-II  0.039348 0 -1.04089 No 
O94979 SC31A_HUMAN Protein transport protein 
Sec31A  
0.025219 0 -1.04899 No 
P10909 CLUS_HUMAN Clusterin  0.004155 0 -1.0523 Yes 
P49773 HINT1_HUMAN Histidine triad nucleotide-
binding protein 1  
0.015388 0 -1.05364 Yes 
P38919 IF4A3_HUMAN Eukaryotic initiation factor 4A-III  0.015378 0 -1.05515 Yes 
P62258 1433E_HUMAN 14-3-3 protein epsilon  0.002343 0 -1.06284 No 
Q13813 SPTN1_HUMAN Spectrin alpha chain, non-
erythrocytic 1  
0.036168 0 -1.06936 No 
P46940 IQGA1_HUMAN Ras GTPase-activating-like 
protein IQGAP1  
0.041896 0 -1.0743 No 
Q9UHD8 SEPT9_HUMAN Septin-9  0.014838 0 -1.08365 Yes 
P24666 PPAC_HUMAN Low molecular weight 
phosphotyrosine protein 
phosphatase  
0.021208 0 -1.08722 Yes 
Q16401 PSMD5_HUMAN 26S proteasome non-ATPase 
regulatory subunit 5  
0.0138 0 -1.12616 Yes 
O60701 UGDH_HUMAN UDP-glucose 6-dehydrogenase  0.003653 0 -1.13156 No 
O60506 HNRPQ_HUMAN Heterogeneous nuclear 
ribonucleoprotein Q  
0.02246 0 -1.1368 No 
P23381 SYWC_HUMAN Tryptophan--tRNA ligase, 
cytoplasmic  
0.046107 0 -1.15377 No 
Q9UJU6 DBNL_HUMAN Drebrin-like protein  0.000765 0 -1.16386 Yes 
P24844 MYL9_HUMAN Myosin regulatory light 
polypeptide 9  
0.000598 0 -1.16553 Yes 
P63313 TYB10_HUMAN Thymosin beta-10  0.020687 0 -1.16915 Yes 
P42167 LAP2B_HUMAN Lamina-associated polypeptide 
2, isoforms beta/gamma  
0.006612 0 -1.17114 Yes 
Q92945 FUBP2_HUMAN Far upstream element-binding 
protein 2  
0.02796 0 -1.17772 No 
P62906 RL10A_HUMAN 60S ribosomal protein L10a  0.001456 0 -1.18222 Yes 
P35052 GPC1_HUMAN Glypican-1  0.024022 0 -1.18866 No 
P33176 KINH_HUMAN Kinesin-1 heavy chain  0.023291 0 -1.19117 No 
P16989 YBOX3_HUMAN Y-box-binding protein 3  0.022127 0 -1.19516 Yes 
P08107 HSP71_HUMAN Heat shock 70 kDa protein 
1A/1B  
0.004045 0 -1.20094 No 
P45974 UBP5_HUMAN Ubiquitin carboxyl-terminal 
hydrolase 5  
0.04381 0 -1.20349 No 
P54727 RD23B_HUMAN UV excision repair protein 
RAD23 homolog B  
0.010912 0 -1.20387 No 
Q8WX93 PALLD_HUMAN Palladin  0.03477 0 -1.21397 No 
O75326 SEM7A_HUMAN Semaphorin-7A  0.021852 0 -1.21938 No 
P46782 RS5_HUMAN 40S ribosomal protein S5  0.016778 0 -1.25287 Yes 
P55285 CADH6_HUMAN Cadherin-6  0.023758 0 -1.25478 No 
P23396 RS3_HUMAN 40S ribosomal protein S3  0.013884 0 -1.25842 No 
P22626 ROA2_HUMAN Heterogeneous nuclear 
ribonucleoproteins A2/B1  





Q00688 FKBP3_HUMAN Peptidyl-prolyl cis-trans 
isomerase FKBP3  
0.004527 0 -1.30994 Yes 
O76003 GLRX3_HUMAN Glutaredoxin-3  0.045414 0 -1.34226 Yes 
Q13509 TBB3_HUMAN Tubulin beta-3 chain  0.009444 0 -1.35281 No 
P10155 RO60_HUMAN 60 kDa SS-A/Ro 
ribonucleoprotein 
0.008415 0 -1.3574 No 
O43294 TGFI1_HUMAN Transforming growth factor 
beta-1-induced transcript 1 
protein  
0.044062 0 -1.36843 Yes 
O95881 TXD12_HUMAN Thioredoxin domain-containing 
protein 12  
0.041023 0 -1.38816 Yes 
Q9NP97 DLRB1_HUMAN Dynein light chain roadblock-
type 1  
0.018618 0 -1.38957 Yes 
Q9BZZ5 API5_HUMAN Apoptosis inhibitor 5  0.008709 0 -1.39758 No 
O95965 ITGBL_HUMAN Integrin beta-like protein 1  8.34E-05 0 -1.39909 No 
O00231 PSD11_HUMAN 26S proteasome non-ATPase 
regulatory subunit 11  
0.000507 0 -1.42558 No 
P27348 1433T_HUMAN 14-3-3 protein theta  0.006331 0 -1.44988 No 
Q15019 SEPT2_HUMAN Septin-2  0.025432 0 -1.45669 No 
P62306 RUXF_HUMAN Small nuclear ribonucleoprotein 
F  
0.028542 0 -1.47478 No 
P05783 K1C18_HUMAN Keratin, type I cytoskeletal 18  0.021737 0 -1.50003 Yes 
O43852 CALU_HUMAN Calumenin  0.034527 0 -1.52271 Yes 
Q02952 AKA12_HUMAN A-kinase anchor protein 12  0.042422 0 -1.52444 No 
P62269 RS18_HUMAN 40S ribosomal protein S18  0.0027 0 -1.54025 No 
P62318 SMD3_HUMAN Small nuclear ribonucleoprotein 
Sm D3  
0.008013 0 -1.54544 Yes 
P41219 PERI_HUMAN Peripherin  0.009195 0 -1.55543 Yes 
P62736 ACTA_HUMAN Actin, aortic smooth muscle  0.000454 0 -1.56497 Yes 
P30044 PRDX5_HUMAN Peroxiredoxin-5, mitochondrial  0.021234 0 -1.57146 Yes 
P31939 PUR9_HUMAN Bifunctional purine biosynthesis 
protein PURH  
0.044877 0 -1.57366 No 
P08865 RSSA_HUMAN 40S ribosomal protein SA  0.024006 0 -1.57425 Yes 
P49591 SYSC_HUMAN Serine--tRNA ligase, cytoplasmic  0.018958 0 -1.57632 No 
P49588 SYAC_HUMAN Alanine--tRNA ligase, 
cytoplasmic  
0.02883 0 -1.58136 No 
P51911 CNN1_HUMAN Calponin-1  0.00661 0 -1.59187 No 
Q9BUD6 SPON2_HUMAN Spondin-2  0.000497 0 -1.59547 Yes 
Q99729 ROAA_HUMAN Heterogeneous nuclear 
ribonucleoprotein A/B  
0.031058 0 -1.59563 No 
Q15459 SF3A1_HUMAN Splicing factor 3A subunit 1  0.042717 0 -1.60287 No 
O00571 DDX3X_HUMAN ATP-dependent RNA helicase 
DDX3X  
0.007926 0 -1.6109 No 
P13798 ACPH_HUMAN Acylamino-acid-releasing 
enzyme  
0.03596 0 -1.61794 Yes 
P15502 ELN_HUMAN Elastin  0.004973 0 -1.62306 Yes 
O00151 PDLI1_HUMAN PDZ and LIM domain protein 1  0.00981 0 -1.62617 No 
P61978 HNRPK_HUMAN Heterogeneous nuclear 
ribonucleoprotein K  
0.005452 0 -1.62981 No 
Q9Y3F4 STRAP_HUMAN Serine-threonine kinase 
receptor-associated protein  





Q13561 DCTN2_HUMAN Dynactin subunit 2  0.00216 0 -1.63838 No 
P62314 SMD1_HUMAN Small nuclear ribonucleoprotein 
Sm D1  
0.001305 0 -1.67436 No 
P05455 LA_HUMAN Lupus La protein  0.002483 0 -1.67533 No 
P62277 RS13_HUMAN 40S ribosomal protein S13  0.007612 0 -1.70047 Yes 
P68371 TBB4B_HUMAN Tubulin beta-4B chain  0.010022 0 -1.71608 No 
Q93052 LPP_HUMAN Lipoma-preferred partner  0.001422 0 -1.73791 Yes 
P27816 MAP4_HUMAN Microtubule-associated protein 
4  
0.001732 0 -1.77733 No 
P07951 TPM2_HUMAN Tropomyosin beta chain  0.003692 0 -1.78386 No 
Q04760 LGUL_HUMAN Lactoylglutathione lyase  0.026019 0 -1.78637 No 
P17661 DESM_HUMAN Desmin  0.001798 0 -1.822 Yes 
P84103 SRSF3_HUMAN Serine/arginine-rich splicing 
factor 3  
0.00309 0 -1.82652 No 
Q08211 DHX9_HUMAN ATP-dependent RNA helicase A  0.010212 0 -1.8393 No 
P62081 RS7_HUMAN 40S ribosomal protein S7  0.038395 0 -1.84632 Yes 
Q04917 1433F_HUMAN 14-3-3 protein eta  0.000823 0 -1.84766 No 
Q01813 K6PP_HUMAN 6-phosphofructokinase type C  0.015171 0 -1.84783 Yes 
P36578 RL4_HUMAN 60S ribosomal protein L4  0.007506 0 -1.85836 Yes 
O14979 HNRDL_HUMAN Heterogeneous nuclear 
ribonucleoprotein D-like  
0.005679 0 -1.86971 Yes 
P62249 RS16_HUMAN 40S ribosomal protein S16  0.004815 0 -1.87635 Yes 
P04632 CPNS1_HUMAN Calpain small subunit 1  0.017777 0 -1.87763 Yes 
P63104 1433Z_HUMAN 14-3-3 protein zeta/delta  0.013334 0 -1.88233 No 
P13497 BMP1_HUMAN Bone morphogenetic protein 1  0.013535 0 -1.90514 Yes 
P47897 SYQ_HUMAN Glutamine--tRNA ligase  0.036949 0 -1.91789 No 
Q92499 DDX1_HUMAN ATP-dependent RNA helicase 
DDX1  
0.010153 0 -1.93879 No 
P19623 SPEE_HUMAN Spermidine synthase  0.007623 0 -1.94363 Yes 
Q15056 IF4H_HUMAN Eukaryotic translation initiation 
factor 4H  
0.001071 0 -1.94396 Yes 
Q05682 CALD1_HUMAN Caldesmon  7.27E-05 0 -1.94973 No 
Q8NC51 PAIRB_HUMAN Plasminogen activator inhibitor 
1 RNA-binding protein  
0.000227 0 -1.95547 No 
P15880 RS2_HUMAN 40S ribosomal protein S2  0.004499 0 -1.95736 Yes 
O75718 CRTAP_HUMAN Cartilage-associated protein  0.00256 0 -1.9648 Yes 
P62913 RL11_HUMAN 60S ribosomal protein L11  0.018074 0 -1.9698 No 
Q07960 RHG01_HUMAN Rho GTPase-activating protein 1  0.025769 0 -1.97224 No 
P42766 RL35_HUMAN 60S ribosomal protein L35  0.006697 0 -1.98016 Yes 
Q15121 PEA15_HUMAN Astrocytic phosphoprotein PEA-
15  
0.002919 0 -2.04093 Yes 
Q07020 RL18_HUMAN 60S ribosomal protein L18  0.033874 0 -2.05112 No 
Q9C005 DPY30_HUMAN Protein dpy-30 homolog  0.011988 0 -2.06845 Yes 
P63261 ACTG_HUMAN Actin, cytoplasmic 2  0.015889 0 -2.10928 Yes 
P62266 RS23_HUMAN 40S ribosomal protein S23  0.019676 0 -2.12442 No 
P04792 HSPB1_HUMAN Heat shock protein beta-1  0.004511 0 -2.13719 Yes 
P09493 TPM1_HUMAN Tropomyosin alpha-1 chain  0.001922 0 -2.28312 Yes 





release factor  
P26373 RL13_HUMAN 60S ribosomal protein L13  0.005806 0 -2.30247 No 
P39019 RS19_HUMAN 40S ribosomal protein S19  0.004364 0 -2.3049 Yes 
O60869 EDF1_HUMAN Endothelial differentiation-
related factor 1  
0.023983 0 -2.32426 Yes 
Q8IZ52 CHSS2_HUMAN Chondroitin sulfate synthase 2  0.004349 0 -2.32674 Yes 
P24534 EF1B_HUMAN Elongation factor 1-beta  0.003253 0 -2.3382 Yes 
P62899 RL31_HUMAN 60S ribosomal protein L31  0.015291 0 -2.37841 No 
P13521 SCG2_HUMAN Secretogranin-2  0.020326 0 -2.38983 Yes 
P09496 CLCA_HUMAN Clathrin light chain A  0.007042 0 -2.40165 Yes 
Q15942 ZYX_HUMAN Zyxin  0.000604 0 -2.41406 Yes 
P08670 VIME_HUMAN Vimentin  0.00306 0 -2.42918 Yes 
P46776 RL27A_HUMAN 60S ribosomal protein L27a  0.008284 0 -2.47581 Yes 
Q15233 NONO_HUMAN Non-POU domain-containing 
octamer-binding protein  
0.003396 0 -2.54724 No 
Q15102 PA1B3_HUMAN Platelet-activating factor 
acetylhydrolase IB subunit 
gamma  
0.03026 0 -2.54927 No 
P63220 RS21_HUMAN 40S ribosomal protein S21  0.003423 0 -2.64639 Yes 
Q02878 RL6_HUMAN 60S ribosomal protein L6  0.002151 0 -2.65525 No 
P18124 RL7_HUMAN 60S ribosomal protein L7  0.004936 0 -2.73801 No 
O14737 PDCD5_HUMAN Programmed cell death protein 
5  
0.008235 0 -2.83988 Yes 
P06703 S10A6_HUMAN Protein S100-A6  0.032342 0 -2.85647 Yes 
P83731 RL24_HUMAN 60S ribosomal protein L24  0.000666 0 -2.97196 Yes 
O95084 PRS23_HUMAN Serine protease 23  0.00026 0 -3.02317 Yes 
P61313 RL15_HUMAN 60S ribosomal protein L15  0.021332 0 -3.09594 No 
Q09666 AHNK_HUMAN Neuroblast differentiation-
associated protein AHNAK  
0.00081 0 -3.15672 No 
P98179 RBM3_HUMAN Putative RNA-binding protein 3  0.004183 0 -3.17134 Yes 
P16949 STMN1_HUMAN Stathmin  0.000838 0 -3.27402 Yes 
P50281 MMP14_HUMAN Matrix metalloproteinase-14  0.003786 0 -3.60015 No 
P08621 RU17_HUMAN U1 small nuclear 
ribonucleoprotein 70 kDa  
0.000379 0 -3.67991 No 
P51991 ROA3_HUMAN Heterogeneous nuclear 
ribonucleoprotein A3  
0.000101 0 -3.68613 No 
Q96L21 RL10L_HUMAN 60S ribosomal protein L10-like  0.001621 0 -3.76404 Yes 
P40429 RL13A_HUMAN 60S ribosomal protein L13a  0.016176 0 -3.83481 Yes 
O75787 RENR_HUMAN Renin receptor  0.015457 0 -3.8551 Yes 
P62241 RS8_HUMAN 40S ribosomal protein S8  0.011054 0 -3.8942 No 
P82979 SARNP_HUMAN SAP domain-containing 
ribonucleoprotein  
0.000827 0 -4.25378 No 
Q13443 ADAM9_HUMAN Disintegrin and 
metalloproteinase domain-
containing protein 9  
0.001098 0 -5.16985 Yes 
O95450 ATS2_HUMAN A disintegrin and 
metalloproteinase with 
thrombospondin motifs 2  
0.001968 0 -5.24947 Yes 
 
